Group ID|Group Name|Treatment Sequence|Treatment Age|Treatment Type|Treatment Quantity|Treatment Unit|Treatment Application|Treatment Remarks|No of individuals in study|Species|Strain|Sex|Age|Group Endpoints|Individual ID|Group ID|Age at death|Pathology type |Pathology location|Pathology Description|
2-3-1|Rn-To+1d-WL 40,23-9 1/77|1| 77|Rn-222 gas|40|working level months|Inhalation| Inhaled over 1 m at 120 WL|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-1-1|1|194|Other deterministic changes|Lower respiratory system|n/a|
2-3-1|Rn-To+1d-WL 40,23-9 1/77|1| 77|Rn-222 gas|40|working level months|Inhalation| Inhaled over 1 m at 120 WL|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-1-2|1|370|Other deterministic changes|Lower respiratory system|n/a|
2-3-1|Rn-To+1d-WL 40,23-9 1/77|1| 77|Rn-222 gas|40|working level months|Inhalation| Inhaled over 1 m at 120 WL|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-1-3|1|427|Other deterministic changes|Lower respiratory system|n/a|
2-3-1|Rn-To+1d-WL 40,23-9 1/77|1| 77|Rn-222 gas|40|working level months|Inhalation| Inhaled over 1 m at 120 WL|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-1-4|1|448|Other deterministic changes|Whole body|n/a|
2-3-1|Rn-To+1d-WL 40,23-9 1/77|1| 77|Rn-222 gas|40|working level months|Inhalation| Inhaled over 1 m at 120 WL|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-1-5|1|472|Hyperplastic changes|Lower respiratory system|n/a|
2-3-1|Rn-To+1d-WL 40,23-9 1/77|1| 77|Rn-222 gas|40|working level months|Inhalation| Inhaled over 1 m at 120 WL|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-1-6|1|613|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-3-1|Rn-To+1d-WL 40,23-9 1/77|1| 77|Rn-222 gas|40|working level months|Inhalation| Inhaled over 1 m at 120 WL|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-1-7|1|621|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-3-1|Rn-To+1d-WL 40,23-9 1/77|1| 77|Rn-222 gas|40|working level months|Inhalation| Inhaled over 1 m at 120 WL|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-1-8|1|636|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-3-1|Rn-To+1d-WL 40,23-9 1/77|1| 77|Rn-222 gas|40|working level months|Inhalation| Inhaled over 1 m at 120 WL|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-1-9|1|675|Other deterministic changes|Whole body|n/a|
2-3-1|Rn-To+1d-WL 40,23-9 1/77|1| 77|Rn-222 gas|40|working level months|Inhalation| Inhaled over 1 m at 120 WL|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-1-10|1|685|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-3-1|Rn-To+1d-WL 40,23-9 1/77|1| 77|Rn-222 gas|40|working level months|Inhalation| Inhaled over 1 m at 120 WL|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-1-11|1|759|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-3-1|Rn-To+1d-WL 40,23-9 1/77|1| 77|Rn-222 gas|40|working level months|Inhalation| Inhaled over 1 m at 120 WL|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-1-12|1|778|Other deterministic changes|Lower respiratory system|n/a|
2-3-1|Rn-To+1d-WL 40,23-9 1/77|1| 77|Rn-222 gas|40|working level months|Inhalation| Inhaled over 1 m at 120 WL|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-1-13|1|794|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-3-1|Rn-To+1d-WL 40,23-9 1/77|1| 77|Rn-222 gas|40|working level months|Inhalation| Inhaled over 1 m at 120 WL|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-1-14|1|798|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-3-1|Rn-To+1d-WL 40,23-9 1/77|1| 77|Rn-222 gas|40|working level months|Inhalation| Inhaled over 1 m at 120 WL|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-1-15|1|821|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-3-1|Rn-To+1d-WL 40,23-9 1/77|1| 77|Rn-222 gas|40|working level months|Inhalation| Inhaled over 1 m at 120 WL|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-1-16|1|822|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-3-1|Rn-To+1d-WL 40,23-9 1/77|1| 77|Rn-222 gas|40|working level months|Inhalation| Inhaled over 1 m at 120 WL|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-1-17|1|829|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-3-1|Rn-To+1d-WL 40,23-9 1/77|1| 77|Rn-222 gas|40|working level months|Inhalation| Inhaled over 1 m at 120 WL|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-1-18|1|853|Neoplasia malignant|Lower respiratory system|n/a|
2-3-1|Rn-To+1d-WL 40,23-9 1/77|1| 77|Rn-222 gas|40|working level months|Inhalation| Inhaled over 1 m at 120 WL|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-1-19|1|860|Other deterministic changes|Whole body|n/a|
2-3-1|Rn-To+1d-WL 40,23-9 1/77|1| 77|Rn-222 gas|40|working level months|Inhalation| Inhaled over 1 m at 120 WL|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-1-20|1|862|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-3-1|Rn-To+1d-WL 40,23-9 1/77|1| 77|Rn-222 gas|40|working level months|Inhalation| Inhaled over 1 m at 120 WL|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-1-21|1|862|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-3-1|Rn-To+1d-WL 40,23-9 1/77|1| 77|Rn-222 gas|40|working level months|Inhalation| Inhaled over 1 m at 120 WL|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-1-22|1|863|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-3-1|Rn-To+1d-WL 40,23-9 1/77|1| 77|Rn-222 gas|40|working level months|Inhalation| Inhaled over 1 m at 120 WL|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-1-23|1|874|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-3-1|Rn-To+1d-WL 40,23-9 1/77|1| 77|Rn-222 gas|40|working level months|Inhalation| Inhaled over 1 m at 120 WL|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-1-24|1|896|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-3-1|Rn-To+1d-WL 40,23-9 1/77|1| 77|Rn-222 gas|40|working level months|Inhalation| Inhaled over 1 m at 120 WL|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-1-25|1|898|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-3-1|Rn-To+1d-WL 40,23-9 1/77|1| 77|Rn-222 gas|40|working level months|Inhalation| Inhaled over 1 m at 120 WL|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-1-26|1|898|Hyperplastic changes|Lower respiratory system|n/a|
2-3-1|Rn-To+1d-WL 40,23-9 1/77|1| 77|Rn-222 gas|40|working level months|Inhalation| Inhaled over 1 m at 120 WL|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-1-27|1|898|Hyperplastic changes|Lower respiratory system|n/a|
2-3-1|Rn-To+1d-WL 40,23-9 1/77|1| 77|Rn-222 gas|40|working level months|Inhalation| Inhaled over 1 m at 120 WL|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-1-28|1|898|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-3-1|Rn-To+1d-WL 40,23-9 1/77|1| 77|Rn-222 gas|40|working level months|Inhalation| Inhaled over 1 m at 120 WL|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-1-29|1|898|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-3-1|Rn-To+1d-WL 40,23-9 1/77|1| 77|Rn-222 gas|40|working level months|Inhalation| Inhaled over 1 m at 120 WL|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-1-30|1|898|Hyperplastic changes|Lower respiratory system|n/a|
2-3-1|Rn-To+1d-WL 40,23-9 1/77|2| 78|tobacco smoke||unit code not relevant|Inhalation| inhal. for 350 h|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-1-1|1|194|Other deterministic changes|Lower respiratory system|n/a|
2-3-1|Rn-To+1d-WL 40,23-9 1/77|2| 78|tobacco smoke||unit code not relevant|Inhalation| inhal. for 350 h|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-1-2|1|370|Other deterministic changes|Lower respiratory system|n/a|
2-3-1|Rn-To+1d-WL 40,23-9 1/77|2| 78|tobacco smoke||unit code not relevant|Inhalation| inhal. for 350 h|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-1-3|1|427|Other deterministic changes|Lower respiratory system|n/a|
2-3-1|Rn-To+1d-WL 40,23-9 1/77|2| 78|tobacco smoke||unit code not relevant|Inhalation| inhal. for 350 h|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-1-4|1|448|Other deterministic changes|Whole body|n/a|
2-3-1|Rn-To+1d-WL 40,23-9 1/77|2| 78|tobacco smoke||unit code not relevant|Inhalation| inhal. for 350 h|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-1-5|1|472|Hyperplastic changes|Lower respiratory system|n/a|
2-3-1|Rn-To+1d-WL 40,23-9 1/77|2| 78|tobacco smoke||unit code not relevant|Inhalation| inhal. for 350 h|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-1-6|1|613|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-3-1|Rn-To+1d-WL 40,23-9 1/77|2| 78|tobacco smoke||unit code not relevant|Inhalation| inhal. for 350 h|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-1-7|1|621|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-3-1|Rn-To+1d-WL 40,23-9 1/77|2| 78|tobacco smoke||unit code not relevant|Inhalation| inhal. for 350 h|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-1-8|1|636|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-3-1|Rn-To+1d-WL 40,23-9 1/77|2| 78|tobacco smoke||unit code not relevant|Inhalation| inhal. for 350 h|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-1-9|1|675|Other deterministic changes|Whole body|n/a|
2-3-1|Rn-To+1d-WL 40,23-9 1/77|2| 78|tobacco smoke||unit code not relevant|Inhalation| inhal. for 350 h|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-1-10|1|685|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-3-1|Rn-To+1d-WL 40,23-9 1/77|2| 78|tobacco smoke||unit code not relevant|Inhalation| inhal. for 350 h|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-1-11|1|759|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-3-1|Rn-To+1d-WL 40,23-9 1/77|2| 78|tobacco smoke||unit code not relevant|Inhalation| inhal. for 350 h|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-1-12|1|778|Other deterministic changes|Lower respiratory system|n/a|
2-3-1|Rn-To+1d-WL 40,23-9 1/77|2| 78|tobacco smoke||unit code not relevant|Inhalation| inhal. for 350 h|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-1-13|1|794|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-3-1|Rn-To+1d-WL 40,23-9 1/77|2| 78|tobacco smoke||unit code not relevant|Inhalation| inhal. for 350 h|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-1-14|1|798|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-3-1|Rn-To+1d-WL 40,23-9 1/77|2| 78|tobacco smoke||unit code not relevant|Inhalation| inhal. for 350 h|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-1-15|1|821|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-3-1|Rn-To+1d-WL 40,23-9 1/77|2| 78|tobacco smoke||unit code not relevant|Inhalation| inhal. for 350 h|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-1-16|1|822|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-3-1|Rn-To+1d-WL 40,23-9 1/77|2| 78|tobacco smoke||unit code not relevant|Inhalation| inhal. for 350 h|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-1-17|1|829|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-3-1|Rn-To+1d-WL 40,23-9 1/77|2| 78|tobacco smoke||unit code not relevant|Inhalation| inhal. for 350 h|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-1-18|1|853|Neoplasia malignant|Lower respiratory system|n/a|
2-3-1|Rn-To+1d-WL 40,23-9 1/77|2| 78|tobacco smoke||unit code not relevant|Inhalation| inhal. for 350 h|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-1-19|1|860|Other deterministic changes|Whole body|n/a|
2-3-1|Rn-To+1d-WL 40,23-9 1/77|2| 78|tobacco smoke||unit code not relevant|Inhalation| inhal. for 350 h|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-1-20|1|862|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-3-1|Rn-To+1d-WL 40,23-9 1/77|2| 78|tobacco smoke||unit code not relevant|Inhalation| inhal. for 350 h|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-1-21|1|862|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-3-1|Rn-To+1d-WL 40,23-9 1/77|2| 78|tobacco smoke||unit code not relevant|Inhalation| inhal. for 350 h|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-1-22|1|863|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-3-1|Rn-To+1d-WL 40,23-9 1/77|2| 78|tobacco smoke||unit code not relevant|Inhalation| inhal. for 350 h|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-1-23|1|874|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-3-1|Rn-To+1d-WL 40,23-9 1/77|2| 78|tobacco smoke||unit code not relevant|Inhalation| inhal. for 350 h|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-1-24|1|896|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-3-1|Rn-To+1d-WL 40,23-9 1/77|2| 78|tobacco smoke||unit code not relevant|Inhalation| inhal. for 350 h|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-1-25|1|898|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-3-1|Rn-To+1d-WL 40,23-9 1/77|2| 78|tobacco smoke||unit code not relevant|Inhalation| inhal. for 350 h|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-1-26|1|898|Hyperplastic changes|Lower respiratory system|n/a|
2-3-1|Rn-To+1d-WL 40,23-9 1/77|2| 78|tobacco smoke||unit code not relevant|Inhalation| inhal. for 350 h|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-1-27|1|898|Hyperplastic changes|Lower respiratory system|n/a|
2-3-1|Rn-To+1d-WL 40,23-9 1/77|2| 78|tobacco smoke||unit code not relevant|Inhalation| inhal. for 350 h|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-1-28|1|898|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-3-1|Rn-To+1d-WL 40,23-9 1/77|2| 78|tobacco smoke||unit code not relevant|Inhalation| inhal. for 350 h|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-1-29|1|898|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-3-1|Rn-To+1d-WL 40,23-9 1/77|2| 78|tobacco smoke||unit code not relevant|Inhalation| inhal. for 350 h|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-1-30|1|898|Hyperplastic changes|Lower respiratory system|n/a|
2-3-2|Rn-To+1d-WL 145,5-2-2 5/72|1| 91|Rn-222 gas|145|working level months|Inhalation| Inhaled over 2 m at 500 WL|14 (14 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice 
|2-3-2-1|2|462|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-3-2|Rn-To+1d-WL 145,5-2-2 5/72|1| 91|Rn-222 gas|145|working level months|Inhalation| Inhaled over 2 m at 500 WL|14 (14 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-3-2-2|2|462|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-3-2|Rn-To+1d-WL 145,5-2-2 5/72|1| 91|Rn-222 gas|145|working level months|Inhalation| Inhaled over 2 m at 500 WL|14 (14 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-3-2-3|2|462|Other deterministic changes|Whole body|n/a|
2-3-2|Rn-To+1d-WL 145,5-2-2 5/72|1| 91|Rn-222 gas|145|working level months|Inhalation| Inhaled over 2 m at 500 WL|14 (14 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-3-2-4|2|462|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-3-2|Rn-To+1d-WL 145,5-2-2 5/72|1| 91|Rn-222 gas|145|working level months|Inhalation| Inhaled over 2 m at 500 WL|14 (14 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-3-2-5|2|462|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-3-2|Rn-To+1d-WL 145,5-2-2 5/72|1| 91|Rn-222 gas|145|working level months|Inhalation| Inhaled over 2 m at 500 WL|14 (14 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-3-2-6|2|462|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-3-2|Rn-To+1d-WL 145,5-2-2 5/72|1| 91|Rn-222 gas|145|working level months|Inhalation| Inhaled over 2 m at 500 WL|14 (14 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-3-2-7|2|462|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-3-2|Rn-To+1d-WL 145,5-2-2 5/72|1| 91|Rn-222 gas|145|working level months|Inhalation| Inhaled over 2 m at 500 WL|14 (14 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-3-2-8|2|462|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-3-2|Rn-To+1d-WL 145,5-2-2 5/72|1| 91|Rn-222 gas|145|working level months|Inhalation| Inhaled over 2 m at 500 WL|14 (14 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-3-2-9|2|567|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-3-2|Rn-To+1d-WL 145,5-2-2 5/72|1| 91|Rn-222 gas|145|working level months|Inhalation| Inhaled over 2 m at 500 WL|14 (14 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-3-2-10|2|567|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-3-2|Rn-To+1d-WL 145,5-2-2 5/72|1| 91|Rn-222 gas|145|working level months|Inhalation| Inhaled over 2 m at 500 WL|14 (14 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-3-2-11|2|567|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-3-2|Rn-To+1d-WL 145,5-2-2 5/72|1| 91|Rn-222 gas|145|working level months|Inhalation| Inhaled over 2 m at 500 WL|14 (14 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-3-2-12|2|567|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-3-2|Rn-To+1d-WL 145,5-2-2 5/72|1| 91|Rn-222 gas|145|working level months|Inhalation| Inhaled over 2 m at 500 WL|14 (14 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-3-2-13|2|567|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-3-2|Rn-To+1d-WL 145,5-2-2 5/72|1| 91|Rn-222 gas|145|working level months|Inhalation| Inhaled over 2 m at 500 WL|14 (14 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-3-2-14|2|788|Other deterministic changes|Whole body|n/a|
2-3-2|Rn-To+1d-WL 145,5-2-2 5/72|2| 92|tobacco smoke||unit code not relevant|Inhalation| inhal for 300 h|14 (14 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-3-2-1|2|462|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-3-2|Rn-To+1d-WL 145,5-2-2 5/72|2| 92|tobacco smoke||unit code not relevant|Inhalation| inhal for 300 h|14 (14 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-3-2-2|2|462|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-3-2|Rn-To+1d-WL 145,5-2-2 5/72|2| 92|tobacco smoke||unit code not relevant|Inhalation| inhal for 300 h|14 (14 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-3-2-3|2|462|Other deterministic changes|Whole body|n/a|
2-3-2|Rn-To+1d-WL 145,5-2-2 5/72|2| 92|tobacco smoke||unit code not relevant|Inhalation| inhal for 300 h|14 (14 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-3-2-4|2|462|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-3-2|Rn-To+1d-WL 145,5-2-2 5/72|2| 92|tobacco smoke||unit code not relevant|Inhalation| inhal for 300 h|14 (14 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-3-2-5|2|462|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-3-2|Rn-To+1d-WL 145,5-2-2 5/72|2| 92|tobacco smoke||unit code not relevant|Inhalation| inhal for 300 h|14 (14 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-3-2-6|2|462|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-3-2|Rn-To+1d-WL 145,5-2-2 5/72|2| 92|tobacco smoke||unit code not relevant|Inhalation| inhal for 300 h|14 (14 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-3-2-7|2|462|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-3-2|Rn-To+1d-WL 145,5-2-2 5/72|2| 92|tobacco smoke||unit code not relevant|Inhalation| inhal for 300 h|14 (14 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-3-2-8|2|462|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-3-2|Rn-To+1d-WL 145,5-2-2 5/72|2| 92|tobacco smoke||unit code not relevant|Inhalation| inhal for 300 h|14 (14 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-3-2-9|2|567|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-3-2|Rn-To+1d-WL 145,5-2-2 5/72|2| 92|tobacco smoke||unit code not relevant|Inhalation| inhal for 300 h|14 (14 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-3-2-10|2|567|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-3-2|Rn-To+1d-WL 145,5-2-2 5/72|2| 92|tobacco smoke||unit code not relevant|Inhalation| inhal for 300 h|14 (14 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-3-2-11|2|567|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-3-2|Rn-To+1d-WL 145,5-2-2 5/72|2| 92|tobacco smoke||unit code not relevant|Inhalation| inhal for 300 h|14 (14 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-3-2-12|2|567|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-3-2|Rn-To+1d-WL 145,5-2-2 5/72|2| 92|tobacco smoke||unit code not relevant|Inhalation| inhal for 300 h|14 (14 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-3-2-13|2|567|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-3-2|Rn-To+1d-WL 145,5-2-2 5/72|2| 92|tobacco smoke||unit code not relevant|Inhalation| inhal for 300 h|14 (14 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-3-2-14|2|788|Other deterministic changes|Whole body|n/a|
2-3-3|Rn-To+1d-WL 200,24-9 1/77|1| 77|Rn-222 gas|200|working level months|Inhalation| Inhaled over 0.5 m at 800 WL|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-3-1|3|416|Hyperplastic changes|Lower respiratory system|n/a|
2-3-3|Rn-To+1d-WL 200,24-9 1/77|1| 77|Rn-222 gas|200|working level months|Inhalation| Inhaled over 0.5 m at 800 WL|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-3-2|3|587|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
2-3-3|Rn-To+1d-WL 200,24-9 1/77|1| 77|Rn-222 gas|200|working level months|Inhalation| Inhaled over 0.5 m at 800 WL|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-3-3|3|615|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-3-3|Rn-To+1d-WL 200,24-9 1/77|1| 77|Rn-222 gas|200|working level months|Inhalation| Inhaled over 0.5 m at 800 WL|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-3-4|3|667|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-3-3|Rn-To+1d-WL 200,24-9 1/77|1| 77|Rn-222 gas|200|working level months|Inhalation| Inhaled over 0.5 m at 800 WL|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-3-5|3|671|Other deterministic changes|Lower respiratory system|n/a|
2-3-3|Rn-To+1d-WL 200,24-9 1/77|1| 77|Rn-222 gas|200|working level months|Inhalation| Inhaled over 0.5 m at 800 WL|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-3-6|3|689|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-3-3|Rn-To+1d-WL 200,24-9 1/77|1| 77|Rn-222 gas|200|working level months|Inhalation| Inhaled over 0.5 m at 800 WL|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-3-7|3|706|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-3|Rn-To+1d-WL 200,24-9 1/77|1| 77|Rn-222 gas|200|working level months|Inhalation| Inhaled over 0.5 m at 800 WL|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-3-8|3|706|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-3-3|Rn-To+1d-WL 200,24-9 1/77|1| 77|Rn-222 gas|200|working level months|Inhalation| Inhaled over 0.5 m at 800 WL|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-3-9|3|714|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-3-3|Rn-To+1d-WL 200,24-9 1/77|1| 77|Rn-222 gas|200|working level months|Inhalation| Inhaled over 0.5 m at 800 WL|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-3-10|3|715|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-3|Rn-To+1d-WL 200,24-9 1/77|1| 77|Rn-222 gas|200|working level months|Inhalation| Inhaled over 0.5 m at 800 WL|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-3-11|3|721|Hyperplastic changes|Lower respiratory system|n/a|
2-3-3|Rn-To+1d-WL 200,24-9 1/77|1| 77|Rn-222 gas|200|working level months|Inhalation| Inhaled over 0.5 m at 800 WL|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-3-12|3|741|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-3-3|Rn-To+1d-WL 200,24-9 1/77|1| 77|Rn-222 gas|200|working level months|Inhalation| Inhaled over 0.5 m at 800 WL|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-3-13|3|751|Neoplasia benign|Lower respiratory system,MA: 0000436 - bronchus|,MPATH: 270 - adenoma|
2-3-3|Rn-To+1d-WL 200,24-9 1/77|1| 77|Rn-222 gas|200|working level months|Inhalation| Inhaled over 0.5 m at 800 WL|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-3-14|3|752|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-3-3|Rn-To+1d-WL 200,24-9 1/77|1| 77|Rn-222 gas|200|working level months|Inhalation| Inhaled over 0.5 m at 800 WL|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-3-15|3|762|Neoplasia malignant|Lower respiratory system|n/a|
2-3-3|Rn-To+1d-WL 200,24-9 1/77|1| 77|Rn-222 gas|200|working level months|Inhalation| Inhaled over 0.5 m at 800 WL|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-3-16|3|770|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-3-3|Rn-To+1d-WL 200,24-9 1/77|1| 77|Rn-222 gas|200|working level months|Inhalation| Inhaled over 0.5 m at 800 WL|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-3-17|3|784|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-3-3|Rn-To+1d-WL 200,24-9 1/77|1| 77|Rn-222 gas|200|working level months|Inhalation| Inhaled over 0.5 m at 800 WL|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-3-18|3|797|Neoplasia malignant|Lower respiratory system|n/a|
2-3-3|Rn-To+1d-WL 200,24-9 1/77|1| 77|Rn-222 gas|200|working level months|Inhalation| Inhaled over 0.5 m at 800 WL|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-3-19|3|800|Hyperplastic changes|Lower respiratory system|n/a|
2-3-3|Rn-To+1d-WL 200,24-9 1/77|1| 77|Rn-222 gas|200|working level months|Inhalation| Inhaled over 0.5 m at 800 WL|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-3-20|3|808|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-3-3|Rn-To+1d-WL 200,24-9 1/77|1| 77|Rn-222 gas|200|working level months|Inhalation| Inhaled over 0.5 m at 800 WL|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-3-21|3|811|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-3|Rn-To+1d-WL 200,24-9 1/77|1| 77|Rn-222 gas|200|working level months|Inhalation| Inhaled over 0.5 m at 800 WL|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-3-22|3|832|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-3-3|Rn-To+1d-WL 200,24-9 1/77|1| 77|Rn-222 gas|200|working level months|Inhalation| Inhaled over 0.5 m at 800 WL|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-3-23|3|833|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-3|Rn-To+1d-WL 200,24-9 1/77|1| 77|Rn-222 gas|200|working level months|Inhalation| Inhaled over 0.5 m at 800 WL|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-3-24|3|841|Hyperplastic changes|Lower respiratory system|n/a|
2-3-3|Rn-To+1d-WL 200,24-9 1/77|1| 77|Rn-222 gas|200|working level months|Inhalation| Inhaled over 0.5 m at 800 WL|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-3-25|3|846|Hyperplastic changes|Lower respiratory system|n/a|
2-3-3|Rn-To+1d-WL 200,24-9 1/77|1| 77|Rn-222 gas|200|working level months|Inhalation| Inhaled over 0.5 m at 800 WL|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-3-26|3|849|Neoplasia malignant|Lower respiratory system|n/a|
2-3-3|Rn-To+1d-WL 200,24-9 1/77|1| 77|Rn-222 gas|200|working level months|Inhalation| Inhaled over 0.5 m at 800 WL|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-3-27|3|870|Hyperplastic changes|Lower respiratory system|n/a|
2-3-3|Rn-To+1d-WL 200,24-9 1/77|1| 77|Rn-222 gas|200|working level months|Inhalation| Inhaled over 0.5 m at 800 WL|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-3-28|3|888|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-3-3|Rn-To+1d-WL 200,24-9 1/77|1| 77|Rn-222 gas|200|working level months|Inhalation| Inhaled over 0.5 m at 800 WL|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-3-29|3|891|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-3-3|Rn-To+1d-WL 200,24-9 1/77|1| 77|Rn-222 gas|200|working level months|Inhalation| Inhaled over 0.5 m at 800 WL|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-3-30|3|891|Hyperplastic changes|Lower respiratory system|n/a|
2-3-3|Rn-To+1d-WL 200,24-9 1/77|2| 77|tobacco smoke||unit code not relevant|Inhalation| inhal. for 350 h|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-3-1|3|416|Hyperplastic changes|Lower respiratory system|n/a|
2-3-3|Rn-To+1d-WL 200,24-9 1/77|2| 77|tobacco smoke||unit code not relevant|Inhalation| inhal. for 350 h|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-3-2|3|587|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
2-3-3|Rn-To+1d-WL 200,24-9 1/77|2| 77|tobacco smoke||unit code not relevant|Inhalation| inhal. for 350 h|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-3-3|3|615|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-3-3|Rn-To+1d-WL 200,24-9 1/77|2| 77|tobacco smoke||unit code not relevant|Inhalation| inhal. for 350 h|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-3-4|3|667|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-3-3|Rn-To+1d-WL 200,24-9 1/77|2| 77|tobacco smoke||unit code not relevant|Inhalation| inhal. for 350 h|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-3-5|3|671|Other deterministic changes|Lower respiratory system|n/a|
2-3-3|Rn-To+1d-WL 200,24-9 1/77|2| 77|tobacco smoke||unit code not relevant|Inhalation| inhal. for 350 h|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-3-6|3|689|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-3-3|Rn-To+1d-WL 200,24-9 1/77|2| 77|tobacco smoke||unit code not relevant|Inhalation| inhal. for 350 h|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-3-7|3|706|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-3|Rn-To+1d-WL 200,24-9 1/77|2| 77|tobacco smoke||unit code not relevant|Inhalation| inhal. for 350 h|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-3-8|3|706|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-3-3|Rn-To+1d-WL 200,24-9 1/77|2| 77|tobacco smoke||unit code not relevant|Inhalation| inhal. for 350 h|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-3-9|3|714|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-3-3|Rn-To+1d-WL 200,24-9 1/77|2| 77|tobacco smoke||unit code not relevant|Inhalation| inhal. for 350 h|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-3-10|3|715|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-3|Rn-To+1d-WL 200,24-9 1/77|2| 77|tobacco smoke||unit code not relevant|Inhalation| inhal. for 350 h|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-3-11|3|721|Hyperplastic changes|Lower respiratory system|n/a|
2-3-3|Rn-To+1d-WL 200,24-9 1/77|2| 77|tobacco smoke||unit code not relevant|Inhalation| inhal. for 350 h|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-3-12|3|741|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-3-3|Rn-To+1d-WL 200,24-9 1/77|2| 77|tobacco smoke||unit code not relevant|Inhalation| inhal. for 350 h|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-3-13|3|751|Neoplasia benign|Lower respiratory system,MA: 0000436 - bronchus|,MPATH: 270 - adenoma|
2-3-3|Rn-To+1d-WL 200,24-9 1/77|2| 77|tobacco smoke||unit code not relevant|Inhalation| inhal. for 350 h|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-3-14|3|752|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-3-3|Rn-To+1d-WL 200,24-9 1/77|2| 77|tobacco smoke||unit code not relevant|Inhalation| inhal. for 350 h|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-3-15|3|762|Neoplasia malignant|Lower respiratory system|n/a|
2-3-3|Rn-To+1d-WL 200,24-9 1/77|2| 77|tobacco smoke||unit code not relevant|Inhalation| inhal. for 350 h|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-3-16|3|770|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-3-3|Rn-To+1d-WL 200,24-9 1/77|2| 77|tobacco smoke||unit code not relevant|Inhalation| inhal. for 350 h|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-3-17|3|784|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-3-3|Rn-To+1d-WL 200,24-9 1/77|2| 77|tobacco smoke||unit code not relevant|Inhalation| inhal. for 350 h|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-3-18|3|797|Neoplasia malignant|Lower respiratory system|n/a|
2-3-3|Rn-To+1d-WL 200,24-9 1/77|2| 77|tobacco smoke||unit code not relevant|Inhalation| inhal. for 350 h|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-3-19|3|800|Hyperplastic changes|Lower respiratory system|n/a|
2-3-3|Rn-To+1d-WL 200,24-9 1/77|2| 77|tobacco smoke||unit code not relevant|Inhalation| inhal. for 350 h|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-3-20|3|808|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-3-3|Rn-To+1d-WL 200,24-9 1/77|2| 77|tobacco smoke||unit code not relevant|Inhalation| inhal. for 350 h|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-3-21|3|811|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-3|Rn-To+1d-WL 200,24-9 1/77|2| 77|tobacco smoke||unit code not relevant|Inhalation| inhal. for 350 h|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-3-22|3|832|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-3-3|Rn-To+1d-WL 200,24-9 1/77|2| 77|tobacco smoke||unit code not relevant|Inhalation| inhal. for 350 h|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-3-23|3|833|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-3|Rn-To+1d-WL 200,24-9 1/77|2| 77|tobacco smoke||unit code not relevant|Inhalation| inhal. for 350 h|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-3-24|3|841|Hyperplastic changes|Lower respiratory system|n/a|
2-3-3|Rn-To+1d-WL 200,24-9 1/77|2| 77|tobacco smoke||unit code not relevant|Inhalation| inhal. for 350 h|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-3-25|3|846|Hyperplastic changes|Lower respiratory system|n/a|
2-3-3|Rn-To+1d-WL 200,24-9 1/77|2| 77|tobacco smoke||unit code not relevant|Inhalation| inhal. for 350 h|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-3-26|3|849|Neoplasia malignant|Lower respiratory system|n/a|
2-3-3|Rn-To+1d-WL 200,24-9 1/77|2| 77|tobacco smoke||unit code not relevant|Inhalation| inhal. for 350 h|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-3-27|3|870|Hyperplastic changes|Lower respiratory system|n/a|
2-3-3|Rn-To+1d-WL 200,24-9 1/77|2| 77|tobacco smoke||unit code not relevant|Inhalation| inhal. for 350 h|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-3-28|3|888|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-3-3|Rn-To+1d-WL 200,24-9 1/77|2| 77|tobacco smoke||unit code not relevant|Inhalation| inhal. for 350 h|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-3-29|3|891|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-3-3|Rn-To+1d-WL 200,24-9 1/77|2| 77|tobacco smoke||unit code not relevant|Inhalation| inhal. for 350 h|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-3-30|3|891|Hyperplastic changes|Lower respiratory system|n/a|
2-3-4|Rn-To+8d-WL 225,S54 G110/83|Sequence:1, Age:77,Type:Rn-222 gas,Quantity:225,Unit:working level months,Application:Inhalation, Remarks:Inhaled over 0.1 m at 3000 WL|45 (0 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|No information on individuals available for this study
2-3-4|Rn-To+8d-WL 225,S54 G110/83|Sequence:2, Age:85,Type:tobacco smoke,Quantity:,Unit:unit code not relevant,Application:not applicable or not supplied, Remarks:inhal. 3h/d 5d/w for 200 d|45 (0 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|No information on individuals available for this study
2-3-5|Rn-To-180d-WL 1600,39-1 10/79|1| 275|Rn-222 gas|1600|working level months|Inhalation| Inhaled over 1 m at 1200 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-5-1|5|26|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-5|Rn-To-180d-WL 1600,39-1 10/79|1| 275|Rn-222 gas|1600|working level months|Inhalation| Inhaled over 1 m at 1200 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-5-2|5|26|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 268 - adenocarcinoma|
2-3-5|Rn-To-180d-WL 1600,39-1 10/79|1| 275|Rn-222 gas|1600|working level months|Inhalation| Inhaled over 1 m at 1200 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-5-3|5|66|Other deterministic changes|Lower respiratory system|n/a|
2-3-5|Rn-To-180d-WL 1600,39-1 10/79|1| 275|Rn-222 gas|1600|working level months|Inhalation| Inhaled over 1 m at 1200 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-5-4|5|263|Other deterministic changes|Whole body|n/a|
2-3-5|Rn-To-180d-WL 1600,39-1 10/79|1| 275|Rn-222 gas|1600|working level months|Inhalation| Inhaled over 1 m at 1200 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-5-5|5|438|Other deterministic changes|Lower respiratory system|n/a|
2-3-5|Rn-To-180d-WL 1600,39-1 10/79|1| 275|Rn-222 gas|1600|working level months|Inhalation| Inhaled over 1 m at 1200 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-5-6|5|463|Other deterministic changes|Lower respiratory system|n/a|
2-3-5|Rn-To-180d-WL 1600,39-1 10/79|1| 275|Rn-222 gas|1600|working level months|Inhalation| Inhaled over 1 m at 1200 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-5-7|5|487|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-3-5|Rn-To-180d-WL 1600,39-1 10/79|1| 275|Rn-222 gas|1600|working level months|Inhalation| Inhaled over 1 m at 1200 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-5-8|5|533|Other deterministic changes|Lower respiratory system|n/a|
2-3-5|Rn-To-180d-WL 1600,39-1 10/79|1| 275|Rn-222 gas|1600|working level months|Inhalation| Inhaled over 1 m at 1200 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-5-9|5|565|Other deterministic changes|Lower respiratory system|n/a|
2-3-5|Rn-To-180d-WL 1600,39-1 10/79|1| 275|Rn-222 gas|1600|working level months|Inhalation| Inhaled over 1 m at 1200 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-5-10|5|606|Other deterministic changes|Lower respiratory system|n/a|
2-3-5|Rn-To-180d-WL 1600,39-1 10/79|1| 275|Rn-222 gas|1600|working level months|Inhalation| Inhaled over 1 m at 1200 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-5-11|5|613|Other deterministic changes|Lower respiratory system|n/a|
2-3-5|Rn-To-180d-WL 1600,39-1 10/79|1| 275|Rn-222 gas|1600|working level months|Inhalation| Inhaled over 1 m at 1200 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-5-12|5|623|Other deterministic changes|Lower respiratory system|n/a|
2-3-5|Rn-To-180d-WL 1600,39-1 10/79|1| 275|Rn-222 gas|1600|working level months|Inhalation| Inhaled over 1 m at 1200 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-5-13|5|624|Other deterministic changes|Lower respiratory system|n/a|
2-3-5|Rn-To-180d-WL 1600,39-1 10/79|1| 275|Rn-222 gas|1600|working level months|Inhalation| Inhaled over 1 m at 1200 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-5-14|5|628|Other deterministic changes|Lower respiratory system|n/a|
2-3-5|Rn-To-180d-WL 1600,39-1 10/79|1| 275|Rn-222 gas|1600|working level months|Inhalation| Inhaled over 1 m at 1200 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-5-15|5|629|Neoplasia malignant|Lower respiratory system,MA: 0000433 - pleura|,MPATH: 365 - mesothelioma|
2-3-5|Rn-To-180d-WL 1600,39-1 10/79|1| 275|Rn-222 gas|1600|working level months|Inhalation| Inhaled over 1 m at 1200 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-5-16|5|641|Other deterministic changes|Lower respiratory system|n/a|
2-3-5|Rn-To-180d-WL 1600,39-1 10/79|1| 275|Rn-222 gas|1600|working level months|Inhalation| Inhaled over 1 m at 1200 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-5-17|5|641|Other deterministic changes|Lower respiratory system|n/a|
2-3-5|Rn-To-180d-WL 1600,39-1 10/79|1| 275|Rn-222 gas|1600|working level months|Inhalation| Inhaled over 1 m at 1200 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-5-18|5|662|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-3-5|Rn-To-180d-WL 1600,39-1 10/79|1| 275|Rn-222 gas|1600|working level months|Inhalation| Inhaled over 1 m at 1200 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-5-19|5|670|Other deterministic changes|Lower respiratory system|n/a|
2-3-5|Rn-To-180d-WL 1600,39-1 10/79|1| 275|Rn-222 gas|1600|working level months|Inhalation| Inhaled over 1 m at 1200 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-5-20|5|688|Hyperplastic changes|Lower respiratory system|n/a|
2-3-5|Rn-To-180d-WL 1600,39-1 10/79|1| 275|Rn-222 gas|1600|working level months|Inhalation| Inhaled over 1 m at 1200 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-5-21|5|695|Preneoplastic changes|Lower respiratory system,MA: 0000422 - bronchiole|,MPATH: 171 - squamous metaplasia|
2-3-5|Rn-To-180d-WL 1600,39-1 10/79|1| 275|Rn-222 gas|1600|working level months|Inhalation| Inhaled over 1 m at 1200 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-5-22|5|721|Preneoplastic changes|Lower respiratory system,MA: 0000422 - bronchiole|,MPATH: 171 - squamous metaplasia|
2-3-5|Rn-To-180d-WL 1600,39-1 10/79|1| 275|Rn-222 gas|1600|working level months|Inhalation| Inhaled over 1 m at 1200 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-5-23|5|746|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-5|Rn-To-180d-WL 1600,39-1 10/79|1| 275|Rn-222 gas|1600|working level months|Inhalation| Inhaled over 1 m at 1200 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-5-24|5|749|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-3-5|Rn-To-180d-WL 1600,39-1 10/79|1| 275|Rn-222 gas|1600|working level months|Inhalation| Inhaled over 1 m at 1200 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-5-25|5|749|Other deterministic changes|Lower respiratory system|n/a|
2-3-5|Rn-To-180d-WL 1600,39-1 10/79|1| 275|Rn-222 gas|1600|working level months|Inhalation| Inhaled over 1 m at 1200 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-5-26|5|752|Other deterministic changes|Lower respiratory system|n/a|
2-3-5|Rn-To-180d-WL 1600,39-1 10/79|1| 275|Rn-222 gas|1600|working level months|Inhalation| Inhaled over 1 m at 1200 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-5-27|5|758|Hyperplastic changes|Lower respiratory system|n/a|
2-3-5|Rn-To-180d-WL 1600,39-1 10/79|1| 275|Rn-222 gas|1600|working level months|Inhalation| Inhaled over 1 m at 1200 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-5-28|5|766|Other deterministic changes|Lower respiratory system|n/a|
2-3-5|Rn-To-180d-WL 1600,39-1 10/79|1| 275|Rn-222 gas|1600|working level months|Inhalation| Inhaled over 1 m at 1200 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-5-29|5|766|Other deterministic changes|Lower respiratory system|n/a|
2-3-5|Rn-To-180d-WL 1600,39-1 10/79|1| 275|Rn-222 gas|1600|working level months|Inhalation| Inhaled over 1 m at 1200 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-5-30|5|774|Hyperplastic changes|Lower respiratory system|n/a|
2-3-5|Rn-To-180d-WL 1600,39-1 10/79|1| 275|Rn-222 gas|1600|working level months|Inhalation| Inhaled over 1 m at 1200 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-5-31|5|777|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
2-3-5|Rn-To-180d-WL 1600,39-1 10/79|1| 275|Rn-222 gas|1600|working level months|Inhalation| Inhaled over 1 m at 1200 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-5-32|5|780|Other deterministic changes|Lower respiratory system|n/a|
2-3-5|Rn-To-180d-WL 1600,39-1 10/79|1| 275|Rn-222 gas|1600|working level months|Inhalation| Inhaled over 1 m at 1200 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-5-33|5|781|Other deterministic changes|Lower respiratory system|n/a|
2-3-5|Rn-To-180d-WL 1600,39-1 10/79|1| 275|Rn-222 gas|1600|working level months|Inhalation| Inhaled over 1 m at 1200 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-5-34|5|781|Other deterministic changes|Lower respiratory system|n/a|
2-3-5|Rn-To-180d-WL 1600,39-1 10/79|1| 275|Rn-222 gas|1600|working level months|Inhalation| Inhaled over 1 m at 1200 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-5-35|5|781|Preneoplastic changes|Lower respiratory system,MA: 0000422 - bronchiole|,MPATH: 171 - squamous metaplasia|
2-3-5|Rn-To-180d-WL 1600,39-1 10/79|1| 275|Rn-222 gas|1600|working level months|Inhalation| Inhaled over 1 m at 1200 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-5-36|5|789|Preneoplastic changes|Lower respiratory system,MA: 0000422 - bronchiole|,MPATH: 171 - squamous metaplasia|
2-3-5|Rn-To-180d-WL 1600,39-1 10/79|1| 275|Rn-222 gas|1600|working level months|Inhalation| Inhaled over 1 m at 1200 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-5-37|5|790|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 408 - soft tissue fibrosarcoma|
2-3-5|Rn-To-180d-WL 1600,39-1 10/79|1| 275|Rn-222 gas|1600|working level months|Inhalation| Inhaled over 1 m at 1200 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-5-38|5|803|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 408 - soft tissue fibrosarcoma|
2-3-5|Rn-To-180d-WL 1600,39-1 10/79|1| 275|Rn-222 gas|1600|working level months|Inhalation| Inhaled over 1 m at 1200 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-5-39|5|808|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-3-5|Rn-To-180d-WL 1600,39-1 10/79|1| 275|Rn-222 gas|1600|working level months|Inhalation| Inhaled over 1 m at 1200 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-5-40|5|808|Other deterministic changes|Lower respiratory system|n/a|
2-3-5|Rn-To-180d-WL 1600,39-1 10/79|1| 275|Rn-222 gas|1600|working level months|Inhalation| Inhaled over 1 m at 1200 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-5-41|5|813|Hyperplastic changes|Lower respiratory system|n/a|
2-3-5|Rn-To-180d-WL 1600,39-1 10/79|1| 275|Rn-222 gas|1600|working level months|Inhalation| Inhaled over 1 m at 1200 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-5-42|5|834|Other deterministic changes|Lower respiratory system|n/a|
2-3-5|Rn-To-180d-WL 1600,39-1 10/79|1| 275|Rn-222 gas|1600|working level months|Inhalation| Inhaled over 1 m at 1200 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-5-43|5|837|Preneoplastic changes|Lower respiratory system,MA: 0000422 - bronchiole|,MPATH: 171 - squamous metaplasia|
2-3-5|Rn-To-180d-WL 1600,39-1 10/79|1| 275|Rn-222 gas|1600|working level months|Inhalation| Inhaled over 1 m at 1200 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-5-44|5|838|Preneoplastic changes|Lower respiratory system,MA: 0000422 - bronchiole|,MPATH: 171 - squamous metaplasia|
2-3-5|Rn-To-180d-WL 1600,39-1 10/79|1| 275|Rn-222 gas|1600|working level months|Inhalation| Inhaled over 1 m at 1200 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-5-45|5|845|Preneoplastic changes|Lower respiratory system,MA: 0000422 - bronchiole|,MPATH: 171 - squamous metaplasia|
2-3-5|Rn-To-180d-WL 1600,39-1 10/79|1| 275|Rn-222 gas|1600|working level months|Inhalation| Inhaled over 1 m at 1200 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-5-46|5|848|Other deterministic changes|Lower respiratory system|n/a|
2-3-5|Rn-To-180d-WL 1600,39-1 10/79|1| 275|Rn-222 gas|1600|working level months|Inhalation| Inhaled over 1 m at 1200 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-5-47|5|862|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-5|Rn-To-180d-WL 1600,39-1 10/79|1| 275|Rn-222 gas|1600|working level months|Inhalation| Inhaled over 1 m at 1200 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-5-48|5|900|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 268 - adenocarcinoma|
2-3-5|Rn-To-180d-WL 1600,39-1 10/79|1| 275|Rn-222 gas|1600|working level months|Inhalation| Inhaled over 1 m at 1200 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-5-49|5|900|Hyperplastic changes|Lower respiratory system|n/a|
2-3-5|Rn-To-180d-WL 1600,39-1 10/79|1| 275|Rn-222 gas|1600|working level months|Inhalation| Inhaled over 1 m at 1200 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-5-50|5|940|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 268 - adenocarcinoma|
2-3-5|Rn-To-180d-WL 1600,39-1 10/79|2| 95|tobacco smoke||unit code not relevant|Inhalation| inhal. for 300h over 6m|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-5-1|5|26|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-5|Rn-To-180d-WL 1600,39-1 10/79|2| 95|tobacco smoke||unit code not relevant|Inhalation| inhal. for 300h over 6m|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-5-2|5|26|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 268 - adenocarcinoma|
2-3-5|Rn-To-180d-WL 1600,39-1 10/79|2| 95|tobacco smoke||unit code not relevant|Inhalation| inhal. for 300h over 6m|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-5-3|5|66|Other deterministic changes|Lower respiratory system|n/a|
2-3-5|Rn-To-180d-WL 1600,39-1 10/79|2| 95|tobacco smoke||unit code not relevant|Inhalation| inhal. for 300h over 6m|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-5-4|5|263|Other deterministic changes|Whole body|n/a|
2-3-5|Rn-To-180d-WL 1600,39-1 10/79|2| 95|tobacco smoke||unit code not relevant|Inhalation| inhal. for 300h over 6m|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-5-5|5|438|Other deterministic changes|Lower respiratory system|n/a|
2-3-5|Rn-To-180d-WL 1600,39-1 10/79|2| 95|tobacco smoke||unit code not relevant|Inhalation| inhal. for 300h over 6m|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-5-6|5|463|Other deterministic changes|Lower respiratory system|n/a|
2-3-5|Rn-To-180d-WL 1600,39-1 10/79|2| 95|tobacco smoke||unit code not relevant|Inhalation| inhal. for 300h over 6m|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-5-7|5|487|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-3-5|Rn-To-180d-WL 1600,39-1 10/79|2| 95|tobacco smoke||unit code not relevant|Inhalation| inhal. for 300h over 6m|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-5-8|5|533|Other deterministic changes|Lower respiratory system|n/a|
2-3-5|Rn-To-180d-WL 1600,39-1 10/79|2| 95|tobacco smoke||unit code not relevant|Inhalation| inhal. for 300h over 6m|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-5-9|5|565|Other deterministic changes|Lower respiratory system|n/a|
2-3-5|Rn-To-180d-WL 1600,39-1 10/79|2| 95|tobacco smoke||unit code not relevant|Inhalation| inhal. for 300h over 6m|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-5-10|5|606|Other deterministic changes|Lower respiratory system|n/a|
2-3-5|Rn-To-180d-WL 1600,39-1 10/79|2| 95|tobacco smoke||unit code not relevant|Inhalation| inhal. for 300h over 6m|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-5-11|5|613|Other deterministic changes|Lower respiratory system|n/a|
2-3-5|Rn-To-180d-WL 1600,39-1 10/79|2| 95|tobacco smoke||unit code not relevant|Inhalation| inhal. for 300h over 6m|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-5-12|5|623|Other deterministic changes|Lower respiratory system|n/a|
2-3-5|Rn-To-180d-WL 1600,39-1 10/79|2| 95|tobacco smoke||unit code not relevant|Inhalation| inhal. for 300h over 6m|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-5-13|5|624|Other deterministic changes|Lower respiratory system|n/a|
2-3-5|Rn-To-180d-WL 1600,39-1 10/79|2| 95|tobacco smoke||unit code not relevant|Inhalation| inhal. for 300h over 6m|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-5-14|5|628|Other deterministic changes|Lower respiratory system|n/a|
2-3-5|Rn-To-180d-WL 1600,39-1 10/79|2| 95|tobacco smoke||unit code not relevant|Inhalation| inhal. for 300h over 6m|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-5-15|5|629|Neoplasia malignant|Lower respiratory system,MA: 0000433 - pleura|,MPATH: 365 - mesothelioma|
2-3-5|Rn-To-180d-WL 1600,39-1 10/79|2| 95|tobacco smoke||unit code not relevant|Inhalation| inhal. for 300h over 6m|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-5-16|5|641|Other deterministic changes|Lower respiratory system|n/a|
2-3-5|Rn-To-180d-WL 1600,39-1 10/79|2| 95|tobacco smoke||unit code not relevant|Inhalation| inhal. for 300h over 6m|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-5-17|5|641|Other deterministic changes|Lower respiratory system|n/a|
2-3-5|Rn-To-180d-WL 1600,39-1 10/79|2| 95|tobacco smoke||unit code not relevant|Inhalation| inhal. for 300h over 6m|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-5-18|5|662|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-3-5|Rn-To-180d-WL 1600,39-1 10/79|2| 95|tobacco smoke||unit code not relevant|Inhalation| inhal. for 300h over 6m|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-5-19|5|670|Other deterministic changes|Lower respiratory system|n/a|
2-3-5|Rn-To-180d-WL 1600,39-1 10/79|2| 95|tobacco smoke||unit code not relevant|Inhalation| inhal. for 300h over 6m|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-5-20|5|688|Hyperplastic changes|Lower respiratory system|n/a|
2-3-5|Rn-To-180d-WL 1600,39-1 10/79|2| 95|tobacco smoke||unit code not relevant|Inhalation| inhal. for 300h over 6m|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-5-21|5|695|Preneoplastic changes|Lower respiratory system,MA: 0000422 - bronchiole|,MPATH: 171 - squamous metaplasia|
2-3-5|Rn-To-180d-WL 1600,39-1 10/79|2| 95|tobacco smoke||unit code not relevant|Inhalation| inhal. for 300h over 6m|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-5-22|5|721|Preneoplastic changes|Lower respiratory system,MA: 0000422 - bronchiole|,MPATH: 171 - squamous metaplasia|
2-3-5|Rn-To-180d-WL 1600,39-1 10/79|2| 95|tobacco smoke||unit code not relevant|Inhalation| inhal. for 300h over 6m|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-5-23|5|746|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-5|Rn-To-180d-WL 1600,39-1 10/79|2| 95|tobacco smoke||unit code not relevant|Inhalation| inhal. for 300h over 6m|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-5-24|5|749|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-3-5|Rn-To-180d-WL 1600,39-1 10/79|2| 95|tobacco smoke||unit code not relevant|Inhalation| inhal. for 300h over 6m|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-5-25|5|749|Other deterministic changes|Lower respiratory system|n/a|
2-3-5|Rn-To-180d-WL 1600,39-1 10/79|2| 95|tobacco smoke||unit code not relevant|Inhalation| inhal. for 300h over 6m|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-5-26|5|752|Other deterministic changes|Lower respiratory system|n/a|
2-3-5|Rn-To-180d-WL 1600,39-1 10/79|2| 95|tobacco smoke||unit code not relevant|Inhalation| inhal. for 300h over 6m|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-5-27|5|758|Hyperplastic changes|Lower respiratory system|n/a|
2-3-5|Rn-To-180d-WL 1600,39-1 10/79|2| 95|tobacco smoke||unit code not relevant|Inhalation| inhal. for 300h over 6m|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-5-28|5|766|Other deterministic changes|Lower respiratory system|n/a|
2-3-5|Rn-To-180d-WL 1600,39-1 10/79|2| 95|tobacco smoke||unit code not relevant|Inhalation| inhal. for 300h over 6m|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-5-29|5|766|Other deterministic changes|Lower respiratory system|n/a|
2-3-5|Rn-To-180d-WL 1600,39-1 10/79|2| 95|tobacco smoke||unit code not relevant|Inhalation| inhal. for 300h over 6m|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-5-30|5|774|Hyperplastic changes|Lower respiratory system|n/a|
2-3-5|Rn-To-180d-WL 1600,39-1 10/79|2| 95|tobacco smoke||unit code not relevant|Inhalation| inhal. for 300h over 6m|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-5-31|5|777|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
2-3-5|Rn-To-180d-WL 1600,39-1 10/79|2| 95|tobacco smoke||unit code not relevant|Inhalation| inhal. for 300h over 6m|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-5-32|5|780|Other deterministic changes|Lower respiratory system|n/a|
2-3-5|Rn-To-180d-WL 1600,39-1 10/79|2| 95|tobacco smoke||unit code not relevant|Inhalation| inhal. for 300h over 6m|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-5-33|5|781|Other deterministic changes|Lower respiratory system|n/a|
2-3-5|Rn-To-180d-WL 1600,39-1 10/79|2| 95|tobacco smoke||unit code not relevant|Inhalation| inhal. for 300h over 6m|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-5-34|5|781|Other deterministic changes|Lower respiratory system|n/a|
2-3-5|Rn-To-180d-WL 1600,39-1 10/79|2| 95|tobacco smoke||unit code not relevant|Inhalation| inhal. for 300h over 6m|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-5-35|5|781|Preneoplastic changes|Lower respiratory system,MA: 0000422 - bronchiole|,MPATH: 171 - squamous metaplasia|
2-3-5|Rn-To-180d-WL 1600,39-1 10/79|2| 95|tobacco smoke||unit code not relevant|Inhalation| inhal. for 300h over 6m|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-5-36|5|789|Preneoplastic changes|Lower respiratory system,MA: 0000422 - bronchiole|,MPATH: 171 - squamous metaplasia|
2-3-5|Rn-To-180d-WL 1600,39-1 10/79|2| 95|tobacco smoke||unit code not relevant|Inhalation| inhal. for 300h over 6m|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-5-37|5|790|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 408 - soft tissue fibrosarcoma|
2-3-5|Rn-To-180d-WL 1600,39-1 10/79|2| 95|tobacco smoke||unit code not relevant|Inhalation| inhal. for 300h over 6m|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-5-38|5|803|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 408 - soft tissue fibrosarcoma|
2-3-5|Rn-To-180d-WL 1600,39-1 10/79|2| 95|tobacco smoke||unit code not relevant|Inhalation| inhal. for 300h over 6m|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-5-39|5|808|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-3-5|Rn-To-180d-WL 1600,39-1 10/79|2| 95|tobacco smoke||unit code not relevant|Inhalation| inhal. for 300h over 6m|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-5-40|5|808|Other deterministic changes|Lower respiratory system|n/a|
2-3-5|Rn-To-180d-WL 1600,39-1 10/79|2| 95|tobacco smoke||unit code not relevant|Inhalation| inhal. for 300h over 6m|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-5-41|5|813|Hyperplastic changes|Lower respiratory system|n/a|
2-3-5|Rn-To-180d-WL 1600,39-1 10/79|2| 95|tobacco smoke||unit code not relevant|Inhalation| inhal. for 300h over 6m|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-5-42|5|834|Other deterministic changes|Lower respiratory system|n/a|
2-3-5|Rn-To-180d-WL 1600,39-1 10/79|2| 95|tobacco smoke||unit code not relevant|Inhalation| inhal. for 300h over 6m|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-5-43|5|837|Preneoplastic changes|Lower respiratory system,MA: 0000422 - bronchiole|,MPATH: 171 - squamous metaplasia|
2-3-5|Rn-To-180d-WL 1600,39-1 10/79|2| 95|tobacco smoke||unit code not relevant|Inhalation| inhal. for 300h over 6m|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-5-44|5|838|Preneoplastic changes|Lower respiratory system,MA: 0000422 - bronchiole|,MPATH: 171 - squamous metaplasia|
2-3-5|Rn-To-180d-WL 1600,39-1 10/79|2| 95|tobacco smoke||unit code not relevant|Inhalation| inhal. for 300h over 6m|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-5-45|5|845|Preneoplastic changes|Lower respiratory system,MA: 0000422 - bronchiole|,MPATH: 171 - squamous metaplasia|
2-3-5|Rn-To-180d-WL 1600,39-1 10/79|2| 95|tobacco smoke||unit code not relevant|Inhalation| inhal. for 300h over 6m|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-5-46|5|848|Other deterministic changes|Lower respiratory system|n/a|
2-3-5|Rn-To-180d-WL 1600,39-1 10/79|2| 95|tobacco smoke||unit code not relevant|Inhalation| inhal. for 300h over 6m|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-5-47|5|862|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-5|Rn-To-180d-WL 1600,39-1 10/79|2| 95|tobacco smoke||unit code not relevant|Inhalation| inhal. for 300h over 6m|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-5-48|5|900|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 268 - adenocarcinoma|
2-3-5|Rn-To-180d-WL 1600,39-1 10/79|2| 95|tobacco smoke||unit code not relevant|Inhalation| inhal. for 300h over 6m|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-5-49|5|900|Hyperplastic changes|Lower respiratory system|n/a|
2-3-5|Rn-To-180d-WL 1600,39-1 10/79|2| 95|tobacco smoke||unit code not relevant|Inhalation| inhal. for 300h over 6m|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-5-50|5|940|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 268 - adenocarcinoma|
2-3-6|Rn-To+43d-WL 1600,39-2 10/79|1| 275|Rn-222 gas|1600|working level months|Inhalation| Inhaled over 1 m at 1200 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-6-1|6|395|Other deterministic changes|Lower respiratory system|n/a|
2-3-6|Rn-To+43d-WL 1600,39-2 10/79|1| 275|Rn-222 gas|1600|working level months|Inhalation| Inhaled over 1 m at 1200 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-6-2|6|395|Other deterministic changes|Lower respiratory system|n/a|
2-3-6|Rn-To+43d-WL 1600,39-2 10/79|1| 275|Rn-222 gas|1600|working level months|Inhalation| Inhaled over 1 m at 1200 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-6-3|6|395|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-3-6|Rn-To+43d-WL 1600,39-2 10/79|1| 275|Rn-222 gas|1600|working level months|Inhalation| Inhaled over 1 m at 1200 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-6-4|6|409|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-3-6|Rn-To+43d-WL 1600,39-2 10/79|1| 275|Rn-222 gas|1600|working level months|Inhalation| Inhaled over 1 m at 1200 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-6-5|6|420|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 268 - adenocarcinoma|
2-3-6|Rn-To+43d-WL 1600,39-2 10/79|1| 275|Rn-222 gas|1600|working level months|Inhalation| Inhaled over 1 m at 1200 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-6-6|6|423|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-3-6|Rn-To+43d-WL 1600,39-2 10/79|1| 275|Rn-222 gas|1600|working level months|Inhalation| Inhaled over 1 m at 1200 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-6-7|6|423|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-3-6|Rn-To+43d-WL 1600,39-2 10/79|1| 275|Rn-222 gas|1600|working level months|Inhalation| Inhaled over 1 m at 1200 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-6-8|6|454|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-6|Rn-To+43d-WL 1600,39-2 10/79|1| 275|Rn-222 gas|1600|working level months|Inhalation| Inhaled over 1 m at 1200 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-6-9|6|465|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-3-6|Rn-To+43d-WL 1600,39-2 10/79|1| 275|Rn-222 gas|1600|working level months|Inhalation| Inhaled over 1 m at 1200 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-6-10|6|516|Other deterministic changes|Lower respiratory system|n/a|
2-3-6|Rn-To+43d-WL 1600,39-2 10/79|1| 275|Rn-222 gas|1600|working level months|Inhalation| Inhaled over 1 m at 1200 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-6-11|6|537|Neoplasia malignant|Integumentary system,MA: 0000151 - skin|,MPATH: 446 - squamous cell carcinoma|
2-3-6|Rn-To+43d-WL 1600,39-2 10/79|1| 275|Rn-222 gas|1600|working level months|Inhalation| Inhaled over 1 m at 1200 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-6-12|6|559|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-6|Rn-To+43d-WL 1600,39-2 10/79|1| 275|Rn-222 gas|1600|working level months|Inhalation| Inhaled over 1 m at 1200 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-6-13|6|600|Other deterministic changes|Lower respiratory system|n/a|
2-3-6|Rn-To+43d-WL 1600,39-2 10/79|1| 275|Rn-222 gas|1600|working level months|Inhalation| Inhaled over 1 m at 1200 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-6-14|6|606|Other deterministic changes|Lower respiratory system|n/a|
2-3-6|Rn-To+43d-WL 1600,39-2 10/79|1| 275|Rn-222 gas|1600|working level months|Inhalation| Inhaled over 1 m at 1200 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-6-15|6|610|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-6|Rn-To+43d-WL 1600,39-2 10/79|1| 275|Rn-222 gas|1600|working level months|Inhalation| Inhaled over 1 m at 1200 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-6-16|6|613|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-6|Rn-To+43d-WL 1600,39-2 10/79|1| 275|Rn-222 gas|1600|working level months|Inhalation| Inhaled over 1 m at 1200 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-6-17|6|613|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-6|Rn-To+43d-WL 1600,39-2 10/79|1| 275|Rn-222 gas|1600|working level months|Inhalation| Inhaled over 1 m at 1200 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-6-18|6|630|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-6|Rn-To+43d-WL 1600,39-2 10/79|1| 275|Rn-222 gas|1600|working level months|Inhalation| Inhaled over 1 m at 1200 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-6-19|6|651|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-6|Rn-To+43d-WL 1600,39-2 10/79|1| 275|Rn-222 gas|1600|working level months|Inhalation| Inhaled over 1 m at 1200 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-6-20|6|658|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-6|Rn-To+43d-WL 1600,39-2 10/79|1| 275|Rn-222 gas|1600|working level months|Inhalation| Inhaled over 1 m at 1200 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-6-21|6|664|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-6|Rn-To+43d-WL 1600,39-2 10/79|1| 275|Rn-222 gas|1600|working level months|Inhalation| Inhaled over 1 m at 1200 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-6-22|6|664|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-6|Rn-To+43d-WL 1600,39-2 10/79|1| 275|Rn-222 gas|1600|working level months|Inhalation| Inhaled over 1 m at 1200 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-6-23|6|664|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-6|Rn-To+43d-WL 1600,39-2 10/79|1| 275|Rn-222 gas|1600|working level months|Inhalation| Inhaled over 1 m at 1200 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-6-24|6|665|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-6|Rn-To+43d-WL 1600,39-2 10/79|1| 275|Rn-222 gas|1600|working level months|Inhalation| Inhaled over 1 m at 1200 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-6-25|6|691|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-6|Rn-To+43d-WL 1600,39-2 10/79|1| 275|Rn-222 gas|1600|working level months|Inhalation| Inhaled over 1 m at 1200 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-6-26|6|691|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-6|Rn-To+43d-WL 1600,39-2 10/79|1| 275|Rn-222 gas|1600|working level months|Inhalation| Inhaled over 1 m at 1200 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-6-27|6|692|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-6|Rn-To+43d-WL 1600,39-2 10/79|1| 275|Rn-222 gas|1600|working level months|Inhalation| Inhaled over 1 m at 1200 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-6-28|6|716|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-6|Rn-To+43d-WL 1600,39-2 10/79|1| 275|Rn-222 gas|1600|working level months|Inhalation| Inhaled over 1 m at 1200 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-6-29|6|716|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-6|Rn-To+43d-WL 1600,39-2 10/79|1| 275|Rn-222 gas|1600|working level months|Inhalation| Inhaled over 1 m at 1200 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-6-30|6|717|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-6|Rn-To+43d-WL 1600,39-2 10/79|1| 275|Rn-222 gas|1600|working level months|Inhalation| Inhaled over 1 m at 1200 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-6-31|6|722|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-6|Rn-To+43d-WL 1600,39-2 10/79|1| 275|Rn-222 gas|1600|working level months|Inhalation| Inhaled over 1 m at 1200 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-6-32|6|728|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-6|Rn-To+43d-WL 1600,39-2 10/79|1| 275|Rn-222 gas|1600|working level months|Inhalation| Inhaled over 1 m at 1200 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-6-33|6|735|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-6|Rn-To+43d-WL 1600,39-2 10/79|1| 275|Rn-222 gas|1600|working level months|Inhalation| Inhaled over 1 m at 1200 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-6-34|6|735|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-6|Rn-To+43d-WL 1600,39-2 10/79|1| 275|Rn-222 gas|1600|working level months|Inhalation| Inhaled over 1 m at 1200 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-6-35|6|736|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-6|Rn-To+43d-WL 1600,39-2 10/79|1| 275|Rn-222 gas|1600|working level months|Inhalation| Inhaled over 1 m at 1200 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-6-36|6|737|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-6|Rn-To+43d-WL 1600,39-2 10/79|1| 275|Rn-222 gas|1600|working level months|Inhalation| Inhaled over 1 m at 1200 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-6-37|6|737|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-6|Rn-To+43d-WL 1600,39-2 10/79|1| 275|Rn-222 gas|1600|working level months|Inhalation| Inhaled over 1 m at 1200 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-6-38|6|745|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-6|Rn-To+43d-WL 1600,39-2 10/79|1| 275|Rn-222 gas|1600|working level months|Inhalation| Inhaled over 1 m at 1200 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-6-39|6|764|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-6|Rn-To+43d-WL 1600,39-2 10/79|1| 275|Rn-222 gas|1600|working level months|Inhalation| Inhaled over 1 m at 1200 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-6-40|6|771|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-6|Rn-To+43d-WL 1600,39-2 10/79|1| 275|Rn-222 gas|1600|working level months|Inhalation| Inhaled over 1 m at 1200 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-6-41|6|772|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-6|Rn-To+43d-WL 1600,39-2 10/79|1| 275|Rn-222 gas|1600|working level months|Inhalation| Inhaled over 1 m at 1200 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-6-42|6|779|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-6|Rn-To+43d-WL 1600,39-2 10/79|1| 275|Rn-222 gas|1600|working level months|Inhalation| Inhaled over 1 m at 1200 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-6-43|6|784|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-6|Rn-To+43d-WL 1600,39-2 10/79|1| 275|Rn-222 gas|1600|working level months|Inhalation| Inhaled over 1 m at 1200 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-6-44|6|785|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-6|Rn-To+43d-WL 1600,39-2 10/79|1| 275|Rn-222 gas|1600|working level months|Inhalation| Inhaled over 1 m at 1200 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-6-45|6|788|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-6|Rn-To+43d-WL 1600,39-2 10/79|1| 275|Rn-222 gas|1600|working level months|Inhalation| Inhaled over 1 m at 1200 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-6-46|6|788|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-6|Rn-To+43d-WL 1600,39-2 10/79|1| 275|Rn-222 gas|1600|working level months|Inhalation| Inhaled over 1 m at 1200 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-6-47|6|820|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-6|Rn-To+43d-WL 1600,39-2 10/79|1| 275|Rn-222 gas|1600|working level months|Inhalation| Inhaled over 1 m at 1200 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-6-48|6|820|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-6|Rn-To+43d-WL 1600,39-2 10/79|1| 275|Rn-222 gas|1600|working level months|Inhalation| Inhaled over 1 m at 1200 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-6-49|6|884|Preneoplastic changes|Lower respiratory system,MA: 0000422 - bronchiole|,MPATH: 171 - squamous metaplasia|
2-3-6|Rn-To+43d-WL 1600,39-2 10/79|1| 275|Rn-222 gas|1600|working level months|Inhalation| Inhaled over 1 m at 1200 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-6-50|6|946|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-6|Rn-To+43d-WL 1600,39-2 10/79|2| 318|tobacco smoke||unit code not relevant|Inhalation| inhal. for 300h over 6m|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-6-1|6|395|Other deterministic changes|Lower respiratory system|n/a|
2-3-6|Rn-To+43d-WL 1600,39-2 10/79|2| 318|tobacco smoke||unit code not relevant|Inhalation| inhal. for 300h over 6m|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-6-2|6|395|Other deterministic changes|Lower respiratory system|n/a|
2-3-6|Rn-To+43d-WL 1600,39-2 10/79|2| 318|tobacco smoke||unit code not relevant|Inhalation| inhal. for 300h over 6m|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-6-3|6|395|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-3-6|Rn-To+43d-WL 1600,39-2 10/79|2| 318|tobacco smoke||unit code not relevant|Inhalation| inhal. for 300h over 6m|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-6-4|6|409|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-3-6|Rn-To+43d-WL 1600,39-2 10/79|2| 318|tobacco smoke||unit code not relevant|Inhalation| inhal. for 300h over 6m|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-6-5|6|420|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 268 - adenocarcinoma|
2-3-6|Rn-To+43d-WL 1600,39-2 10/79|2| 318|tobacco smoke||unit code not relevant|Inhalation| inhal. for 300h over 6m|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-6-6|6|423|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-3-6|Rn-To+43d-WL 1600,39-2 10/79|2| 318|tobacco smoke||unit code not relevant|Inhalation| inhal. for 300h over 6m|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-6-7|6|423|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-3-6|Rn-To+43d-WL 1600,39-2 10/79|2| 318|tobacco smoke||unit code not relevant|Inhalation| inhal. for 300h over 6m|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-6-8|6|454|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-6|Rn-To+43d-WL 1600,39-2 10/79|2| 318|tobacco smoke||unit code not relevant|Inhalation| inhal. for 300h over 6m|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-6-9|6|465|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-3-6|Rn-To+43d-WL 1600,39-2 10/79|2| 318|tobacco smoke||unit code not relevant|Inhalation| inhal. for 300h over 6m|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-6-10|6|516|Other deterministic changes|Lower respiratory system|n/a|
2-3-6|Rn-To+43d-WL 1600,39-2 10/79|2| 318|tobacco smoke||unit code not relevant|Inhalation| inhal. for 300h over 6m|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-6-11|6|537|Neoplasia malignant|Integumentary system,MA: 0000151 - skin|,MPATH: 446 - squamous cell carcinoma|
2-3-6|Rn-To+43d-WL 1600,39-2 10/79|2| 318|tobacco smoke||unit code not relevant|Inhalation| inhal. for 300h over 6m|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-6-12|6|559|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-6|Rn-To+43d-WL 1600,39-2 10/79|2| 318|tobacco smoke||unit code not relevant|Inhalation| inhal. for 300h over 6m|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-6-13|6|600|Other deterministic changes|Lower respiratory system|n/a|
2-3-6|Rn-To+43d-WL 1600,39-2 10/79|2| 318|tobacco smoke||unit code not relevant|Inhalation| inhal. for 300h over 6m|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-6-14|6|606|Other deterministic changes|Lower respiratory system|n/a|
2-3-6|Rn-To+43d-WL 1600,39-2 10/79|2| 318|tobacco smoke||unit code not relevant|Inhalation| inhal. for 300h over 6m|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-6-15|6|610|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-6|Rn-To+43d-WL 1600,39-2 10/79|2| 318|tobacco smoke||unit code not relevant|Inhalation| inhal. for 300h over 6m|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-6-16|6|613|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-6|Rn-To+43d-WL 1600,39-2 10/79|2| 318|tobacco smoke||unit code not relevant|Inhalation| inhal. for 300h over 6m|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-6-17|6|613|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-6|Rn-To+43d-WL 1600,39-2 10/79|2| 318|tobacco smoke||unit code not relevant|Inhalation| inhal. for 300h over 6m|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-6-18|6|630|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-6|Rn-To+43d-WL 1600,39-2 10/79|2| 318|tobacco smoke||unit code not relevant|Inhalation| inhal. for 300h over 6m|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-6-19|6|651|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-6|Rn-To+43d-WL 1600,39-2 10/79|2| 318|tobacco smoke||unit code not relevant|Inhalation| inhal. for 300h over 6m|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-6-20|6|658|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-6|Rn-To+43d-WL 1600,39-2 10/79|2| 318|tobacco smoke||unit code not relevant|Inhalation| inhal. for 300h over 6m|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-6-21|6|664|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-6|Rn-To+43d-WL 1600,39-2 10/79|2| 318|tobacco smoke||unit code not relevant|Inhalation| inhal. for 300h over 6m|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-6-22|6|664|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-6|Rn-To+43d-WL 1600,39-2 10/79|2| 318|tobacco smoke||unit code not relevant|Inhalation| inhal. for 300h over 6m|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-6-23|6|664|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-6|Rn-To+43d-WL 1600,39-2 10/79|2| 318|tobacco smoke||unit code not relevant|Inhalation| inhal. for 300h over 6m|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-6-24|6|665|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-6|Rn-To+43d-WL 1600,39-2 10/79|2| 318|tobacco smoke||unit code not relevant|Inhalation| inhal. for 300h over 6m|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-6-25|6|691|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-6|Rn-To+43d-WL 1600,39-2 10/79|2| 318|tobacco smoke||unit code not relevant|Inhalation| inhal. for 300h over 6m|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-6-26|6|691|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-6|Rn-To+43d-WL 1600,39-2 10/79|2| 318|tobacco smoke||unit code not relevant|Inhalation| inhal. for 300h over 6m|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-6-27|6|692|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-6|Rn-To+43d-WL 1600,39-2 10/79|2| 318|tobacco smoke||unit code not relevant|Inhalation| inhal. for 300h over 6m|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-6-28|6|716|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-6|Rn-To+43d-WL 1600,39-2 10/79|2| 318|tobacco smoke||unit code not relevant|Inhalation| inhal. for 300h over 6m|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-6-29|6|716|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-6|Rn-To+43d-WL 1600,39-2 10/79|2| 318|tobacco smoke||unit code not relevant|Inhalation| inhal. for 300h over 6m|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-6-30|6|717|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-6|Rn-To+43d-WL 1600,39-2 10/79|2| 318|tobacco smoke||unit code not relevant|Inhalation| inhal. for 300h over 6m|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-6-31|6|722|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-6|Rn-To+43d-WL 1600,39-2 10/79|2| 318|tobacco smoke||unit code not relevant|Inhalation| inhal. for 300h over 6m|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-6-32|6|728|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-6|Rn-To+43d-WL 1600,39-2 10/79|2| 318|tobacco smoke||unit code not relevant|Inhalation| inhal. for 300h over 6m|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-6-33|6|735|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-6|Rn-To+43d-WL 1600,39-2 10/79|2| 318|tobacco smoke||unit code not relevant|Inhalation| inhal. for 300h over 6m|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-6-34|6|735|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-6|Rn-To+43d-WL 1600,39-2 10/79|2| 318|tobacco smoke||unit code not relevant|Inhalation| inhal. for 300h over 6m|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-6-35|6|736|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-6|Rn-To+43d-WL 1600,39-2 10/79|2| 318|tobacco smoke||unit code not relevant|Inhalation| inhal. for 300h over 6m|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-6-36|6|737|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-6|Rn-To+43d-WL 1600,39-2 10/79|2| 318|tobacco smoke||unit code not relevant|Inhalation| inhal. for 300h over 6m|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-6-37|6|737|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-6|Rn-To+43d-WL 1600,39-2 10/79|2| 318|tobacco smoke||unit code not relevant|Inhalation| inhal. for 300h over 6m|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-6-38|6|745|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-6|Rn-To+43d-WL 1600,39-2 10/79|2| 318|tobacco smoke||unit code not relevant|Inhalation| inhal. for 300h over 6m|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-6-39|6|764|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-6|Rn-To+43d-WL 1600,39-2 10/79|2| 318|tobacco smoke||unit code not relevant|Inhalation| inhal. for 300h over 6m|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-6-40|6|771|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-6|Rn-To+43d-WL 1600,39-2 10/79|2| 318|tobacco smoke||unit code not relevant|Inhalation| inhal. for 300h over 6m|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-6-41|6|772|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-6|Rn-To+43d-WL 1600,39-2 10/79|2| 318|tobacco smoke||unit code not relevant|Inhalation| inhal. for 300h over 6m|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-6-42|6|779|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-6|Rn-To+43d-WL 1600,39-2 10/79|2| 318|tobacco smoke||unit code not relevant|Inhalation| inhal. for 300h over 6m|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-6-43|6|784|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-6|Rn-To+43d-WL 1600,39-2 10/79|2| 318|tobacco smoke||unit code not relevant|Inhalation| inhal. for 300h over 6m|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-6-44|6|785|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-6|Rn-To+43d-WL 1600,39-2 10/79|2| 318|tobacco smoke||unit code not relevant|Inhalation| inhal. for 300h over 6m|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-6-45|6|788|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-6|Rn-To+43d-WL 1600,39-2 10/79|2| 318|tobacco smoke||unit code not relevant|Inhalation| inhal. for 300h over 6m|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-6-46|6|788|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-6|Rn-To+43d-WL 1600,39-2 10/79|2| 318|tobacco smoke||unit code not relevant|Inhalation| inhal. for 300h over 6m|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-6-47|6|820|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-6|Rn-To+43d-WL 1600,39-2 10/79|2| 318|tobacco smoke||unit code not relevant|Inhalation| inhal. for 300h over 6m|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-6-48|6|820|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-6|Rn-To+43d-WL 1600,39-2 10/79|2| 318|tobacco smoke||unit code not relevant|Inhalation| inhal. for 300h over 6m|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-6-49|6|884|Preneoplastic changes|Lower respiratory system,MA: 0000422 - bronchiole|,MPATH: 171 - squamous metaplasia|
2-3-6|Rn-To+43d-WL 1600,39-2 10/79|2| 318|tobacco smoke||unit code not relevant|Inhalation| inhal. for 300h over 6m|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-6-50|6|946|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-7|Rn-To+12.5d-WL 1600,S53 G1 TS 10/83|Sequence:1, Age:77,Type:Rn-222 gas,Quantity:1600,Unit:working level months,Application:Inhalation, Remarks:Inhaled over 4 m at 3000 WL|50 (0 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|No information on individuals available for this study
2-3-7|Rn-To+12.5d-WL 1600,S53 G1 TS 10/83|Sequence:2, Age:78,Type:tobacco smoke not filtered,Quantity:,Unit:unit code not relevant,Application:Inhalation, Remarks:inhal. for 12.5 d|50 (0 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|No information on individuals available for this study
2-3-8|n/a,S53 G2 TS 10/83|Sequence:1, Age:77,Type:Rn-222 gas,Quantity:1600,Unit:working level months,Application:Inhalation, Remarks:Inhaled over 4 m at 3000 WL|50 (0 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|No information on individuals available for this study
2-3-8|n/a,S53 G2 TS 10/83|Sequence:2, Age:78,Type:tobacco smoke,Quantity:,Unit:unit code not relevant,Application:Inhalation, Remarks:inhal. for 12.5 d|50 (0 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|No information on individuals available for this study
2-3-9|Rn-To30h-WL 1800,RN#-47 4/81|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 1.5 m at 1350 WL|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-9-1|9|231|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| benign,MPATH: 268 - adenocarcinoma|
2-3-9|Rn-To30h-WL 1800,RN#-47 4/81|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 1.5 m at 1350 WL|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-9-2|9|244|Other deterministic changes|Lower respiratory system|n/a|
2-3-9|Rn-To30h-WL 1800,RN#-47 4/81|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 1.5 m at 1350 WL|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-9-3|9|279|Other deterministic changes|Lower respiratory system|n/a|
2-3-9|Rn-To30h-WL 1800,RN#-47 4/81|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 1.5 m at 1350 WL|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-9-4|9|334|Other deterministic changes|Whole body|n/a|
2-3-9|Rn-To30h-WL 1800,RN#-47 4/81|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 1.5 m at 1350 WL|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-9-5|9|366|Other deterministic changes|Lower respiratory system|n/a|
2-3-9|Rn-To30h-WL 1800,RN#-47 4/81|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 1.5 m at 1350 WL|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-9-6|9|375|Other deterministic changes|Lower respiratory system|n/a|
2-3-9|Rn-To30h-WL 1800,RN#-47 4/81|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 1.5 m at 1350 WL|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-9-7|9|416|Hyperplastic changes|Lower respiratory system|n/a|
2-3-9|Rn-To30h-WL 1800,RN#-47 4/81|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 1.5 m at 1350 WL|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-9-8|9|459|Neoplasia malignant|Integumentary system,MA: 0000151 - skin|,MPATH: 446 - squamous cell carcinoma|
2-3-9|Rn-To30h-WL 1800,RN#-47 4/81|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 1.5 m at 1350 WL|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-9-9|9|472|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system| benign,MPATH: 408 - soft tissue fibrosarcoma|
2-3-9|Rn-To30h-WL 1800,RN#-47 4/81|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 1.5 m at 1350 WL|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-9-10|9|475|Other deterministic changes|Lower respiratory system|n/a|
2-3-9|Rn-To30h-WL 1800,RN#-47 4/81|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 1.5 m at 1350 WL|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-9-11|9|488|Other deterministic changes|Lower respiratory system|n/a|
2-3-9|Rn-To30h-WL 1800,RN#-47 4/81|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 1.5 m at 1350 WL|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-9-12|9|493|Other deterministic changes|Lower respiratory system|n/a|
2-3-9|Rn-To30h-WL 1800,RN#-47 4/81|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 1.5 m at 1350 WL|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-9-13|9|496|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system| benign,MPATH: 408 - soft tissue fibrosarcoma|
2-3-9|Rn-To30h-WL 1800,RN#-47 4/81|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 1.5 m at 1350 WL|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-9-14|9|502|Hyperplastic changes|Lower respiratory system|n/a|
2-3-9|Rn-To30h-WL 1800,RN#-47 4/81|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 1.5 m at 1350 WL|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-9-15|9|503|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| benign,MPATH: 268 - adenocarcinoma|
2-3-9|Rn-To30h-WL 1800,RN#-47 4/81|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 1.5 m at 1350 WL|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-9-16|9|534|Other deterministic changes|Lower respiratory system|n/a|
2-3-9|Rn-To30h-WL 1800,RN#-47 4/81|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 1.5 m at 1350 WL|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-9-17|9|563|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| benign,MPATH: 268 - adenocarcinoma|
2-3-9|Rn-To30h-WL 1800,RN#-47 4/81|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 1.5 m at 1350 WL|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-9-18|9|572|Other deterministic changes|Lower respiratory system|n/a|
2-3-9|Rn-To30h-WL 1800,RN#-47 4/81|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 1.5 m at 1350 WL|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-9-19|9|578|Other deterministic changes|Lower respiratory system|n/a|
2-3-9|Rn-To30h-WL 1800,RN#-47 4/81|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 1.5 m at 1350 WL|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-9-20|9|590|Hyperplastic changes|Lower respiratory system|n/a|
2-3-9|Rn-To30h-WL 1800,RN#-47 4/81|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 1.5 m at 1350 WL|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-9-21|9|591|Other deterministic changes|Lower respiratory system|n/a|
2-3-9|Rn-To30h-WL 1800,RN#-47 4/81|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 1.5 m at 1350 WL|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-9-22|9|594|Other deterministic changes|Lower respiratory system|n/a|
2-3-9|Rn-To30h-WL 1800,RN#-47 4/81|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 1.5 m at 1350 WL|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-9-23|9|607|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-3-9|Rn-To30h-WL 1800,RN#-47 4/81|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 1.5 m at 1350 WL|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-9-24|9|621|Other deterministic changes|Lower respiratory system|n/a|
2-3-9|Rn-To30h-WL 1800,RN#-47 4/81|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 1.5 m at 1350 WL|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-9-25|9|621|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|,MPATH: 268 - adenocarcinoma|
2-3-9|Rn-To30h-WL 1800,RN#-47 4/81|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 1.5 m at 1350 WL|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-9-26|9|627|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system| benign,MPATH: 408 - soft tissue fibrosarcoma|
2-3-9|Rn-To30h-WL 1800,RN#-47 4/81|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 1.5 m at 1350 WL|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-9-27|9|627|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system| benign,MPATH: 408 - soft tissue fibrosarcoma|
2-3-9|Rn-To30h-WL 1800,RN#-47 4/81|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 1.5 m at 1350 WL|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-9-28|9|632|Neoplasia malignant|Integumentary system,MA: 0000151 - skin|,MPATH: 446 - squamous cell carcinoma|
2-3-9|Rn-To30h-WL 1800,RN#-47 4/81|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 1.5 m at 1350 WL|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-9-29|9|641|Hyperplastic changes|Lower respiratory system|n/a|
2-3-9|Rn-To30h-WL 1800,RN#-47 4/81|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 1.5 m at 1350 WL|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-9-30|9|671|Hyperplastic changes|Lower respiratory system|n/a|
2-3-9|Rn-To30h-WL 1800,RN#-47 4/81|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 1.5 m at 1350 WL|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-9-31|9|675|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system| benign,MPATH: 408 - soft tissue fibrosarcoma|
2-3-9|Rn-To30h-WL 1800,RN#-47 4/81|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 1.5 m at 1350 WL|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-9-32|9|689|Neoplasia benign|Lower respiratory system|n/a|
2-3-9|Rn-To30h-WL 1800,RN#-47 4/81|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 1.5 m at 1350 WL|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-9-33|9|689|Inflammation and/or fibrotic diseases|Musculo-skeletal system,MA: 0000011 - connective tissue|,MPATH: 212 - inflammation|
2-3-9|Rn-To30h-WL 1800,RN#-47 4/81|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 1.5 m at 1350 WL|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-9-34|9|691|Hyperplastic changes|Lower respiratory system|n/a|
2-3-9|Rn-To30h-WL 1800,RN#-47 4/81|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 1.5 m at 1350 WL|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-9-35|9|750|Other deterministic changes|Lower respiratory system|n/a|
2-3-9|Rn-To30h-WL 1800,RN#-47 4/81|2| 78|tobacco smoke||unit code not relevant|Inhalation| 2.5h/d 30h total|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-9-1|9|231|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| benign,MPATH: 268 - adenocarcinoma|
2-3-9|Rn-To30h-WL 1800,RN#-47 4/81|2| 78|tobacco smoke||unit code not relevant|Inhalation| 2.5h/d 30h total|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-9-2|9|244|Other deterministic changes|Lower respiratory system|n/a|
2-3-9|Rn-To30h-WL 1800,RN#-47 4/81|2| 78|tobacco smoke||unit code not relevant|Inhalation| 2.5h/d 30h total|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-9-3|9|279|Other deterministic changes|Lower respiratory system|n/a|
2-3-9|Rn-To30h-WL 1800,RN#-47 4/81|2| 78|tobacco smoke||unit code not relevant|Inhalation| 2.5h/d 30h total|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-9-4|9|334|Other deterministic changes|Whole body|n/a|
2-3-9|Rn-To30h-WL 1800,RN#-47 4/81|2| 78|tobacco smoke||unit code not relevant|Inhalation| 2.5h/d 30h total|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-9-5|9|366|Other deterministic changes|Lower respiratory system|n/a|
2-3-9|Rn-To30h-WL 1800,RN#-47 4/81|2| 78|tobacco smoke||unit code not relevant|Inhalation| 2.5h/d 30h total|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-9-6|9|375|Other deterministic changes|Lower respiratory system|n/a|
2-3-9|Rn-To30h-WL 1800,RN#-47 4/81|2| 78|tobacco smoke||unit code not relevant|Inhalation| 2.5h/d 30h total|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-9-7|9|416|Hyperplastic changes|Lower respiratory system|n/a|
2-3-9|Rn-To30h-WL 1800,RN#-47 4/81|2| 78|tobacco smoke||unit code not relevant|Inhalation| 2.5h/d 30h total|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-9-8|9|459|Neoplasia malignant|Integumentary system,MA: 0000151 - skin|,MPATH: 446 - squamous cell carcinoma|
2-3-9|Rn-To30h-WL 1800,RN#-47 4/81|2| 78|tobacco smoke||unit code not relevant|Inhalation| 2.5h/d 30h total|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-9-9|9|472|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system| benign,MPATH: 408 - soft tissue fibrosarcoma|
2-3-9|Rn-To30h-WL 1800,RN#-47 4/81|2| 78|tobacco smoke||unit code not relevant|Inhalation| 2.5h/d 30h total|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-9-10|9|475|Other deterministic changes|Lower respiratory system|n/a|
2-3-9|Rn-To30h-WL 1800,RN#-47 4/81|2| 78|tobacco smoke||unit code not relevant|Inhalation| 2.5h/d 30h total|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-9-11|9|488|Other deterministic changes|Lower respiratory system|n/a|
2-3-9|Rn-To30h-WL 1800,RN#-47 4/81|2| 78|tobacco smoke||unit code not relevant|Inhalation| 2.5h/d 30h total|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-9-12|9|493|Other deterministic changes|Lower respiratory system|n/a|
2-3-9|Rn-To30h-WL 1800,RN#-47 4/81|2| 78|tobacco smoke||unit code not relevant|Inhalation| 2.5h/d 30h total|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-9-13|9|496|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system| benign,MPATH: 408 - soft tissue fibrosarcoma|
2-3-9|Rn-To30h-WL 1800,RN#-47 4/81|2| 78|tobacco smoke||unit code not relevant|Inhalation| 2.5h/d 30h total|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-9-14|9|502|Hyperplastic changes|Lower respiratory system|n/a|
2-3-9|Rn-To30h-WL 1800,RN#-47 4/81|2| 78|tobacco smoke||unit code not relevant|Inhalation| 2.5h/d 30h total|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-9-15|9|503|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| benign,MPATH: 268 - adenocarcinoma|
2-3-9|Rn-To30h-WL 1800,RN#-47 4/81|2| 78|tobacco smoke||unit code not relevant|Inhalation| 2.5h/d 30h total|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-9-16|9|534|Other deterministic changes|Lower respiratory system|n/a|
2-3-9|Rn-To30h-WL 1800,RN#-47 4/81|2| 78|tobacco smoke||unit code not relevant|Inhalation| 2.5h/d 30h total|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-9-17|9|563|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| benign,MPATH: 268 - adenocarcinoma|
2-3-9|Rn-To30h-WL 1800,RN#-47 4/81|2| 78|tobacco smoke||unit code not relevant|Inhalation| 2.5h/d 30h total|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-9-18|9|572|Other deterministic changes|Lower respiratory system|n/a|
2-3-9|Rn-To30h-WL 1800,RN#-47 4/81|2| 78|tobacco smoke||unit code not relevant|Inhalation| 2.5h/d 30h total|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-9-19|9|578|Other deterministic changes|Lower respiratory system|n/a|
2-3-9|Rn-To30h-WL 1800,RN#-47 4/81|2| 78|tobacco smoke||unit code not relevant|Inhalation| 2.5h/d 30h total|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-9-20|9|590|Hyperplastic changes|Lower respiratory system|n/a|
2-3-9|Rn-To30h-WL 1800,RN#-47 4/81|2| 78|tobacco smoke||unit code not relevant|Inhalation| 2.5h/d 30h total|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-9-21|9|591|Other deterministic changes|Lower respiratory system|n/a|
2-3-9|Rn-To30h-WL 1800,RN#-47 4/81|2| 78|tobacco smoke||unit code not relevant|Inhalation| 2.5h/d 30h total|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-9-22|9|594|Other deterministic changes|Lower respiratory system|n/a|
2-3-9|Rn-To30h-WL 1800,RN#-47 4/81|2| 78|tobacco smoke||unit code not relevant|Inhalation| 2.5h/d 30h total|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-9-23|9|607|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-3-9|Rn-To30h-WL 1800,RN#-47 4/81|2| 78|tobacco smoke||unit code not relevant|Inhalation| 2.5h/d 30h total|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-9-24|9|621|Other deterministic changes|Lower respiratory system|n/a|
2-3-9|Rn-To30h-WL 1800,RN#-47 4/81|2| 78|tobacco smoke||unit code not relevant|Inhalation| 2.5h/d 30h total|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-9-25|9|621|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|,MPATH: 268 - adenocarcinoma|
2-3-9|Rn-To30h-WL 1800,RN#-47 4/81|2| 78|tobacco smoke||unit code not relevant|Inhalation| 2.5h/d 30h total|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-9-26|9|627|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system| benign,MPATH: 408 - soft tissue fibrosarcoma|
2-3-9|Rn-To30h-WL 1800,RN#-47 4/81|2| 78|tobacco smoke||unit code not relevant|Inhalation| 2.5h/d 30h total|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-9-27|9|627|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system| benign,MPATH: 408 - soft tissue fibrosarcoma|
2-3-9|Rn-To30h-WL 1800,RN#-47 4/81|2| 78|tobacco smoke||unit code not relevant|Inhalation| 2.5h/d 30h total|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-9-28|9|632|Neoplasia malignant|Integumentary system,MA: 0000151 - skin|,MPATH: 446 - squamous cell carcinoma|
2-3-9|Rn-To30h-WL 1800,RN#-47 4/81|2| 78|tobacco smoke||unit code not relevant|Inhalation| 2.5h/d 30h total|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-9-29|9|641|Hyperplastic changes|Lower respiratory system|n/a|
2-3-9|Rn-To30h-WL 1800,RN#-47 4/81|2| 78|tobacco smoke||unit code not relevant|Inhalation| 2.5h/d 30h total|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-9-30|9|671|Hyperplastic changes|Lower respiratory system|n/a|
2-3-9|Rn-To30h-WL 1800,RN#-47 4/81|2| 78|tobacco smoke||unit code not relevant|Inhalation| 2.5h/d 30h total|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-9-31|9|675|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system| benign,MPATH: 408 - soft tissue fibrosarcoma|
2-3-9|Rn-To30h-WL 1800,RN#-47 4/81|2| 78|tobacco smoke||unit code not relevant|Inhalation| 2.5h/d 30h total|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-9-32|9|689|Neoplasia benign|Lower respiratory system|n/a|
2-3-9|Rn-To30h-WL 1800,RN#-47 4/81|2| 78|tobacco smoke||unit code not relevant|Inhalation| 2.5h/d 30h total|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-9-33|9|689|Inflammation and/or fibrotic diseases|Musculo-skeletal system,MA: 0000011 - connective tissue|,MPATH: 212 - inflammation|
2-3-9|Rn-To30h-WL 1800,RN#-47 4/81|2| 78|tobacco smoke||unit code not relevant|Inhalation| 2.5h/d 30h total|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-9-34|9|691|Hyperplastic changes|Lower respiratory system|n/a|
2-3-9|Rn-To30h-WL 1800,RN#-47 4/81|2| 78|tobacco smoke||unit code not relevant|Inhalation| 2.5h/d 30h total|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-9-35|9|750|Other deterministic changes|Lower respiratory system|n/a|
2-3-10|Rn-To100h-WL 1800,RN3-47 4/81|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 1.5 m at 1350 WL|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-10-1|10|301|Other deterministic changes|Lower respiratory system|n/a|
2-3-10|Rn-To100h-WL 1800,RN3-47 4/81|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 1.5 m at 1350 WL|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-10-2|10|341|Other deterministic changes|Whole body|n/a|
2-3-10|Rn-To100h-WL 1800,RN3-47 4/81|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 1.5 m at 1350 WL|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-10-3|10|429|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system| benign,MPATH: 408 - soft tissue fibrosarcoma|
2-3-10|Rn-To100h-WL 1800,RN3-47 4/81|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 1.5 m at 1350 WL|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-10-4|10|433|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-3-10|Rn-To100h-WL 1800,RN3-47 4/81|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 1.5 m at 1350 WL|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-10-5|10|480|Hyperplastic changes|Lower respiratory system|n/a|
2-3-10|Rn-To100h-WL 1800,RN3-47 4/81|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 1.5 m at 1350 WL|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-10-6|10|480|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland| benign,MPATH: 278 - follicular adenocarcinoma|
2-3-10|Rn-To100h-WL 1800,RN3-47 4/81|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 1.5 m at 1350 WL|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-10-7|10|520|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-3-10|Rn-To100h-WL 1800,RN3-47 4/81|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 1.5 m at 1350 WL|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-10-8|10|530|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-10|Rn-To100h-WL 1800,RN3-47 4/81|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 1.5 m at 1350 WL|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-10-9|10|542|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-10|Rn-To100h-WL 1800,RN3-47 4/81|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 1.5 m at 1350 WL|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-10-10|10|558|Neoplasia malignant|Adrenal gland  among endocrine systems|n/a|
2-3-10|Rn-To100h-WL 1800,RN3-47 4/81|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 1.5 m at 1350 WL|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-10-11|10|566|Neoplasia benign|Upper digestive tract,MA: 0000346 - salivary gland| benign,MPATH: 218 - neoplasm|
2-3-10|Rn-To100h-WL 1800,RN3-47 4/81|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 1.5 m at 1350 WL|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-10-12|10|584|Neoplasia malignant|Integumentary system,MA: 0000151 - skin|,MPATH: 446 - squamous cell carcinoma|
2-3-10|Rn-To100h-WL 1800,RN3-47 4/81|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 1.5 m at 1350 WL|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-10-13|10|585|Other deterministic changes|Lower respiratory system|n/a|
2-3-10|Rn-To100h-WL 1800,RN3-47 4/81|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 1.5 m at 1350 WL|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-10-14|10|597|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-10|Rn-To100h-WL 1800,RN3-47 4/81|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 1.5 m at 1350 WL|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-10-15|10|599|Hyperplastic changes|Lower respiratory system|n/a|
2-3-10|Rn-To100h-WL 1800,RN3-47 4/81|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 1.5 m at 1350 WL|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-10-16|10|599|Neoplasia malignant|Integumentary system,MA: 0000151 - skin|,MPATH: 446 - squamous cell carcinoma|
2-3-10|Rn-To100h-WL 1800,RN3-47 4/81|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 1.5 m at 1350 WL|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-10-17|10|605|Hyperplastic changes|Lower respiratory system|n/a|
2-3-10|Rn-To100h-WL 1800,RN3-47 4/81|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 1.5 m at 1350 WL|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-10-18|10|621|Neoplasia malignant|Adrenal gland  among endocrine systems,MA: 0000116 - adrenal gland| benign,MPATH: 549 - carcinoma|
2-3-10|Rn-To100h-WL 1800,RN3-47 4/81|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 1.5 m at 1350 WL|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-10-19|10|621|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-10|Rn-To100h-WL 1800,RN3-47 4/81|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 1.5 m at 1350 WL|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-10-20|10|622|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-10|Rn-To100h-WL 1800,RN3-47 4/81|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 1.5 m at 1350 WL|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-10-21|10|629|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-3-10|Rn-To100h-WL 1800,RN3-47 4/81|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 1.5 m at 1350 WL|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-10-22|10|629|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-3-10|Rn-To100h-WL 1800,RN3-47 4/81|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 1.5 m at 1350 WL|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-10-23|10|631|Other deterministic changes|Lower respiratory system|n/a|
2-3-10|Rn-To100h-WL 1800,RN3-47 4/81|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 1.5 m at 1350 WL|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-10-24|10|641|Hyperplastic changes|Lower respiratory system|n/a|
2-3-10|Rn-To100h-WL 1800,RN3-47 4/81|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 1.5 m at 1350 WL|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-10-25|10|646|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-10|Rn-To100h-WL 1800,RN3-47 4/81|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 1.5 m at 1350 WL|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-10-26|10|649|Other deterministic changes|Lower respiratory system|n/a|
2-3-10|Rn-To100h-WL 1800,RN3-47 4/81|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 1.5 m at 1350 WL|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-10-27|10|655|Neoplasia malignant|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 549 - carcinoma|
2-3-10|Rn-To100h-WL 1800,RN3-47 4/81|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 1.5 m at 1350 WL|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-10-28|10|677|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system| benign,MPATH: 408 - soft tissue fibrosarcoma|
2-3-10|Rn-To100h-WL 1800,RN3-47 4/81|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 1.5 m at 1350 WL|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-10-29|10|685|Neoplasia benign|Lower respiratory system|n/a|
2-3-10|Rn-To100h-WL 1800,RN3-47 4/81|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 1.5 m at 1350 WL|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-10-30|10|704|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-10|Rn-To100h-WL 1800,RN3-47 4/81|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 1.5 m at 1350 WL|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-10-31|10|711|Other deterministic changes|Whole body|n/a|
2-3-10|Rn-To100h-WL 1800,RN3-47 4/81|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 1.5 m at 1350 WL|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-10-32|10|718|Other deterministic changes|Whole body|n/a|
2-3-10|Rn-To100h-WL 1800,RN3-47 4/81|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 1.5 m at 1350 WL|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-10-33|10|733|Other deterministic changes|Whole body|n/a|
2-3-10|Rn-To100h-WL 1800,RN3-47 4/81|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 1.5 m at 1350 WL|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-10-34|10|750|Other deterministic changes|Whole body|n/a|
2-3-10|Rn-To100h-WL 1800,RN3-47 4/81|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 1.5 m at 1350 WL|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-10-35|10|750|Other deterministic changes|Lower respiratory system|n/a|
2-3-10|Rn-To100h-WL 1800,RN3-47 4/81|2| 92|tobacco smoke||unit code not relevant|Inhalation| inhaled 2.5h/d 100h total|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-10-1|10|301|Other deterministic changes|Lower respiratory system|n/a|
2-3-10|Rn-To100h-WL 1800,RN3-47 4/81|2| 92|tobacco smoke||unit code not relevant|Inhalation| inhaled 2.5h/d 100h total|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-10-2|10|341|Other deterministic changes|Whole body|n/a|
2-3-10|Rn-To100h-WL 1800,RN3-47 4/81|2| 92|tobacco smoke||unit code not relevant|Inhalation| inhaled 2.5h/d 100h total|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-10-3|10|429|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system| benign,MPATH: 408 - soft tissue fibrosarcoma|
2-3-10|Rn-To100h-WL 1800,RN3-47 4/81|2| 92|tobacco smoke||unit code not relevant|Inhalation| inhaled 2.5h/d 100h total|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-10-4|10|433|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-3-10|Rn-To100h-WL 1800,RN3-47 4/81|2| 92|tobacco smoke||unit code not relevant|Inhalation| inhaled 2.5h/d 100h total|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-10-5|10|480|Hyperplastic changes|Lower respiratory system|n/a|
2-3-10|Rn-To100h-WL 1800,RN3-47 4/81|2| 92|tobacco smoke||unit code not relevant|Inhalation| inhaled 2.5h/d 100h total|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-10-6|10|480|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland| benign,MPATH: 278 - follicular adenocarcinoma|
2-3-10|Rn-To100h-WL 1800,RN3-47 4/81|2| 92|tobacco smoke||unit code not relevant|Inhalation| inhaled 2.5h/d 100h total|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-10-7|10|520|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-3-10|Rn-To100h-WL 1800,RN3-47 4/81|2| 92|tobacco smoke||unit code not relevant|Inhalation| inhaled 2.5h/d 100h total|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-10-8|10|530|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-10|Rn-To100h-WL 1800,RN3-47 4/81|2| 92|tobacco smoke||unit code not relevant|Inhalation| inhaled 2.5h/d 100h total|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-10-9|10|542|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-10|Rn-To100h-WL 1800,RN3-47 4/81|2| 92|tobacco smoke||unit code not relevant|Inhalation| inhaled 2.5h/d 100h total|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-10-10|10|558|Neoplasia malignant|Adrenal gland  among endocrine systems|n/a|
2-3-10|Rn-To100h-WL 1800,RN3-47 4/81|2| 92|tobacco smoke||unit code not relevant|Inhalation| inhaled 2.5h/d 100h total|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-10-11|10|566|Neoplasia benign|Upper digestive tract,MA: 0000346 - salivary gland| benign,MPATH: 218 - neoplasm|
2-3-10|Rn-To100h-WL 1800,RN3-47 4/81|2| 92|tobacco smoke||unit code not relevant|Inhalation| inhaled 2.5h/d 100h total|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-10-12|10|584|Neoplasia malignant|Integumentary system,MA: 0000151 - skin|,MPATH: 446 - squamous cell carcinoma|
2-3-10|Rn-To100h-WL 1800,RN3-47 4/81|2| 92|tobacco smoke||unit code not relevant|Inhalation| inhaled 2.5h/d 100h total|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-10-13|10|585|Other deterministic changes|Lower respiratory system|n/a|
2-3-10|Rn-To100h-WL 1800,RN3-47 4/81|2| 92|tobacco smoke||unit code not relevant|Inhalation| inhaled 2.5h/d 100h total|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-10-14|10|597|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-10|Rn-To100h-WL 1800,RN3-47 4/81|2| 92|tobacco smoke||unit code not relevant|Inhalation| inhaled 2.5h/d 100h total|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-10-15|10|599|Hyperplastic changes|Lower respiratory system|n/a|
2-3-10|Rn-To100h-WL 1800,RN3-47 4/81|2| 92|tobacco smoke||unit code not relevant|Inhalation| inhaled 2.5h/d 100h total|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-10-16|10|599|Neoplasia malignant|Integumentary system,MA: 0000151 - skin|,MPATH: 446 - squamous cell carcinoma|
2-3-10|Rn-To100h-WL 1800,RN3-47 4/81|2| 92|tobacco smoke||unit code not relevant|Inhalation| inhaled 2.5h/d 100h total|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-10-17|10|605|Hyperplastic changes|Lower respiratory system|n/a|
2-3-10|Rn-To100h-WL 1800,RN3-47 4/81|2| 92|tobacco smoke||unit code not relevant|Inhalation| inhaled 2.5h/d 100h total|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-10-18|10|621|Neoplasia malignant|Adrenal gland  among endocrine systems,MA: 0000116 - adrenal gland| benign,MPATH: 549 - carcinoma|
2-3-10|Rn-To100h-WL 1800,RN3-47 4/81|2| 92|tobacco smoke||unit code not relevant|Inhalation| inhaled 2.5h/d 100h total|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-10-19|10|621|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-10|Rn-To100h-WL 1800,RN3-47 4/81|2| 92|tobacco smoke||unit code not relevant|Inhalation| inhaled 2.5h/d 100h total|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-10-20|10|622|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-10|Rn-To100h-WL 1800,RN3-47 4/81|2| 92|tobacco smoke||unit code not relevant|Inhalation| inhaled 2.5h/d 100h total|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-10-21|10|629|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-3-10|Rn-To100h-WL 1800,RN3-47 4/81|2| 92|tobacco smoke||unit code not relevant|Inhalation| inhaled 2.5h/d 100h total|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-10-22|10|629|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-3-10|Rn-To100h-WL 1800,RN3-47 4/81|2| 92|tobacco smoke||unit code not relevant|Inhalation| inhaled 2.5h/d 100h total|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-10-23|10|631|Other deterministic changes|Lower respiratory system|n/a|
2-3-10|Rn-To100h-WL 1800,RN3-47 4/81|2| 92|tobacco smoke||unit code not relevant|Inhalation| inhaled 2.5h/d 100h total|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-10-24|10|641|Hyperplastic changes|Lower respiratory system|n/a|
2-3-10|Rn-To100h-WL 1800,RN3-47 4/81|2| 92|tobacco smoke||unit code not relevant|Inhalation| inhaled 2.5h/d 100h total|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-10-25|10|646|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-10|Rn-To100h-WL 1800,RN3-47 4/81|2| 92|tobacco smoke||unit code not relevant|Inhalation| inhaled 2.5h/d 100h total|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-10-26|10|649|Other deterministic changes|Lower respiratory system|n/a|
2-3-10|Rn-To100h-WL 1800,RN3-47 4/81|2| 92|tobacco smoke||unit code not relevant|Inhalation| inhaled 2.5h/d 100h total|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-10-27|10|655|Neoplasia malignant|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 549 - carcinoma|
2-3-10|Rn-To100h-WL 1800,RN3-47 4/81|2| 92|tobacco smoke||unit code not relevant|Inhalation| inhaled 2.5h/d 100h total|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-10-28|10|677|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system| benign,MPATH: 408 - soft tissue fibrosarcoma|
2-3-10|Rn-To100h-WL 1800,RN3-47 4/81|2| 92|tobacco smoke||unit code not relevant|Inhalation| inhaled 2.5h/d 100h total|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-10-29|10|685|Neoplasia benign|Lower respiratory system|n/a|
2-3-10|Rn-To100h-WL 1800,RN3-47 4/81|2| 92|tobacco smoke||unit code not relevant|Inhalation| inhaled 2.5h/d 100h total|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-10-30|10|704|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-10|Rn-To100h-WL 1800,RN3-47 4/81|2| 92|tobacco smoke||unit code not relevant|Inhalation| inhaled 2.5h/d 100h total|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-10-31|10|711|Other deterministic changes|Whole body|n/a|
2-3-10|Rn-To100h-WL 1800,RN3-47 4/81|2| 92|tobacco smoke||unit code not relevant|Inhalation| inhaled 2.5h/d 100h total|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-10-32|10|718|Other deterministic changes|Whole body|n/a|
2-3-10|Rn-To100h-WL 1800,RN3-47 4/81|2| 92|tobacco smoke||unit code not relevant|Inhalation| inhaled 2.5h/d 100h total|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-10-33|10|733|Other deterministic changes|Whole body|n/a|
2-3-10|Rn-To100h-WL 1800,RN3-47 4/81|2| 92|tobacco smoke||unit code not relevant|Inhalation| inhaled 2.5h/d 100h total|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-10-34|10|750|Other deterministic changes|Whole body|n/a|
2-3-10|Rn-To100h-WL 1800,RN3-47 4/81|2| 92|tobacco smoke||unit code not relevant|Inhalation| inhaled 2.5h/d 100h total|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-10-35|10|750|Other deterministic changes|Lower respiratory system|n/a|
2-3-11|Rn-To+350h-WL 1800,16-2 3/75|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 2 m at 1384 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-11-1|11|474|Other deterministic changes|Whole body|n/a|
2-3-11|Rn-To+350h-WL 1800,16-2 3/75|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 2 m at 1384 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-11-2|11|474|Other deterministic changes|Whole body|n/a|
2-3-11|Rn-To+350h-WL 1800,16-2 3/75|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 2 m at 1384 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-11-3|11|568|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-11|Rn-To+350h-WL 1800,16-2 3/75|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 2 m at 1384 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-11-4|11|568|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-3-11|Rn-To+350h-WL 1800,16-2 3/75|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 2 m at 1384 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-11-5|11|571|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-11|Rn-To+350h-WL 1800,16-2 3/75|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 2 m at 1384 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-11-6|11|597|Hyperplastic changes|Lower respiratory system|n/a|
2-3-11|Rn-To+350h-WL 1800,16-2 3/75|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 2 m at 1384 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-11-7|11|617|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-11|Rn-To+350h-WL 1800,16-2 3/75|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 2 m at 1384 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-11-8|11|630|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-11|Rn-To+350h-WL 1800,16-2 3/75|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 2 m at 1384 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-11-9|11|650|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-11|Rn-To+350h-WL 1800,16-2 3/75|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 2 m at 1384 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-11-10|11|658|Neoplasia malignant|Integumentary system,MA: 0000151 - skin|,MPATH: 446 - squamous cell carcinoma|
2-3-11|Rn-To+350h-WL 1800,16-2 3/75|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 2 m at 1384 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-11-11|11|658|Neoplasia benign|Bloodvessels among cardiovascular system|n/a|
2-3-11|Rn-To+350h-WL 1800,16-2 3/75|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 2 m at 1384 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-11-12|11|658|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-11|Rn-To+350h-WL 1800,16-2 3/75|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 2 m at 1384 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-11-13|11|668|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-11|Rn-To+350h-WL 1800,16-2 3/75|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 2 m at 1384 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-11-14|11|687|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-11|Rn-To+350h-WL 1800,16-2 3/75|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 2 m at 1384 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-11-15|11|693|Neoplasia benign|Lower respiratory system,MA: 0000436 - bronchus|,MPATH: 270 - adenoma|
2-3-11|Rn-To+350h-WL 1800,16-2 3/75|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 2 m at 1384 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-11-16|11|694|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-11|Rn-To+350h-WL 1800,16-2 3/75|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 2 m at 1384 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-11-17|11|694|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
2-3-11|Rn-To+350h-WL 1800,16-2 3/75|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 2 m at 1384 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-11-18|11|699|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-11|Rn-To+350h-WL 1800,16-2 3/75|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 2 m at 1384 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-11-19|11|699|Neoplasia malignant|Upper respiratory system,MA: 0000442 - upper respiratory tract|,MPATH: 218 - neoplasm|
2-3-11|Rn-To+350h-WL 1800,16-2 3/75|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 2 m at 1384 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-11-20|11|714|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-11|Rn-To+350h-WL 1800,16-2 3/75|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 2 m at 1384 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-11-21|11|716|Neoplasia benign|Lower respiratory system,MA: 0000436 - bronchus|,MPATH: 270 - adenoma|
2-3-11|Rn-To+350h-WL 1800,16-2 3/75|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 2 m at 1384 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-11-22|11|735|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-11|Rn-To+350h-WL 1800,16-2 3/75|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 2 m at 1384 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-11-23|11|743|Hyperplastic changes|Lower respiratory system|n/a|
2-3-11|Rn-To+350h-WL 1800,16-2 3/75|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 2 m at 1384 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-11-24|11|749|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-11|Rn-To+350h-WL 1800,16-2 3/75|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 2 m at 1384 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-11-25|11|757|Neoplasia benign|Lower respiratory system,MA: 0000436 - bronchus|,MPATH: 270 - adenoma|
2-3-11|Rn-To+350h-WL 1800,16-2 3/75|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 2 m at 1384 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-11-26|11|765|Inflammation and/or fibrotic diseases|Musculo-skeletal system,MA: 0000011 - connective tissue|,MPATH: 212 - inflammation|
2-3-11|Rn-To+350h-WL 1800,16-2 3/75|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 2 m at 1384 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-11-27|11|765|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-11|Rn-To+350h-WL 1800,16-2 3/75|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 2 m at 1384 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-11-28|11|767|Preneoplastic changes|Lower respiratory system,MA: 0000422 - bronchiole|,MPATH: 171 - squamous metaplasia|
2-3-11|Rn-To+350h-WL 1800,16-2 3/75|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 2 m at 1384 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-11-29|11|769|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
2-3-11|Rn-To+350h-WL 1800,16-2 3/75|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 2 m at 1384 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-11-30|11|772|Inflammation and/or fibrotic diseases|Musculo-skeletal system,MA: 0000011 - connective tissue|,MPATH: 212 - inflammation|
2-3-11|Rn-To+350h-WL 1800,16-2 3/75|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 2 m at 1384 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-11-31|11|784|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-11|Rn-To+350h-WL 1800,16-2 3/75|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 2 m at 1384 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-11-32|11|798|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-11|Rn-To+350h-WL 1800,16-2 3/75|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 2 m at 1384 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-11-33|11|805|Neoplasia benign|Lower respiratory system,MA: 0000436 - bronchus|,MPATH: 270 - adenoma|
2-3-11|Rn-To+350h-WL 1800,16-2 3/75|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 2 m at 1384 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-11-34|11|808|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-11|Rn-To+350h-WL 1800,16-2 3/75|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 2 m at 1384 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-11-35|11|811|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-11|Rn-To+350h-WL 1800,16-2 3/75|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 2 m at 1384 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-11-36|11|819|Neoplasia benign|Lower respiratory system,MA: 0000436 - bronchus|,MPATH: 270 - adenoma|
2-3-11|Rn-To+350h-WL 1800,16-2 3/75|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 2 m at 1384 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-11-37|11|819|Hyperplastic changes|Lower respiratory system|n/a|
2-3-11|Rn-To+350h-WL 1800,16-2 3/75|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 2 m at 1384 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-11-38|11|819|Neoplasia benign|Lower respiratory system,MA: 0000436 - bronchus|,MPATH: 270 - adenoma|
2-3-11|Rn-To+350h-WL 1800,16-2 3/75|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 2 m at 1384 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-11-39|11|821|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-11|Rn-To+350h-WL 1800,16-2 3/75|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 2 m at 1384 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-11-40|11|826|Inflammation and/or fibrotic diseases|Musculo-skeletal system,MA: 0000011 - connective tissue|,MPATH: 212 - inflammation|
2-3-11|Rn-To+350h-WL 1800,16-2 3/75|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 2 m at 1384 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-11-41|11|846|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
2-3-11|Rn-To+350h-WL 1800,16-2 3/75|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 2 m at 1384 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-11-42|11|848|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-11|Rn-To+350h-WL 1800,16-2 3/75|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 2 m at 1384 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-11-43|11|856|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
2-3-11|Rn-To+350h-WL 1800,16-2 3/75|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 2 m at 1384 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-11-44|11|881|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-11|Rn-To+350h-WL 1800,16-2 3/75|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 2 m at 1384 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-11-45|11|881|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-11|Rn-To+350h-WL 1800,16-2 3/75|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 2 m at 1384 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-11-46|11|882|Preneoplastic changes|Lower respiratory system,MA: 0000422 - bronchiole|,MPATH: 171 - squamous metaplasia|
2-3-11|Rn-To+350h-WL 1800,16-2 3/75|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 2 m at 1384 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-11-47|11|882|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-11|Rn-To+350h-WL 1800,16-2 3/75|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 2 m at 1384 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-11-48|11|882|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-11|Rn-To+350h-WL 1800,16-2 3/75|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 2 m at 1384 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-11-49|11|882|Inflammation and/or fibrotic diseases|Musculo-skeletal system,MA: 0000011 - connective tissue|,MPATH: 212 - inflammation|
2-3-11|Rn-To+350h-WL 1800,16-2 3/75|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 2 m at 1384 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-11-50|11|882|Inflammation and/or fibrotic diseases|Musculo-skeletal system,MA: 0000011 - connective tissue|,MPATH: 212 - inflammation|
2-3-11|Rn-To+350h-WL 1800,16-2 3/75|2| 77|tobacco smoke||unit code not relevant|Inhalation| 130h total|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-11-1|11|474|Other deterministic changes|Whole body|n/a|
2-3-11|Rn-To+350h-WL 1800,16-2 3/75|2| 77|tobacco smoke||unit code not relevant|Inhalation| 130h total|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-11-2|11|474|Other deterministic changes|Whole body|n/a|
2-3-11|Rn-To+350h-WL 1800,16-2 3/75|2| 77|tobacco smoke||unit code not relevant|Inhalation| 130h total|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-11-3|11|568|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-11|Rn-To+350h-WL 1800,16-2 3/75|2| 77|tobacco smoke||unit code not relevant|Inhalation| 130h total|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-11-4|11|568|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-3-11|Rn-To+350h-WL 1800,16-2 3/75|2| 77|tobacco smoke||unit code not relevant|Inhalation| 130h total|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-11-5|11|571|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-11|Rn-To+350h-WL 1800,16-2 3/75|2| 77|tobacco smoke||unit code not relevant|Inhalation| 130h total|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-11-6|11|597|Hyperplastic changes|Lower respiratory system|n/a|
2-3-11|Rn-To+350h-WL 1800,16-2 3/75|2| 77|tobacco smoke||unit code not relevant|Inhalation| 130h total|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-11-7|11|617|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-11|Rn-To+350h-WL 1800,16-2 3/75|2| 77|tobacco smoke||unit code not relevant|Inhalation| 130h total|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-11-8|11|630|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-11|Rn-To+350h-WL 1800,16-2 3/75|2| 77|tobacco smoke||unit code not relevant|Inhalation| 130h total|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-11-9|11|650|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-11|Rn-To+350h-WL 1800,16-2 3/75|2| 77|tobacco smoke||unit code not relevant|Inhalation| 130h total|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-11-10|11|658|Neoplasia malignant|Integumentary system,MA: 0000151 - skin|,MPATH: 446 - squamous cell carcinoma|
2-3-11|Rn-To+350h-WL 1800,16-2 3/75|2| 77|tobacco smoke||unit code not relevant|Inhalation| 130h total|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-11-11|11|658|Neoplasia benign|Bloodvessels among cardiovascular system|n/a|
2-3-11|Rn-To+350h-WL 1800,16-2 3/75|2| 77|tobacco smoke||unit code not relevant|Inhalation| 130h total|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-11-12|11|658|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-11|Rn-To+350h-WL 1800,16-2 3/75|2| 77|tobacco smoke||unit code not relevant|Inhalation| 130h total|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-11-13|11|668|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-11|Rn-To+350h-WL 1800,16-2 3/75|2| 77|tobacco smoke||unit code not relevant|Inhalation| 130h total|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-11-14|11|687|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-11|Rn-To+350h-WL 1800,16-2 3/75|2| 77|tobacco smoke||unit code not relevant|Inhalation| 130h total|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-11-15|11|693|Neoplasia benign|Lower respiratory system,MA: 0000436 - bronchus|,MPATH: 270 - adenoma|
2-3-11|Rn-To+350h-WL 1800,16-2 3/75|2| 77|tobacco smoke||unit code not relevant|Inhalation| 130h total|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-11-16|11|694|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-11|Rn-To+350h-WL 1800,16-2 3/75|2| 77|tobacco smoke||unit code not relevant|Inhalation| 130h total|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-11-17|11|694|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
2-3-11|Rn-To+350h-WL 1800,16-2 3/75|2| 77|tobacco smoke||unit code not relevant|Inhalation| 130h total|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-11-18|11|699|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-11|Rn-To+350h-WL 1800,16-2 3/75|2| 77|tobacco smoke||unit code not relevant|Inhalation| 130h total|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-11-19|11|699|Neoplasia malignant|Upper respiratory system,MA: 0000442 - upper respiratory tract|,MPATH: 218 - neoplasm|
2-3-11|Rn-To+350h-WL 1800,16-2 3/75|2| 77|tobacco smoke||unit code not relevant|Inhalation| 130h total|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-11-20|11|714|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-11|Rn-To+350h-WL 1800,16-2 3/75|2| 77|tobacco smoke||unit code not relevant|Inhalation| 130h total|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-11-21|11|716|Neoplasia benign|Lower respiratory system,MA: 0000436 - bronchus|,MPATH: 270 - adenoma|
2-3-11|Rn-To+350h-WL 1800,16-2 3/75|2| 77|tobacco smoke||unit code not relevant|Inhalation| 130h total|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-11-22|11|735|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-11|Rn-To+350h-WL 1800,16-2 3/75|2| 77|tobacco smoke||unit code not relevant|Inhalation| 130h total|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-11-23|11|743|Hyperplastic changes|Lower respiratory system|n/a|
2-3-11|Rn-To+350h-WL 1800,16-2 3/75|2| 77|tobacco smoke||unit code not relevant|Inhalation| 130h total|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-11-24|11|749|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-11|Rn-To+350h-WL 1800,16-2 3/75|2| 77|tobacco smoke||unit code not relevant|Inhalation| 130h total|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-11-25|11|757|Neoplasia benign|Lower respiratory system,MA: 0000436 - bronchus|,MPATH: 270 - adenoma|
2-3-11|Rn-To+350h-WL 1800,16-2 3/75|2| 77|tobacco smoke||unit code not relevant|Inhalation| 130h total|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-11-26|11|765|Inflammation and/or fibrotic diseases|Musculo-skeletal system,MA: 0000011 - connective tissue|,MPATH: 212 - inflammation|
2-3-11|Rn-To+350h-WL 1800,16-2 3/75|2| 77|tobacco smoke||unit code not relevant|Inhalation| 130h total|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-11-27|11|765|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-11|Rn-To+350h-WL 1800,16-2 3/75|2| 77|tobacco smoke||unit code not relevant|Inhalation| 130h total|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-11-28|11|767|Preneoplastic changes|Lower respiratory system,MA: 0000422 - bronchiole|,MPATH: 171 - squamous metaplasia|
2-3-11|Rn-To+350h-WL 1800,16-2 3/75|2| 77|tobacco smoke||unit code not relevant|Inhalation| 130h total|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-11-29|11|769|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
2-3-11|Rn-To+350h-WL 1800,16-2 3/75|2| 77|tobacco smoke||unit code not relevant|Inhalation| 130h total|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-11-30|11|772|Inflammation and/or fibrotic diseases|Musculo-skeletal system,MA: 0000011 - connective tissue|,MPATH: 212 - inflammation|
2-3-11|Rn-To+350h-WL 1800,16-2 3/75|2| 77|tobacco smoke||unit code not relevant|Inhalation| 130h total|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-11-31|11|784|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-11|Rn-To+350h-WL 1800,16-2 3/75|2| 77|tobacco smoke||unit code not relevant|Inhalation| 130h total|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-11-32|11|798|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-11|Rn-To+350h-WL 1800,16-2 3/75|2| 77|tobacco smoke||unit code not relevant|Inhalation| 130h total|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-11-33|11|805|Neoplasia benign|Lower respiratory system,MA: 0000436 - bronchus|,MPATH: 270 - adenoma|
2-3-11|Rn-To+350h-WL 1800,16-2 3/75|2| 77|tobacco smoke||unit code not relevant|Inhalation| 130h total|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-11-34|11|808|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-11|Rn-To+350h-WL 1800,16-2 3/75|2| 77|tobacco smoke||unit code not relevant|Inhalation| 130h total|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-11-35|11|811|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-11|Rn-To+350h-WL 1800,16-2 3/75|2| 77|tobacco smoke||unit code not relevant|Inhalation| 130h total|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-11-36|11|819|Neoplasia benign|Lower respiratory system,MA: 0000436 - bronchus|,MPATH: 270 - adenoma|
2-3-11|Rn-To+350h-WL 1800,16-2 3/75|2| 77|tobacco smoke||unit code not relevant|Inhalation| 130h total|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-11-37|11|819|Hyperplastic changes|Lower respiratory system|n/a|
2-3-11|Rn-To+350h-WL 1800,16-2 3/75|2| 77|tobacco smoke||unit code not relevant|Inhalation| 130h total|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-11-38|11|819|Neoplasia benign|Lower respiratory system,MA: 0000436 - bronchus|,MPATH: 270 - adenoma|
2-3-11|Rn-To+350h-WL 1800,16-2 3/75|2| 77|tobacco smoke||unit code not relevant|Inhalation| 130h total|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-11-39|11|821|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-11|Rn-To+350h-WL 1800,16-2 3/75|2| 77|tobacco smoke||unit code not relevant|Inhalation| 130h total|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-11-40|11|826|Inflammation and/or fibrotic diseases|Musculo-skeletal system,MA: 0000011 - connective tissue|,MPATH: 212 - inflammation|
2-3-11|Rn-To+350h-WL 1800,16-2 3/75|2| 77|tobacco smoke||unit code not relevant|Inhalation| 130h total|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-11-41|11|846|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
2-3-11|Rn-To+350h-WL 1800,16-2 3/75|2| 77|tobacco smoke||unit code not relevant|Inhalation| 130h total|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-11-42|11|848|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-11|Rn-To+350h-WL 1800,16-2 3/75|2| 77|tobacco smoke||unit code not relevant|Inhalation| 130h total|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-11-43|11|856|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
2-3-11|Rn-To+350h-WL 1800,16-2 3/75|2| 77|tobacco smoke||unit code not relevant|Inhalation| 130h total|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-11-44|11|881|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-11|Rn-To+350h-WL 1800,16-2 3/75|2| 77|tobacco smoke||unit code not relevant|Inhalation| 130h total|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-11-45|11|881|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-11|Rn-To+350h-WL 1800,16-2 3/75|2| 77|tobacco smoke||unit code not relevant|Inhalation| 130h total|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-11-46|11|882|Preneoplastic changes|Lower respiratory system,MA: 0000422 - bronchiole|,MPATH: 171 - squamous metaplasia|
2-3-11|Rn-To+350h-WL 1800,16-2 3/75|2| 77|tobacco smoke||unit code not relevant|Inhalation| 130h total|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-11-47|11|882|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-11|Rn-To+350h-WL 1800,16-2 3/75|2| 77|tobacco smoke||unit code not relevant|Inhalation| 130h total|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-11-48|11|882|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-11|Rn-To+350h-WL 1800,16-2 3/75|2| 77|tobacco smoke||unit code not relevant|Inhalation| 130h total|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-11-49|11|882|Inflammation and/or fibrotic diseases|Musculo-skeletal system,MA: 0000011 - connective tissue|,MPATH: 212 - inflammation|
2-3-11|Rn-To+350h-WL 1800,16-2 3/75|2| 77|tobacco smoke||unit code not relevant|Inhalation| 130h total|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-11-50|11|882|Inflammation and/or fibrotic diseases|Musculo-skeletal system,MA: 0000011 - connective tissue|,MPATH: 212 - inflammation|
2-3-12|Rn-To+150dRE-WL 2100,RN3-50 9/81|1| 77|Rn-222 gas|4000|working level months|Inhalation| Inhaled over 2 m at 4800 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-12-1|12|266|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-3-12|Rn-To+150dRE-WL 2100,RN3-50 9/81|1| 77|Rn-222 gas|4000|working level months|Inhalation| Inhaled over 2 m at 4800 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-12-2|12|266|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-3-12|Rn-To+150dRE-WL 2100,RN3-50 9/81|1| 77|Rn-222 gas|4000|working level months|Inhalation| Inhaled over 2 m at 4800 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-12-3|12|266|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-3-12|Rn-To+150dRE-WL 2100,RN3-50 9/81|1| 77|Rn-222 gas|4000|working level months|Inhalation| Inhaled over 2 m at 4800 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-12-4|12|266|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-3-12|Rn-To+150dRE-WL 2100,RN3-50 9/81|1| 77|Rn-222 gas|4000|working level months|Inhalation| Inhaled over 2 m at 4800 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-12-5|12|266|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-3-12|Rn-To+150dRE-WL 2100,RN3-50 9/81|1| 77|Rn-222 gas|4000|working level months|Inhalation| Inhaled over 2 m at 4800 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-12-6|12|266|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-3-12|Rn-To+150dRE-WL 2100,RN3-50 9/81|1| 77|Rn-222 gas|4000|working level months|Inhalation| Inhaled over 2 m at 4800 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-12-7|12|266|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-3-12|Rn-To+150dRE-WL 2100,RN3-50 9/81|1| 77|Rn-222 gas|4000|working level months|Inhalation| Inhaled over 2 m at 4800 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-12-8|12|270|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-3-12|Rn-To+150dRE-WL 2100,RN3-50 9/81|1| 77|Rn-222 gas|4000|working level months|Inhalation| Inhaled over 2 m at 4800 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-12-9|12|281|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-3-12|Rn-To+150dRE-WL 2100,RN3-50 9/81|1| 77|Rn-222 gas|4000|working level months|Inhalation| Inhaled over 2 m at 4800 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-12-10|12|281|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-3-12|Rn-To+150dRE-WL 2100,RN3-50 9/81|1| 77|Rn-222 gas|4000|working level months|Inhalation| Inhaled over 2 m at 4800 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-12-11|12|286|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-3-12|Rn-To+150dRE-WL 2100,RN3-50 9/81|1| 77|Rn-222 gas|4000|working level months|Inhalation| Inhaled over 2 m at 4800 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-12-12|12|287|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-3-12|Rn-To+150dRE-WL 2100,RN3-50 9/81|1| 77|Rn-222 gas|4000|working level months|Inhalation| Inhaled over 2 m at 4800 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-12-13|12|287|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-3-12|Rn-To+150dRE-WL 2100,RN3-50 9/81|1| 77|Rn-222 gas|4000|working level months|Inhalation| Inhaled over 2 m at 4800 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-12-14|12|291|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-3-12|Rn-To+150dRE-WL 2100,RN3-50 9/81|1| 77|Rn-222 gas|4000|working level months|Inhalation| Inhaled over 2 m at 4800 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-12-15|12|291|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-3-12|Rn-To+150dRE-WL 2100,RN3-50 9/81|1| 77|Rn-222 gas|4000|working level months|Inhalation| Inhaled over 2 m at 4800 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-12-16|12|292|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-3-12|Rn-To+150dRE-WL 2100,RN3-50 9/81|1| 77|Rn-222 gas|4000|working level months|Inhalation| Inhaled over 2 m at 4800 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-12-17|12|299|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-3-12|Rn-To+150dRE-WL 2100,RN3-50 9/81|1| 77|Rn-222 gas|4000|working level months|Inhalation| Inhaled over 2 m at 4800 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-12-18|12|300|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-3-12|Rn-To+150dRE-WL 2100,RN3-50 9/81|1| 77|Rn-222 gas|4000|working level months|Inhalation| Inhaled over 2 m at 4800 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-12-19|12|305|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-3-12|Rn-To+150dRE-WL 2100,RN3-50 9/81|1| 77|Rn-222 gas|4000|working level months|Inhalation| Inhaled over 2 m at 4800 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-12-20|12|307|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-3-12|Rn-To+150dRE-WL 2100,RN3-50 9/81|1| 77|Rn-222 gas|4000|working level months|Inhalation| Inhaled over 2 m at 4800 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-12-21|12|308|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-3-12|Rn-To+150dRE-WL 2100,RN3-50 9/81|1| 77|Rn-222 gas|4000|working level months|Inhalation| Inhaled over 2 m at 4800 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-12-22|12|319|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-3-12|Rn-To+150dRE-WL 2100,RN3-50 9/81|1| 77|Rn-222 gas|4000|working level months|Inhalation| Inhaled over 2 m at 4800 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-12-23|12|323|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-3-12|Rn-To+150dRE-WL 2100,RN3-50 9/81|1| 77|Rn-222 gas|4000|working level months|Inhalation| Inhaled over 2 m at 4800 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-12-24|12|330|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-3-12|Rn-To+150dRE-WL 2100,RN3-50 9/81|1| 77|Rn-222 gas|4000|working level months|Inhalation| Inhaled over 2 m at 4800 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-12-25|12|341|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-3-12|Rn-To+150dRE-WL 2100,RN3-50 9/81|1| 77|Rn-222 gas|4000|working level months|Inhalation| Inhaled over 2 m at 4800 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-12-26|12|349|Other deterministic changes|Lower respiratory system|n/a|
2-3-12|Rn-To+150dRE-WL 2100,RN3-50 9/81|1| 77|Rn-222 gas|4000|working level months|Inhalation| Inhaled over 2 m at 4800 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-12-27|12|351|Other deterministic changes|Lower respiratory system|n/a|
2-3-12|Rn-To+150dRE-WL 2100,RN3-50 9/81|1| 77|Rn-222 gas|4000|working level months|Inhalation| Inhaled over 2 m at 4800 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-12-28|12|357|Other deterministic changes|Lower respiratory system|n/a|
2-3-12|Rn-To+150dRE-WL 2100,RN3-50 9/81|1| 77|Rn-222 gas|4000|working level months|Inhalation| Inhaled over 2 m at 4800 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-12-29|12|364|Other deterministic changes|Lower respiratory system|n/a|
2-3-12|Rn-To+150dRE-WL 2100,RN3-50 9/81|1| 77|Rn-222 gas|4000|working level months|Inhalation| Inhaled over 2 m at 4800 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-12-30|12|364|Other deterministic changes|Lower respiratory system|n/a|
2-3-12|Rn-To+150dRE-WL 2100,RN3-50 9/81|1| 77|Rn-222 gas|4000|working level months|Inhalation| Inhaled over 2 m at 4800 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-12-31|12|368|Other deterministic changes|Lower respiratory system|n/a|
2-3-12|Rn-To+150dRE-WL 2100,RN3-50 9/81|1| 77|Rn-222 gas|4000|working level months|Inhalation| Inhaled over 2 m at 4800 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-12-32|12|368|Other deterministic changes|Lower respiratory system|n/a|
2-3-12|Rn-To+150dRE-WL 2100,RN3-50 9/81|1| 77|Rn-222 gas|4000|working level months|Inhalation| Inhaled over 2 m at 4800 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-12-33|12|386|Other deterministic changes|Lower respiratory system|n/a|
2-3-12|Rn-To+150dRE-WL 2100,RN3-50 9/81|1| 77|Rn-222 gas|4000|working level months|Inhalation| Inhaled over 2 m at 4800 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-12-34|12|388|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-3-12|Rn-To+150dRE-WL 2100,RN3-50 9/81|1| 77|Rn-222 gas|4000|working level months|Inhalation| Inhaled over 2 m at 4800 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-12-35|12|390|Other deterministic changes|Lower respiratory system|n/a|
2-3-12|Rn-To+150dRE-WL 2100,RN3-50 9/81|1| 77|Rn-222 gas|4000|working level months|Inhalation| Inhaled over 2 m at 4800 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-12-36|12|396|Other deterministic changes|Lower respiratory system|n/a|
2-3-12|Rn-To+150dRE-WL 2100,RN3-50 9/81|1| 77|Rn-222 gas|4000|working level months|Inhalation| Inhaled over 2 m at 4800 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-12-37|12|396|Other deterministic changes|Lower respiratory system|n/a|
2-3-12|Rn-To+150dRE-WL 2100,RN3-50 9/81|1| 77|Rn-222 gas|4000|working level months|Inhalation| Inhaled over 2 m at 4800 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-12-38|12|414|Other deterministic changes|Lower respiratory system|n/a|
2-3-12|Rn-To+150dRE-WL 2100,RN3-50 9/81|1| 77|Rn-222 gas|4000|working level months|Inhalation| Inhaled over 2 m at 4800 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-12-39|12|419|Other deterministic changes|Lower respiratory system|n/a|
2-3-12|Rn-To+150dRE-WL 2100,RN3-50 9/81|1| 77|Rn-222 gas|4000|working level months|Inhalation| Inhaled over 2 m at 4800 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-12-40|12|424|Other deterministic changes|Lower respiratory system|n/a|
2-3-12|Rn-To+150dRE-WL 2100,RN3-50 9/81|1| 77|Rn-222 gas|4000|working level months|Inhalation| Inhaled over 2 m at 4800 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-12-41|12|425|Other deterministic changes|Lower respiratory system|n/a|
2-3-12|Rn-To+150dRE-WL 2100,RN3-50 9/81|1| 77|Rn-222 gas|4000|working level months|Inhalation| Inhaled over 2 m at 4800 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-12-42|12|428|Other deterministic changes|Lower respiratory system|n/a|
2-3-12|Rn-To+150dRE-WL 2100,RN3-50 9/81|1| 77|Rn-222 gas|4000|working level months|Inhalation| Inhaled over 2 m at 4800 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-12-43|12|456|Inflammation and/or fibrotic diseases|Musculo-skeletal system,MA: 0000011 - connective tissue|,MPATH: 212 - inflammation|
2-3-12|Rn-To+150dRE-WL 2100,RN3-50 9/81|1| 77|Rn-222 gas|4000|working level months|Inhalation| Inhaled over 2 m at 4800 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-12-44|12|502|Hyperplastic changes|Lower respiratory system|n/a|
2-3-12|Rn-To+150dRE-WL 2100,RN3-50 9/81|1| 77|Rn-222 gas|4000|working level months|Inhalation| Inhaled over 2 m at 4800 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-12-45|12|522|Other deterministic changes|Lower respiratory system|n/a|
2-3-12|Rn-To+150dRE-WL 2100,RN3-50 9/81|1| 77|Rn-222 gas|4000|working level months|Inhalation| Inhaled over 2 m at 4800 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-12-46|12|547|Neoplasia malignant|Integumentary system,MA: 0000151 - skin| metastatic,MPATH: 219 - adnexal and skin appendage tumor|
2-3-12|Rn-To+150dRE-WL 2100,RN3-50 9/81|1| 77|Rn-222 gas|4000|working level months|Inhalation| Inhaled over 2 m at 4800 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-12-47|12|564|Neoplasia malignant|Lower respiratory system|n/a|
2-3-12|Rn-To+150dRE-WL 2100,RN3-50 9/81|1| 77|Rn-222 gas|4000|working level months|Inhalation| Inhaled over 2 m at 4800 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-12-48|12|579|Hyperplastic changes|Lower respiratory system|n/a|
2-3-12|Rn-To+150dRE-WL 2100,RN3-50 9/81|1| 77|Rn-222 gas|4000|working level months|Inhalation| Inhaled over 2 m at 4800 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-12-49|12|579|Other deterministic changes|Lower respiratory system|n/a|
2-3-12|Rn-To+150dRE-WL 2100,RN3-50 9/81|1| 77|Rn-222 gas|4000|working level months|Inhalation| Inhaled over 2 m at 4800 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-12-50|12|579|Hyperplastic changes|Lower respiratory system|n/a|
2-3-12|Rn-To+150dRE-WL 2100,RN3-50 9/81|2| 78|tobacco smoke||unit code not relevant|Inhalation| inhal. for 350 h|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-12-1|12|266|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-3-12|Rn-To+150dRE-WL 2100,RN3-50 9/81|2| 78|tobacco smoke||unit code not relevant|Inhalation| inhal. for 350 h|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-12-2|12|266|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-3-12|Rn-To+150dRE-WL 2100,RN3-50 9/81|2| 78|tobacco smoke||unit code not relevant|Inhalation| inhal. for 350 h|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-12-3|12|266|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-3-12|Rn-To+150dRE-WL 2100,RN3-50 9/81|2| 78|tobacco smoke||unit code not relevant|Inhalation| inhal. for 350 h|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-12-4|12|266|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-3-12|Rn-To+150dRE-WL 2100,RN3-50 9/81|2| 78|tobacco smoke||unit code not relevant|Inhalation| inhal. for 350 h|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-12-5|12|266|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-3-12|Rn-To+150dRE-WL 2100,RN3-50 9/81|2| 78|tobacco smoke||unit code not relevant|Inhalation| inhal. for 350 h|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-12-6|12|266|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-3-12|Rn-To+150dRE-WL 2100,RN3-50 9/81|2| 78|tobacco smoke||unit code not relevant|Inhalation| inhal. for 350 h|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-12-7|12|266|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-3-12|Rn-To+150dRE-WL 2100,RN3-50 9/81|2| 78|tobacco smoke||unit code not relevant|Inhalation| inhal. for 350 h|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-12-8|12|270|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-3-12|Rn-To+150dRE-WL 2100,RN3-50 9/81|2| 78|tobacco smoke||unit code not relevant|Inhalation| inhal. for 350 h|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-12-9|12|281|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-3-12|Rn-To+150dRE-WL 2100,RN3-50 9/81|2| 78|tobacco smoke||unit code not relevant|Inhalation| inhal. for 350 h|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-12-10|12|281|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-3-12|Rn-To+150dRE-WL 2100,RN3-50 9/81|2| 78|tobacco smoke||unit code not relevant|Inhalation| inhal. for 350 h|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-12-11|12|286|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-3-12|Rn-To+150dRE-WL 2100,RN3-50 9/81|2| 78|tobacco smoke||unit code not relevant|Inhalation| inhal. for 350 h|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-12-12|12|287|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-3-12|Rn-To+150dRE-WL 2100,RN3-50 9/81|2| 78|tobacco smoke||unit code not relevant|Inhalation| inhal. for 350 h|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-12-13|12|287|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-3-12|Rn-To+150dRE-WL 2100,RN3-50 9/81|2| 78|tobacco smoke||unit code not relevant|Inhalation| inhal. for 350 h|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-12-14|12|291|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-3-12|Rn-To+150dRE-WL 2100,RN3-50 9/81|2| 78|tobacco smoke||unit code not relevant|Inhalation| inhal. for 350 h|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-12-15|12|291|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-3-12|Rn-To+150dRE-WL 2100,RN3-50 9/81|2| 78|tobacco smoke||unit code not relevant|Inhalation| inhal. for 350 h|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-12-16|12|292|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-3-12|Rn-To+150dRE-WL 2100,RN3-50 9/81|2| 78|tobacco smoke||unit code not relevant|Inhalation| inhal. for 350 h|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-12-17|12|299|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-3-12|Rn-To+150dRE-WL 2100,RN3-50 9/81|2| 78|tobacco smoke||unit code not relevant|Inhalation| inhal. for 350 h|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-12-18|12|300|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-3-12|Rn-To+150dRE-WL 2100,RN3-50 9/81|2| 78|tobacco smoke||unit code not relevant|Inhalation| inhal. for 350 h|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-12-19|12|305|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-3-12|Rn-To+150dRE-WL 2100,RN3-50 9/81|2| 78|tobacco smoke||unit code not relevant|Inhalation| inhal. for 350 h|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-12-20|12|307|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-3-12|Rn-To+150dRE-WL 2100,RN3-50 9/81|2| 78|tobacco smoke||unit code not relevant|Inhalation| inhal. for 350 h|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-12-21|12|308|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-3-12|Rn-To+150dRE-WL 2100,RN3-50 9/81|2| 78|tobacco smoke||unit code not relevant|Inhalation| inhal. for 350 h|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-12-22|12|319|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-3-12|Rn-To+150dRE-WL 2100,RN3-50 9/81|2| 78|tobacco smoke||unit code not relevant|Inhalation| inhal. for 350 h|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-12-23|12|323|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-3-12|Rn-To+150dRE-WL 2100,RN3-50 9/81|2| 78|tobacco smoke||unit code not relevant|Inhalation| inhal. for 350 h|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-12-24|12|330|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-3-12|Rn-To+150dRE-WL 2100,RN3-50 9/81|2| 78|tobacco smoke||unit code not relevant|Inhalation| inhal. for 350 h|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-12-25|12|341|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-3-12|Rn-To+150dRE-WL 2100,RN3-50 9/81|2| 78|tobacco smoke||unit code not relevant|Inhalation| inhal. for 350 h|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-12-26|12|349|Other deterministic changes|Lower respiratory system|n/a|
2-3-12|Rn-To+150dRE-WL 2100,RN3-50 9/81|2| 78|tobacco smoke||unit code not relevant|Inhalation| inhal. for 350 h|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-12-27|12|351|Other deterministic changes|Lower respiratory system|n/a|
2-3-12|Rn-To+150dRE-WL 2100,RN3-50 9/81|2| 78|tobacco smoke||unit code not relevant|Inhalation| inhal. for 350 h|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-12-28|12|357|Other deterministic changes|Lower respiratory system|n/a|
2-3-12|Rn-To+150dRE-WL 2100,RN3-50 9/81|2| 78|tobacco smoke||unit code not relevant|Inhalation| inhal. for 350 h|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-12-29|12|364|Other deterministic changes|Lower respiratory system|n/a|
2-3-12|Rn-To+150dRE-WL 2100,RN3-50 9/81|2| 78|tobacco smoke||unit code not relevant|Inhalation| inhal. for 350 h|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-12-30|12|364|Other deterministic changes|Lower respiratory system|n/a|
2-3-12|Rn-To+150dRE-WL 2100,RN3-50 9/81|2| 78|tobacco smoke||unit code not relevant|Inhalation| inhal. for 350 h|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-12-31|12|368|Other deterministic changes|Lower respiratory system|n/a|
2-3-12|Rn-To+150dRE-WL 2100,RN3-50 9/81|2| 78|tobacco smoke||unit code not relevant|Inhalation| inhal. for 350 h|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-12-32|12|368|Other deterministic changes|Lower respiratory system|n/a|
2-3-12|Rn-To+150dRE-WL 2100,RN3-50 9/81|2| 78|tobacco smoke||unit code not relevant|Inhalation| inhal. for 350 h|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-12-33|12|386|Other deterministic changes|Lower respiratory system|n/a|
2-3-12|Rn-To+150dRE-WL 2100,RN3-50 9/81|2| 78|tobacco smoke||unit code not relevant|Inhalation| inhal. for 350 h|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-12-34|12|388|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-3-12|Rn-To+150dRE-WL 2100,RN3-50 9/81|2| 78|tobacco smoke||unit code not relevant|Inhalation| inhal. for 350 h|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-12-35|12|390|Other deterministic changes|Lower respiratory system|n/a|
2-3-12|Rn-To+150dRE-WL 2100,RN3-50 9/81|2| 78|tobacco smoke||unit code not relevant|Inhalation| inhal. for 350 h|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-12-36|12|396|Other deterministic changes|Lower respiratory system|n/a|
2-3-12|Rn-To+150dRE-WL 2100,RN3-50 9/81|2| 78|tobacco smoke||unit code not relevant|Inhalation| inhal. for 350 h|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-12-37|12|396|Other deterministic changes|Lower respiratory system|n/a|
2-3-12|Rn-To+150dRE-WL 2100,RN3-50 9/81|2| 78|tobacco smoke||unit code not relevant|Inhalation| inhal. for 350 h|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-12-38|12|414|Other deterministic changes|Lower respiratory system|n/a|
2-3-12|Rn-To+150dRE-WL 2100,RN3-50 9/81|2| 78|tobacco smoke||unit code not relevant|Inhalation| inhal. for 350 h|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-12-39|12|419|Other deterministic changes|Lower respiratory system|n/a|
2-3-12|Rn-To+150dRE-WL 2100,RN3-50 9/81|2| 78|tobacco smoke||unit code not relevant|Inhalation| inhal. for 350 h|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-12-40|12|424|Other deterministic changes|Lower respiratory system|n/a|
2-3-12|Rn-To+150dRE-WL 2100,RN3-50 9/81|2| 78|tobacco smoke||unit code not relevant|Inhalation| inhal. for 350 h|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-12-41|12|425|Other deterministic changes|Lower respiratory system|n/a|
2-3-12|Rn-To+150dRE-WL 2100,RN3-50 9/81|2| 78|tobacco smoke||unit code not relevant|Inhalation| inhal. for 350 h|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-12-42|12|428|Other deterministic changes|Lower respiratory system|n/a|
2-3-12|Rn-To+150dRE-WL 2100,RN3-50 9/81|2| 78|tobacco smoke||unit code not relevant|Inhalation| inhal. for 350 h|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-12-43|12|456|Inflammation and/or fibrotic diseases|Musculo-skeletal system,MA: 0000011 - connective tissue|,MPATH: 212 - inflammation|
2-3-12|Rn-To+150dRE-WL 2100,RN3-50 9/81|2| 78|tobacco smoke||unit code not relevant|Inhalation| inhal. for 350 h|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-12-44|12|502|Hyperplastic changes|Lower respiratory system|n/a|
2-3-12|Rn-To+150dRE-WL 2100,RN3-50 9/81|2| 78|tobacco smoke||unit code not relevant|Inhalation| inhal. for 350 h|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-12-45|12|522|Other deterministic changes|Lower respiratory system|n/a|
2-3-12|Rn-To+150dRE-WL 2100,RN3-50 9/81|2| 78|tobacco smoke||unit code not relevant|Inhalation| inhal. for 350 h|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-12-46|12|547|Neoplasia malignant|Integumentary system,MA: 0000151 - skin| metastatic,MPATH: 219 - adnexal and skin appendage tumor|
2-3-12|Rn-To+150dRE-WL 2100,RN3-50 9/81|2| 78|tobacco smoke||unit code not relevant|Inhalation| inhal. for 350 h|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-12-47|12|564|Neoplasia malignant|Lower respiratory system|n/a|
2-3-12|Rn-To+150dRE-WL 2100,RN3-50 9/81|2| 78|tobacco smoke||unit code not relevant|Inhalation| inhal. for 350 h|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-12-48|12|579|Hyperplastic changes|Lower respiratory system|n/a|
2-3-12|Rn-To+150dRE-WL 2100,RN3-50 9/81|2| 78|tobacco smoke||unit code not relevant|Inhalation| inhal. for 350 h|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-12-49|12|579|Other deterministic changes|Lower respiratory system|n/a|
2-3-12|Rn-To+150dRE-WL 2100,RN3-50 9/81|2| 78|tobacco smoke||unit code not relevant|Inhalation| inhal. for 350 h|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-12-50|12|579|Hyperplastic changes|Lower respiratory system|n/a|
2-3-12|Rn-To+150dRE-WL 2100,RN3-50 9/81|3| 317|retinoic acid|25|milligrams per kg animal|Injection, not specified| injected 24*7 d|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-12-1|12|266|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-3-12|Rn-To+150dRE-WL 2100,RN3-50 9/81|3| 317|retinoic acid|25|milligrams per kg animal|Injection, not specified| injected 24*7 d|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-12-2|12|266|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-3-12|Rn-To+150dRE-WL 2100,RN3-50 9/81|3| 317|retinoic acid|25|milligrams per kg animal|Injection, not specified| injected 24*7 d|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-12-3|12|266|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-3-12|Rn-To+150dRE-WL 2100,RN3-50 9/81|3| 317|retinoic acid|25|milligrams per kg animal|Injection, not specified| injected 24*7 d|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-12-4|12|266|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-3-12|Rn-To+150dRE-WL 2100,RN3-50 9/81|3| 317|retinoic acid|25|milligrams per kg animal|Injection, not specified| injected 24*7 d|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-12-5|12|266|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-3-12|Rn-To+150dRE-WL 2100,RN3-50 9/81|3| 317|retinoic acid|25|milligrams per kg animal|Injection, not specified| injected 24*7 d|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-12-6|12|266|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-3-12|Rn-To+150dRE-WL 2100,RN3-50 9/81|3| 317|retinoic acid|25|milligrams per kg animal|Injection, not specified| injected 24*7 d|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-12-7|12|266|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-3-12|Rn-To+150dRE-WL 2100,RN3-50 9/81|3| 317|retinoic acid|25|milligrams per kg animal|Injection, not specified| injected 24*7 d|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-12-8|12|270|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-3-12|Rn-To+150dRE-WL 2100,RN3-50 9/81|3| 317|retinoic acid|25|milligrams per kg animal|Injection, not specified| injected 24*7 d|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-12-9|12|281|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-3-12|Rn-To+150dRE-WL 2100,RN3-50 9/81|3| 317|retinoic acid|25|milligrams per kg animal|Injection, not specified| injected 24*7 d|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-12-10|12|281|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-3-12|Rn-To+150dRE-WL 2100,RN3-50 9/81|3| 317|retinoic acid|25|milligrams per kg animal|Injection, not specified| injected 24*7 d|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-12-11|12|286|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-3-12|Rn-To+150dRE-WL 2100,RN3-50 9/81|3| 317|retinoic acid|25|milligrams per kg animal|Injection, not specified| injected 24*7 d|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-12-12|12|287|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-3-12|Rn-To+150dRE-WL 2100,RN3-50 9/81|3| 317|retinoic acid|25|milligrams per kg animal|Injection, not specified| injected 24*7 d|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-12-13|12|287|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-3-12|Rn-To+150dRE-WL 2100,RN3-50 9/81|3| 317|retinoic acid|25|milligrams per kg animal|Injection, not specified| injected 24*7 d|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-12-14|12|291|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-3-12|Rn-To+150dRE-WL 2100,RN3-50 9/81|3| 317|retinoic acid|25|milligrams per kg animal|Injection, not specified| injected 24*7 d|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-12-15|12|291|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-3-12|Rn-To+150dRE-WL 2100,RN3-50 9/81|3| 317|retinoic acid|25|milligrams per kg animal|Injection, not specified| injected 24*7 d|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-12-16|12|292|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-3-12|Rn-To+150dRE-WL 2100,RN3-50 9/81|3| 317|retinoic acid|25|milligrams per kg animal|Injection, not specified| injected 24*7 d|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-12-17|12|299|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-3-12|Rn-To+150dRE-WL 2100,RN3-50 9/81|3| 317|retinoic acid|25|milligrams per kg animal|Injection, not specified| injected 24*7 d|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-12-18|12|300|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-3-12|Rn-To+150dRE-WL 2100,RN3-50 9/81|3| 317|retinoic acid|25|milligrams per kg animal|Injection, not specified| injected 24*7 d|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-12-19|12|305|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-3-12|Rn-To+150dRE-WL 2100,RN3-50 9/81|3| 317|retinoic acid|25|milligrams per kg animal|Injection, not specified| injected 24*7 d|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-12-20|12|307|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-3-12|Rn-To+150dRE-WL 2100,RN3-50 9/81|3| 317|retinoic acid|25|milligrams per kg animal|Injection, not specified| injected 24*7 d|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-12-21|12|308|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-3-12|Rn-To+150dRE-WL 2100,RN3-50 9/81|3| 317|retinoic acid|25|milligrams per kg animal|Injection, not specified| injected 24*7 d|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-12-22|12|319|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-3-12|Rn-To+150dRE-WL 2100,RN3-50 9/81|3| 317|retinoic acid|25|milligrams per kg animal|Injection, not specified| injected 24*7 d|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-12-23|12|323|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-3-12|Rn-To+150dRE-WL 2100,RN3-50 9/81|3| 317|retinoic acid|25|milligrams per kg animal|Injection, not specified| injected 24*7 d|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-12-24|12|330|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-3-12|Rn-To+150dRE-WL 2100,RN3-50 9/81|3| 317|retinoic acid|25|milligrams per kg animal|Injection, not specified| injected 24*7 d|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-12-25|12|341|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-3-12|Rn-To+150dRE-WL 2100,RN3-50 9/81|3| 317|retinoic acid|25|milligrams per kg animal|Injection, not specified| injected 24*7 d|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-12-26|12|349|Other deterministic changes|Lower respiratory system|n/a|
2-3-12|Rn-To+150dRE-WL 2100,RN3-50 9/81|3| 317|retinoic acid|25|milligrams per kg animal|Injection, not specified| injected 24*7 d|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-12-27|12|351|Other deterministic changes|Lower respiratory system|n/a|
2-3-12|Rn-To+150dRE-WL 2100,RN3-50 9/81|3| 317|retinoic acid|25|milligrams per kg animal|Injection, not specified| injected 24*7 d|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-12-28|12|357|Other deterministic changes|Lower respiratory system|n/a|
2-3-12|Rn-To+150dRE-WL 2100,RN3-50 9/81|3| 317|retinoic acid|25|milligrams per kg animal|Injection, not specified| injected 24*7 d|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-12-29|12|364|Other deterministic changes|Lower respiratory system|n/a|
2-3-12|Rn-To+150dRE-WL 2100,RN3-50 9/81|3| 317|retinoic acid|25|milligrams per kg animal|Injection, not specified| injected 24*7 d|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-12-30|12|364|Other deterministic changes|Lower respiratory system|n/a|
2-3-12|Rn-To+150dRE-WL 2100,RN3-50 9/81|3| 317|retinoic acid|25|milligrams per kg animal|Injection, not specified| injected 24*7 d|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-12-31|12|368|Other deterministic changes|Lower respiratory system|n/a|
2-3-12|Rn-To+150dRE-WL 2100,RN3-50 9/81|3| 317|retinoic acid|25|milligrams per kg animal|Injection, not specified| injected 24*7 d|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-12-32|12|368|Other deterministic changes|Lower respiratory system|n/a|
2-3-12|Rn-To+150dRE-WL 2100,RN3-50 9/81|3| 317|retinoic acid|25|milligrams per kg animal|Injection, not specified| injected 24*7 d|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-12-33|12|386|Other deterministic changes|Lower respiratory system|n/a|
2-3-12|Rn-To+150dRE-WL 2100,RN3-50 9/81|3| 317|retinoic acid|25|milligrams per kg animal|Injection, not specified| injected 24*7 d|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-12-34|12|388|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-3-12|Rn-To+150dRE-WL 2100,RN3-50 9/81|3| 317|retinoic acid|25|milligrams per kg animal|Injection, not specified| injected 24*7 d|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-12-35|12|390|Other deterministic changes|Lower respiratory system|n/a|
2-3-12|Rn-To+150dRE-WL 2100,RN3-50 9/81|3| 317|retinoic acid|25|milligrams per kg animal|Injection, not specified| injected 24*7 d|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-12-36|12|396|Other deterministic changes|Lower respiratory system|n/a|
2-3-12|Rn-To+150dRE-WL 2100,RN3-50 9/81|3| 317|retinoic acid|25|milligrams per kg animal|Injection, not specified| injected 24*7 d|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-12-37|12|396|Other deterministic changes|Lower respiratory system|n/a|
2-3-12|Rn-To+150dRE-WL 2100,RN3-50 9/81|3| 317|retinoic acid|25|milligrams per kg animal|Injection, not specified| injected 24*7 d|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-12-38|12|414|Other deterministic changes|Lower respiratory system|n/a|
2-3-12|Rn-To+150dRE-WL 2100,RN3-50 9/81|3| 317|retinoic acid|25|milligrams per kg animal|Injection, not specified| injected 24*7 d|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-12-39|12|419|Other deterministic changes|Lower respiratory system|n/a|
2-3-12|Rn-To+150dRE-WL 2100,RN3-50 9/81|3| 317|retinoic acid|25|milligrams per kg animal|Injection, not specified| injected 24*7 d|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-12-40|12|424|Other deterministic changes|Lower respiratory system|n/a|
2-3-12|Rn-To+150dRE-WL 2100,RN3-50 9/81|3| 317|retinoic acid|25|milligrams per kg animal|Injection, not specified| injected 24*7 d|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-12-41|12|425|Other deterministic changes|Lower respiratory system|n/a|
2-3-12|Rn-To+150dRE-WL 2100,RN3-50 9/81|3| 317|retinoic acid|25|milligrams per kg animal|Injection, not specified| injected 24*7 d|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-12-42|12|428|Other deterministic changes|Lower respiratory system|n/a|
2-3-12|Rn-To+150dRE-WL 2100,RN3-50 9/81|3| 317|retinoic acid|25|milligrams per kg animal|Injection, not specified| injected 24*7 d|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-12-43|12|456|Inflammation and/or fibrotic diseases|Musculo-skeletal system,MA: 0000011 - connective tissue|,MPATH: 212 - inflammation|
2-3-12|Rn-To+150dRE-WL 2100,RN3-50 9/81|3| 317|retinoic acid|25|milligrams per kg animal|Injection, not specified| injected 24*7 d|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-12-44|12|502|Hyperplastic changes|Lower respiratory system|n/a|
2-3-12|Rn-To+150dRE-WL 2100,RN3-50 9/81|3| 317|retinoic acid|25|milligrams per kg animal|Injection, not specified| injected 24*7 d|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-12-45|12|522|Other deterministic changes|Lower respiratory system|n/a|
2-3-12|Rn-To+150dRE-WL 2100,RN3-50 9/81|3| 317|retinoic acid|25|milligrams per kg animal|Injection, not specified| injected 24*7 d|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-12-46|12|547|Neoplasia malignant|Integumentary system,MA: 0000151 - skin| metastatic,MPATH: 219 - adnexal and skin appendage tumor|
2-3-12|Rn-To+150dRE-WL 2100,RN3-50 9/81|3| 317|retinoic acid|25|milligrams per kg animal|Injection, not specified| injected 24*7 d|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-12-47|12|564|Neoplasia malignant|Lower respiratory system|n/a|
2-3-12|Rn-To+150dRE-WL 2100,RN3-50 9/81|3| 317|retinoic acid|25|milligrams per kg animal|Injection, not specified| injected 24*7 d|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-12-48|12|579|Hyperplastic changes|Lower respiratory system|n/a|
2-3-12|Rn-To+150dRE-WL 2100,RN3-50 9/81|3| 317|retinoic acid|25|milligrams per kg animal|Injection, not specified| injected 24*7 d|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-12-49|12|579|Other deterministic changes|Lower respiratory system|n/a|
2-3-12|Rn-To+150dRE-WL 2100,RN3-50 9/81|3| 317|retinoic acid|25|milligrams per kg animal|Injection, not specified| injected 24*7 d|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-12-50|12|579|Hyperplastic changes|Lower respiratory system|n/a|
2-3-13|Rn-To+280d-WL 2240,36-1 5/75|1| 77|Rn-222 gas|1600|working level months|Inhalation| Inhaled over 4 m at 3000 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-13-1|13|378|Other deterministic changes|Lower respiratory system|n/a|
2-3-13|Rn-To+280d-WL 2240,36-1 5/75|1| 77|Rn-222 gas|1600|working level months|Inhalation| Inhaled over 4 m at 3000 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-13-2|13|401|Neoplasia benign|Lower respiratory system|n/a|
2-3-13|Rn-To+280d-WL 2240,36-1 5/75|1| 77|Rn-222 gas|1600|working level months|Inhalation| Inhaled over 4 m at 3000 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-13-3|13|482|Hyperplastic changes|Lower respiratory system|n/a|
2-3-13|Rn-To+280d-WL 2240,36-1 5/75|1| 77|Rn-222 gas|1600|working level months|Inhalation| Inhaled over 4 m at 3000 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-13-4|13|484|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-13|Rn-To+280d-WL 2240,36-1 5/75|1| 77|Rn-222 gas|1600|working level months|Inhalation| Inhaled over 4 m at 3000 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-13-5|13|490|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 268 - adenocarcinoma|
2-3-13|Rn-To+280d-WL 2240,36-1 5/75|1| 77|Rn-222 gas|1600|working level months|Inhalation| Inhaled over 4 m at 3000 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-13-6|13|617|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-13|Rn-To+280d-WL 2240,36-1 5/75|1| 77|Rn-222 gas|1600|working level months|Inhalation| Inhaled over 4 m at 3000 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-13-7|13|650|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
2-3-13|Rn-To+280d-WL 2240,36-1 5/75|1| 77|Rn-222 gas|1600|working level months|Inhalation| Inhaled over 4 m at 3000 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-13-8|13|653|Neoplasia benign|Lower respiratory system|n/a|
2-3-13|Rn-To+280d-WL 2240,36-1 5/75|1| 77|Rn-222 gas|1600|working level months|Inhalation| Inhaled over 4 m at 3000 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-13-9|13|786|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-13|Rn-To+280d-WL 2240,36-1 5/75|1| 77|Rn-222 gas|1600|working level months|Inhalation| Inhaled over 4 m at 3000 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-13-10|13|875|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-13|Rn-To+280d-WL 2240,36-1 5/75|2| 257|tobacco smoke||unit code not relevant|Inhalation| inhaled for 3.5 m|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-13-1|13|378|Other deterministic changes|Lower respiratory system|n/a|
2-3-13|Rn-To+280d-WL 2240,36-1 5/75|2| 257|tobacco smoke||unit code not relevant|Inhalation| inhaled for 3.5 m|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-13-2|13|401|Neoplasia benign|Lower respiratory system|n/a|
2-3-13|Rn-To+280d-WL 2240,36-1 5/75|2| 257|tobacco smoke||unit code not relevant|Inhalation| inhaled for 3.5 m|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-13-3|13|482|Hyperplastic changes|Lower respiratory system|n/a|
2-3-13|Rn-To+280d-WL 2240,36-1 5/75|2| 257|tobacco smoke||unit code not relevant|Inhalation| inhaled for 3.5 m|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-13-4|13|484|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-13|Rn-To+280d-WL 2240,36-1 5/75|2| 257|tobacco smoke||unit code not relevant|Inhalation| inhaled for 3.5 m|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-13-5|13|490|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 268 - adenocarcinoma|
2-3-13|Rn-To+280d-WL 2240,36-1 5/75|2| 257|tobacco smoke||unit code not relevant|Inhalation| inhaled for 3.5 m|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-13-6|13|617|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-13|Rn-To+280d-WL 2240,36-1 5/75|2| 257|tobacco smoke||unit code not relevant|Inhalation| inhaled for 3.5 m|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-13-7|13|650|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
2-3-13|Rn-To+280d-WL 2240,36-1 5/75|2| 257|tobacco smoke||unit code not relevant|Inhalation| inhaled for 3.5 m|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-13-8|13|653|Neoplasia benign|Lower respiratory system|n/a|
2-3-13|Rn-To+280d-WL 2240,36-1 5/75|2| 257|tobacco smoke||unit code not relevant|Inhalation| inhaled for 3.5 m|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-13-9|13|786|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-13|Rn-To+280d-WL 2240,36-1 5/75|2| 257|tobacco smoke||unit code not relevant|Inhalation| inhaled for 3.5 m|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-13-10|13|875|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-14|Rn-To+280dBNF-WL 2240,38 6/79|1| 77|Rn-222 gas|2240|working level months|Inhalation| Inhaled over 2.5 m at 1200 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-14-1|14|378|Other deterministic changes|Lower respiratory system|n/a|
2-3-14|Rn-To+280dBNF-WL 2240,38 6/79|1| 77|Rn-222 gas|2240|working level months|Inhalation| Inhaled over 2.5 m at 1200 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-14-2|14|401|Neoplasia benign|Lower respiratory system|n/a|
2-3-14|Rn-To+280dBNF-WL 2240,38 6/79|1| 77|Rn-222 gas|2240|working level months|Inhalation| Inhaled over 2.5 m at 1200 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-14-3|14|482|Hyperplastic changes|Lower respiratory system|n/a|
2-3-14|Rn-To+280dBNF-WL 2240,38 6/79|1| 77|Rn-222 gas|2240|working level months|Inhalation| Inhaled over 2.5 m at 1200 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-14-4|14|484|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-14|Rn-To+280dBNF-WL 2240,38 6/79|1| 77|Rn-222 gas|2240|working level months|Inhalation| Inhaled over 2.5 m at 1200 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-14-5|14|490|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 268 - adenocarcinoma|
2-3-14|Rn-To+280dBNF-WL 2240,38 6/79|1| 77|Rn-222 gas|2240|working level months|Inhalation| Inhaled over 2.5 m at 1200 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-14-6|14|617|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-14|Rn-To+280dBNF-WL 2240,38 6/79|1| 77|Rn-222 gas|2240|working level months|Inhalation| Inhaled over 2.5 m at 1200 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-14-7|14|650|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
2-3-14|Rn-To+280dBNF-WL 2240,38 6/79|1| 77|Rn-222 gas|2240|working level months|Inhalation| Inhaled over 2.5 m at 1200 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-14-8|14|653|Neoplasia benign|Lower respiratory system|n/a|
2-3-14|Rn-To+280dBNF-WL 2240,38 6/79|1| 77|Rn-222 gas|2240|working level months|Inhalation| Inhaled over 2.5 m at 1200 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-14-9|14|786|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-14|Rn-To+280dBNF-WL 2240,38 6/79|1| 77|Rn-222 gas|2240|working level months|Inhalation| Inhaled over 2.5 m at 1200 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-14-10|14|875|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-14|Rn-To+280dBNF-WL 2240,38 6/79|2| 357|tobacco smoke||unit code not relevant|Inhalation| inhaled for 3.5 m|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-14-1|14|378|Other deterministic changes|Lower respiratory system|n/a|
2-3-14|Rn-To+280dBNF-WL 2240,38 6/79|2| 357|tobacco smoke||unit code not relevant|Inhalation| inhaled for 3.5 m|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-14-2|14|401|Neoplasia benign|Lower respiratory system|n/a|
2-3-14|Rn-To+280dBNF-WL 2240,38 6/79|2| 357|tobacco smoke||unit code not relevant|Inhalation| inhaled for 3.5 m|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-14-3|14|482|Hyperplastic changes|Lower respiratory system|n/a|
2-3-14|Rn-To+280dBNF-WL 2240,38 6/79|2| 357|tobacco smoke||unit code not relevant|Inhalation| inhaled for 3.5 m|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-14-4|14|484|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-14|Rn-To+280dBNF-WL 2240,38 6/79|2| 357|tobacco smoke||unit code not relevant|Inhalation| inhaled for 3.5 m|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-14-5|14|490|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 268 - adenocarcinoma|
2-3-14|Rn-To+280dBNF-WL 2240,38 6/79|2| 357|tobacco smoke||unit code not relevant|Inhalation| inhaled for 3.5 m|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-14-6|14|617|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-14|Rn-To+280dBNF-WL 2240,38 6/79|2| 357|tobacco smoke||unit code not relevant|Inhalation| inhaled for 3.5 m|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-14-7|14|650|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
2-3-14|Rn-To+280dBNF-WL 2240,38 6/79|2| 357|tobacco smoke||unit code not relevant|Inhalation| inhaled for 3.5 m|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-14-8|14|653|Neoplasia benign|Lower respiratory system|n/a|
2-3-14|Rn-To+280dBNF-WL 2240,38 6/79|2| 357|tobacco smoke||unit code not relevant|Inhalation| inhaled for 3.5 m|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-14-9|14|786|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-14|Rn-To+280dBNF-WL 2240,38 6/79|2| 357|tobacco smoke||unit code not relevant|Inhalation| inhaled for 3.5 m|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-14-10|14|875|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-14|Rn-To+280dBNF-WL 2240,38 6/79|3| 357|BNF -naphtoflavone|25|milligrams per kg animal|Injection, not specified| inject|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-14-1|14|378|Other deterministic changes|Lower respiratory system|n/a|
2-3-14|Rn-To+280dBNF-WL 2240,38 6/79|3| 357|BNF -naphtoflavone|25|milligrams per kg animal|Injection, not specified| inject|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-14-2|14|401|Neoplasia benign|Lower respiratory system|n/a|
2-3-14|Rn-To+280dBNF-WL 2240,38 6/79|3| 357|BNF -naphtoflavone|25|milligrams per kg animal|Injection, not specified| inject|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-14-3|14|482|Hyperplastic changes|Lower respiratory system|n/a|
2-3-14|Rn-To+280dBNF-WL 2240,38 6/79|3| 357|BNF -naphtoflavone|25|milligrams per kg animal|Injection, not specified| inject|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-14-4|14|484|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-14|Rn-To+280dBNF-WL 2240,38 6/79|3| 357|BNF -naphtoflavone|25|milligrams per kg animal|Injection, not specified| inject|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-14-5|14|490|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 268 - adenocarcinoma|
2-3-14|Rn-To+280dBNF-WL 2240,38 6/79|3| 357|BNF -naphtoflavone|25|milligrams per kg animal|Injection, not specified| inject|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-14-6|14|617|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-14|Rn-To+280dBNF-WL 2240,38 6/79|3| 357|BNF -naphtoflavone|25|milligrams per kg animal|Injection, not specified| inject|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-14-7|14|650|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
2-3-14|Rn-To+280dBNF-WL 2240,38 6/79|3| 357|BNF -naphtoflavone|25|milligrams per kg animal|Injection, not specified| inject|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-14-8|14|653|Neoplasia benign|Lower respiratory system|n/a|
2-3-14|Rn-To+280dBNF-WL 2240,38 6/79|3| 357|BNF -naphtoflavone|25|milligrams per kg animal|Injection, not specified| inject|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-14-9|14|786|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-14|Rn-To+280dBNF-WL 2240,38 6/79|3| 357|BNF -naphtoflavone|25|milligrams per kg animal|Injection, not specified| inject|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-14-10|14|875|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-15|Rn-To-WL 4000,8-1 3/73|1| 77|Rn-222 gas|4000|working level months|Inhalation| Inhaled over 2 m at 4800 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-15-1|15|7|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-3-15|Rn-To-WL 4000,8-1 3/73|1| 77|Rn-222 gas|4000|working level months|Inhalation| Inhaled over 2 m at 4800 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-15-2|15|186|Other deterministic changes|Whole body|n/a|
2-3-15|Rn-To-WL 4000,8-1 3/73|1| 77|Rn-222 gas|4000|working level months|Inhalation| Inhaled over 2 m at 4800 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-15-3|15|216|Other deterministic changes|Whole body|n/a|
2-3-15|Rn-To-WL 4000,8-1 3/73|1| 77|Rn-222 gas|4000|working level months|Inhalation| Inhaled over 2 m at 4800 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-15-4|15|216|Other deterministic changes|Whole body|n/a|
2-3-15|Rn-To-WL 4000,8-1 3/73|1| 77|Rn-222 gas|4000|working level months|Inhalation| Inhaled over 2 m at 4800 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-15-5|15|226|Other deterministic changes|Whole body|n/a|
2-3-15|Rn-To-WL 4000,8-1 3/73|1| 77|Rn-222 gas|4000|working level months|Inhalation| Inhaled over 2 m at 4800 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-15-6|15|229|Other deterministic changes|Whole body|n/a|
2-3-15|Rn-To-WL 4000,8-1 3/73|1| 77|Rn-222 gas|4000|working level months|Inhalation| Inhaled over 2 m at 4800 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-15-7|15|252|Other deterministic changes|Whole body|n/a|
2-3-15|Rn-To-WL 4000,8-1 3/73|1| 77|Rn-222 gas|4000|working level months|Inhalation| Inhaled over 2 m at 4800 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-15-8|15|256|Other deterministic changes|Whole body|n/a|
2-3-15|Rn-To-WL 4000,8-1 3/73|1| 77|Rn-222 gas|4000|working level months|Inhalation| Inhaled over 2 m at 4800 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-15-9|15|263|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-3-15|Rn-To-WL 4000,8-1 3/73|1| 77|Rn-222 gas|4000|working level months|Inhalation| Inhaled over 2 m at 4800 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-15-10|15|276|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-3-15|Rn-To-WL 4000,8-1 3/73|1| 77|Rn-222 gas|4000|working level months|Inhalation| Inhaled over 2 m at 4800 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-15-11|15|276|Hyperplastic changes|Lower respiratory system|n/a|
2-3-15|Rn-To-WL 4000,8-1 3/73|1| 77|Rn-222 gas|4000|working level months|Inhalation| Inhaled over 2 m at 4800 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-15-12|15|276|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-3-15|Rn-To-WL 4000,8-1 3/73|1| 77|Rn-222 gas|4000|working level months|Inhalation| Inhaled over 2 m at 4800 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-15-13|15|276|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-3-15|Rn-To-WL 4000,8-1 3/73|1| 77|Rn-222 gas|4000|working level months|Inhalation| Inhaled over 2 m at 4800 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-15-14|15|276|Neoplasia benign|Lower respiratory system,MA: 0000436 - bronchus|,MPATH: 270 - adenoma|
2-3-15|Rn-To-WL 4000,8-1 3/73|1| 77|Rn-222 gas|4000|working level months|Inhalation| Inhaled over 2 m at 4800 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-15-15|15|276|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-3-15|Rn-To-WL 4000,8-1 3/73|1| 77|Rn-222 gas|4000|working level months|Inhalation| Inhaled over 2 m at 4800 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-15-16|15|276|Neoplasia benign|Lower respiratory system,MA: 0000436 - bronchus|,MPATH: 270 - adenoma|
2-3-15|Rn-To-WL 4000,8-1 3/73|1| 77|Rn-222 gas|4000|working level months|Inhalation| Inhaled over 2 m at 4800 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-15-17|15|276|Neoplasia benign|Lower respiratory system,MA: 0000436 - bronchus|,MPATH: 270 - adenoma|
2-3-15|Rn-To-WL 4000,8-1 3/73|1| 77|Rn-222 gas|4000|working level months|Inhalation| Inhaled over 2 m at 4800 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-15-18|15|276|Hyperplastic changes|Lower respiratory system|n/a|
2-3-15|Rn-To-WL 4000,8-1 3/73|1| 77|Rn-222 gas|4000|working level months|Inhalation| Inhaled over 2 m at 4800 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-15-19|15|356|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-3-15|Rn-To-WL 4000,8-1 3/73|1| 77|Rn-222 gas|4000|working level months|Inhalation| Inhaled over 2 m at 4800 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-15-20|15|357|Other deterministic changes|Whole body|n/a|
2-3-15|Rn-To-WL 4000,8-1 3/73|1| 77|Rn-222 gas|4000|working level months|Inhalation| Inhaled over 2 m at 4800 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-15-21|15|363|Other deterministic changes|Whole body|n/a|
2-3-15|Rn-To-WL 4000,8-1 3/73|1| 77|Rn-222 gas|4000|working level months|Inhalation| Inhaled over 2 m at 4800 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-15-22|15|365|Other deterministic changes|Whole body|n/a|
2-3-15|Rn-To-WL 4000,8-1 3/73|1| 77|Rn-222 gas|4000|working level months|Inhalation| Inhaled over 2 m at 4800 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-15-23|15|390|Neoplasia benign|Lower respiratory system,MA: 0000436 - bronchus|,MPATH: 270 - adenoma|
2-3-15|Rn-To-WL 4000,8-1 3/73|1| 77|Rn-222 gas|4000|working level months|Inhalation| Inhaled over 2 m at 4800 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-15-24|15|427|Neoplasia malignant|Upper respiratory system,MA: 0000442 - upper respiratory tract|,MPATH: 218 - neoplasm|
2-3-15|Rn-To-WL 4000,8-1 3/73|1| 77|Rn-222 gas|4000|working level months|Inhalation| Inhaled over 2 m at 4800 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-15-25|15|431|Neoplasia benign|Lower respiratory system,MA: 0000436 - bronchus|,MPATH: 270 - adenoma|
2-3-15|Rn-To-WL 4000,8-1 3/73|1| 77|Rn-222 gas|4000|working level months|Inhalation| Inhaled over 2 m at 4800 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-15-26|15|447|Other deterministic changes|Whole body|n/a|
2-3-15|Rn-To-WL 4000,8-1 3/73|1| 77|Rn-222 gas|4000|working level months|Inhalation| Inhaled over 2 m at 4800 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-15-27|15|455|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-15|Rn-To-WL 4000,8-1 3/73|1| 77|Rn-222 gas|4000|working level months|Inhalation| Inhaled over 2 m at 4800 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-15-28|15|467|Preneoplastic changes|Lower respiratory system,MA: 0000422 - bronchiole|,MPATH: 171 - squamous metaplasia|
2-3-15|Rn-To-WL 4000,8-1 3/73|1| 77|Rn-222 gas|4000|working level months|Inhalation| Inhaled over 2 m at 4800 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-15-29|15|467|Preneoplastic changes|Lower respiratory system,MA: 0000422 - bronchiole|,MPATH: 171 - squamous metaplasia|
2-3-15|Rn-To-WL 4000,8-1 3/73|1| 77|Rn-222 gas|4000|working level months|Inhalation| Inhaled over 2 m at 4800 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-15-30|15|467|Preneoplastic changes|Lower respiratory system,MA: 0000422 - bronchiole|,MPATH: 171 - squamous metaplasia|
2-3-15|Rn-To-WL 4000,8-1 3/73|1| 77|Rn-222 gas|4000|working level months|Inhalation| Inhaled over 2 m at 4800 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-15-31|15|467|Preneoplastic changes|Lower respiratory system,MA: 0000422 - bronchiole|,MPATH: 171 - squamous metaplasia|
2-3-15|Rn-To-WL 4000,8-1 3/73|1| 77|Rn-222 gas|4000|working level months|Inhalation| Inhaled over 2 m at 4800 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-15-32|15|467|Preneoplastic changes|Lower respiratory system,MA: 0000422 - bronchiole|,MPATH: 171 - squamous metaplasia|
2-3-15|Rn-To-WL 4000,8-1 3/73|1| 77|Rn-222 gas|4000|working level months|Inhalation| Inhaled over 2 m at 4800 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-15-33|15|467|Preneoplastic changes|Lower respiratory system,MA: 0000422 - bronchiole|,MPATH: 171 - squamous metaplasia|
2-3-15|Rn-To-WL 4000,8-1 3/73|1| 77|Rn-222 gas|4000|working level months|Inhalation| Inhaled over 2 m at 4800 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-15-34|15|467|Neoplasia benign|Lower respiratory system,MA: 0000433 - pleura|,MPATH: 365 - mesothelioma|
2-3-15|Rn-To-WL 4000,8-1 3/73|1| 77|Rn-222 gas|4000|working level months|Inhalation| Inhaled over 2 m at 4800 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-15-35|15|467|Hyperplastic changes|Lower respiratory system|n/a|
2-3-15|Rn-To-WL 4000,8-1 3/73|1| 77|Rn-222 gas|4000|working level months|Inhalation| Inhaled over 2 m at 4800 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-15-36|15|485|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-15|Rn-To-WL 4000,8-1 3/73|1| 77|Rn-222 gas|4000|working level months|Inhalation| Inhaled over 2 m at 4800 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-15-37|15|535|Hyperplastic changes|Lower respiratory system|n/a|
2-3-15|Rn-To-WL 4000,8-1 3/73|1| 77|Rn-222 gas|4000|working level months|Inhalation| Inhaled over 2 m at 4800 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-15-38|15|545|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-15|Rn-To-WL 4000,8-1 3/73|1| 77|Rn-222 gas|4000|working level months|Inhalation| Inhaled over 2 m at 4800 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-15-39|15|553|Neoplasia benign|Lower respiratory system,MA: 0000436 - bronchus|,MPATH: 270 - adenoma|
2-3-15|Rn-To-WL 4000,8-1 3/73|1| 77|Rn-222 gas|4000|working level months|Inhalation| Inhaled over 2 m at 4800 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-15-40|15|561|Hyperplastic changes|Lower respiratory system|n/a|
2-3-15|Rn-To-WL 4000,8-1 3/73|1| 77|Rn-222 gas|4000|working level months|Inhalation| Inhaled over 2 m at 4800 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-15-41|15|576|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-15|Rn-To-WL 4000,8-1 3/73|1| 77|Rn-222 gas|4000|working level months|Inhalation| Inhaled over 2 m at 4800 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-15-42|15|576|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-15|Rn-To-WL 4000,8-1 3/73|1| 77|Rn-222 gas|4000|working level months|Inhalation| Inhaled over 2 m at 4800 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-15-43|15|576|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-15|Rn-To-WL 4000,8-1 3/73|1| 77|Rn-222 gas|4000|working level months|Inhalation| Inhaled over 2 m at 4800 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-15-44|15|576|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-15|Rn-To-WL 4000,8-1 3/73|1| 77|Rn-222 gas|4000|working level months|Inhalation| Inhaled over 2 m at 4800 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-15-45|15|576|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-15|Rn-To-WL 4000,8-1 3/73|1| 77|Rn-222 gas|4000|working level months|Inhalation| Inhaled over 2 m at 4800 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-15-46|15|576|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-15|Rn-To-WL 4000,8-1 3/73|1| 77|Rn-222 gas|4000|working level months|Inhalation| Inhaled over 2 m at 4800 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-15-47|15|625|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-15|Rn-To-WL 4000,8-1 3/73|1| 77|Rn-222 gas|4000|working level months|Inhalation| Inhaled over 2 m at 4800 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-15-48|15|643|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-3-15|Rn-To-WL 4000,8-1 3/73|1| 77|Rn-222 gas|4000|working level months|Inhalation| Inhaled over 2 m at 4800 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-15-49|15|650|Inflammation and/or fibrotic diseases|Musculo-skeletal system,MA: 0000011 - connective tissue|,MPATH: 212 - inflammation|
2-3-15|Rn-To-WL 4000,8-1 3/73|1| 77|Rn-222 gas|4000|working level months|Inhalation| Inhaled over 2 m at 4800 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-15-50|15|650|Neoplasia benign|Lower respiratory system,MA: 0000436 - bronchus|,MPATH: 270 - adenoma|
2-3-15|Rn-To-WL 4000,8-1 3/73|2| 77|tobacco smoke||unit code not relevant|Inhalation| inhaled for 350 h|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-15-1|15|7|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-3-15|Rn-To-WL 4000,8-1 3/73|2| 77|tobacco smoke||unit code not relevant|Inhalation| inhaled for 350 h|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-15-2|15|186|Other deterministic changes|Whole body|n/a|
2-3-15|Rn-To-WL 4000,8-1 3/73|2| 77|tobacco smoke||unit code not relevant|Inhalation| inhaled for 350 h|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-15-3|15|216|Other deterministic changes|Whole body|n/a|
2-3-15|Rn-To-WL 4000,8-1 3/73|2| 77|tobacco smoke||unit code not relevant|Inhalation| inhaled for 350 h|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-15-4|15|216|Other deterministic changes|Whole body|n/a|
2-3-15|Rn-To-WL 4000,8-1 3/73|2| 77|tobacco smoke||unit code not relevant|Inhalation| inhaled for 350 h|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-15-5|15|226|Other deterministic changes|Whole body|n/a|
2-3-15|Rn-To-WL 4000,8-1 3/73|2| 77|tobacco smoke||unit code not relevant|Inhalation| inhaled for 350 h|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-15-6|15|229|Other deterministic changes|Whole body|n/a|
2-3-15|Rn-To-WL 4000,8-1 3/73|2| 77|tobacco smoke||unit code not relevant|Inhalation| inhaled for 350 h|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-15-7|15|252|Other deterministic changes|Whole body|n/a|
2-3-15|Rn-To-WL 4000,8-1 3/73|2| 77|tobacco smoke||unit code not relevant|Inhalation| inhaled for 350 h|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-15-8|15|256|Other deterministic changes|Whole body|n/a|
2-3-15|Rn-To-WL 4000,8-1 3/73|2| 77|tobacco smoke||unit code not relevant|Inhalation| inhaled for 350 h|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-15-9|15|263|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-3-15|Rn-To-WL 4000,8-1 3/73|2| 77|tobacco smoke||unit code not relevant|Inhalation| inhaled for 350 h|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-15-10|15|276|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-3-15|Rn-To-WL 4000,8-1 3/73|2| 77|tobacco smoke||unit code not relevant|Inhalation| inhaled for 350 h|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-15-11|15|276|Hyperplastic changes|Lower respiratory system|n/a|
2-3-15|Rn-To-WL 4000,8-1 3/73|2| 77|tobacco smoke||unit code not relevant|Inhalation| inhaled for 350 h|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-15-12|15|276|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-3-15|Rn-To-WL 4000,8-1 3/73|2| 77|tobacco smoke||unit code not relevant|Inhalation| inhaled for 350 h|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-15-13|15|276|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-3-15|Rn-To-WL 4000,8-1 3/73|2| 77|tobacco smoke||unit code not relevant|Inhalation| inhaled for 350 h|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-15-14|15|276|Neoplasia benign|Lower respiratory system,MA: 0000436 - bronchus|,MPATH: 270 - adenoma|
2-3-15|Rn-To-WL 4000,8-1 3/73|2| 77|tobacco smoke||unit code not relevant|Inhalation| inhaled for 350 h|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-15-15|15|276|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-3-15|Rn-To-WL 4000,8-1 3/73|2| 77|tobacco smoke||unit code not relevant|Inhalation| inhaled for 350 h|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-15-16|15|276|Neoplasia benign|Lower respiratory system,MA: 0000436 - bronchus|,MPATH: 270 - adenoma|
2-3-15|Rn-To-WL 4000,8-1 3/73|2| 77|tobacco smoke||unit code not relevant|Inhalation| inhaled for 350 h|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-15-17|15|276|Neoplasia benign|Lower respiratory system,MA: 0000436 - bronchus|,MPATH: 270 - adenoma|
2-3-15|Rn-To-WL 4000,8-1 3/73|2| 77|tobacco smoke||unit code not relevant|Inhalation| inhaled for 350 h|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-15-18|15|276|Hyperplastic changes|Lower respiratory system|n/a|
2-3-15|Rn-To-WL 4000,8-1 3/73|2| 77|tobacco smoke||unit code not relevant|Inhalation| inhaled for 350 h|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-15-19|15|356|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-3-15|Rn-To-WL 4000,8-1 3/73|2| 77|tobacco smoke||unit code not relevant|Inhalation| inhaled for 350 h|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-15-20|15|357|Other deterministic changes|Whole body|n/a|
2-3-15|Rn-To-WL 4000,8-1 3/73|2| 77|tobacco smoke||unit code not relevant|Inhalation| inhaled for 350 h|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-15-21|15|363|Other deterministic changes|Whole body|n/a|
2-3-15|Rn-To-WL 4000,8-1 3/73|2| 77|tobacco smoke||unit code not relevant|Inhalation| inhaled for 350 h|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-15-22|15|365|Other deterministic changes|Whole body|n/a|
2-3-15|Rn-To-WL 4000,8-1 3/73|2| 77|tobacco smoke||unit code not relevant|Inhalation| inhaled for 350 h|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-15-23|15|390|Neoplasia benign|Lower respiratory system,MA: 0000436 - bronchus|,MPATH: 270 - adenoma|
2-3-15|Rn-To-WL 4000,8-1 3/73|2| 77|tobacco smoke||unit code not relevant|Inhalation| inhaled for 350 h|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-15-24|15|427|Neoplasia malignant|Upper respiratory system,MA: 0000442 - upper respiratory tract|,MPATH: 218 - neoplasm|
2-3-15|Rn-To-WL 4000,8-1 3/73|2| 77|tobacco smoke||unit code not relevant|Inhalation| inhaled for 350 h|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-15-25|15|431|Neoplasia benign|Lower respiratory system,MA: 0000436 - bronchus|,MPATH: 270 - adenoma|
2-3-15|Rn-To-WL 4000,8-1 3/73|2| 77|tobacco smoke||unit code not relevant|Inhalation| inhaled for 350 h|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-15-26|15|447|Other deterministic changes|Whole body|n/a|
2-3-15|Rn-To-WL 4000,8-1 3/73|2| 77|tobacco smoke||unit code not relevant|Inhalation| inhaled for 350 h|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-15-27|15|455|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-15|Rn-To-WL 4000,8-1 3/73|2| 77|tobacco smoke||unit code not relevant|Inhalation| inhaled for 350 h|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-15-28|15|467|Preneoplastic changes|Lower respiratory system,MA: 0000422 - bronchiole|,MPATH: 171 - squamous metaplasia|
2-3-15|Rn-To-WL 4000,8-1 3/73|2| 77|tobacco smoke||unit code not relevant|Inhalation| inhaled for 350 h|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-15-29|15|467|Preneoplastic changes|Lower respiratory system,MA: 0000422 - bronchiole|,MPATH: 171 - squamous metaplasia|
2-3-15|Rn-To-WL 4000,8-1 3/73|2| 77|tobacco smoke||unit code not relevant|Inhalation| inhaled for 350 h|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-15-30|15|467|Preneoplastic changes|Lower respiratory system,MA: 0000422 - bronchiole|,MPATH: 171 - squamous metaplasia|
2-3-15|Rn-To-WL 4000,8-1 3/73|2| 77|tobacco smoke||unit code not relevant|Inhalation| inhaled for 350 h|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-15-31|15|467|Preneoplastic changes|Lower respiratory system,MA: 0000422 - bronchiole|,MPATH: 171 - squamous metaplasia|
2-3-15|Rn-To-WL 4000,8-1 3/73|2| 77|tobacco smoke||unit code not relevant|Inhalation| inhaled for 350 h|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-15-32|15|467|Preneoplastic changes|Lower respiratory system,MA: 0000422 - bronchiole|,MPATH: 171 - squamous metaplasia|
2-3-15|Rn-To-WL 4000,8-1 3/73|2| 77|tobacco smoke||unit code not relevant|Inhalation| inhaled for 350 h|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-15-33|15|467|Preneoplastic changes|Lower respiratory system,MA: 0000422 - bronchiole|,MPATH: 171 - squamous metaplasia|
2-3-15|Rn-To-WL 4000,8-1 3/73|2| 77|tobacco smoke||unit code not relevant|Inhalation| inhaled for 350 h|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-15-34|15|467|Neoplasia benign|Lower respiratory system,MA: 0000433 - pleura|,MPATH: 365 - mesothelioma|
2-3-15|Rn-To-WL 4000,8-1 3/73|2| 77|tobacco smoke||unit code not relevant|Inhalation| inhaled for 350 h|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-15-35|15|467|Hyperplastic changes|Lower respiratory system|n/a|
2-3-15|Rn-To-WL 4000,8-1 3/73|2| 77|tobacco smoke||unit code not relevant|Inhalation| inhaled for 350 h|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-15-36|15|485|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-15|Rn-To-WL 4000,8-1 3/73|2| 77|tobacco smoke||unit code not relevant|Inhalation| inhaled for 350 h|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-15-37|15|535|Hyperplastic changes|Lower respiratory system|n/a|
2-3-15|Rn-To-WL 4000,8-1 3/73|2| 77|tobacco smoke||unit code not relevant|Inhalation| inhaled for 350 h|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-15-38|15|545|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-15|Rn-To-WL 4000,8-1 3/73|2| 77|tobacco smoke||unit code not relevant|Inhalation| inhaled for 350 h|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-15-39|15|553|Neoplasia benign|Lower respiratory system,MA: 0000436 - bronchus|,MPATH: 270 - adenoma|
2-3-15|Rn-To-WL 4000,8-1 3/73|2| 77|tobacco smoke||unit code not relevant|Inhalation| inhaled for 350 h|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-15-40|15|561|Hyperplastic changes|Lower respiratory system|n/a|
2-3-15|Rn-To-WL 4000,8-1 3/73|2| 77|tobacco smoke||unit code not relevant|Inhalation| inhaled for 350 h|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-15-41|15|576|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-15|Rn-To-WL 4000,8-1 3/73|2| 77|tobacco smoke||unit code not relevant|Inhalation| inhaled for 350 h|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-15-42|15|576|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-15|Rn-To-WL 4000,8-1 3/73|2| 77|tobacco smoke||unit code not relevant|Inhalation| inhaled for 350 h|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-15-43|15|576|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-15|Rn-To-WL 4000,8-1 3/73|2| 77|tobacco smoke||unit code not relevant|Inhalation| inhaled for 350 h|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-15-44|15|576|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-15|Rn-To-WL 4000,8-1 3/73|2| 77|tobacco smoke||unit code not relevant|Inhalation| inhaled for 350 h|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-15-45|15|576|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-15|Rn-To-WL 4000,8-1 3/73|2| 77|tobacco smoke||unit code not relevant|Inhalation| inhaled for 350 h|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-15-46|15|576|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-15|Rn-To-WL 4000,8-1 3/73|2| 77|tobacco smoke||unit code not relevant|Inhalation| inhaled for 350 h|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-15-47|15|625|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-15|Rn-To-WL 4000,8-1 3/73|2| 77|tobacco smoke||unit code not relevant|Inhalation| inhaled for 350 h|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-15-48|15|643|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-3-15|Rn-To-WL 4000,8-1 3/73|2| 77|tobacco smoke||unit code not relevant|Inhalation| inhaled for 350 h|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-15-49|15|650|Inflammation and/or fibrotic diseases|Musculo-skeletal system,MA: 0000011 - connective tissue|,MPATH: 212 - inflammation|
2-3-15|Rn-To-WL 4000,8-1 3/73|2| 77|tobacco smoke||unit code not relevant|Inhalation| inhaled for 350 h|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-15-50|15|650|Neoplasia benign|Lower respiratory system,MA: 0000436 - bronchus|,MPATH: 270 - adenoma|
2-3-16|Rn-So+80d-WL 1050,30-2 1/78|1| 77|Rn-222 gas|1050|working level months|Inhalation| Inhaled over 0.75 m at 1050 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-16-1|16|28|Other deterministic changes|Lower respiratory system|n/a|
2-3-16|Rn-So+80d-WL 1050,30-2 1/78|1| 77|Rn-222 gas|1050|working level months|Inhalation| Inhaled over 0.75 m at 1050 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-16-2|16|29|Other deterministic changes|Lower respiratory system|n/a|
2-3-16|Rn-So+80d-WL 1050,30-2 1/78|1| 77|Rn-222 gas|1050|working level months|Inhalation| Inhaled over 0.75 m at 1050 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-16-3|16|314|Other deterministic changes|Lower respiratory system|n/a|
2-3-16|Rn-So+80d-WL 1050,30-2 1/78|1| 77|Rn-222 gas|1050|working level months|Inhalation| Inhaled over 0.75 m at 1050 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-16-4|16|493|Other deterministic changes|Lower respiratory system|n/a|
2-3-16|Rn-So+80d-WL 1050,30-2 1/78|1| 77|Rn-222 gas|1050|working level months|Inhalation| Inhaled over 0.75 m at 1050 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-16-5|16|501|Other deterministic changes|Lower respiratory system|n/a|
2-3-16|Rn-So+80d-WL 1050,30-2 1/78|1| 77|Rn-222 gas|1050|working level months|Inhalation| Inhaled over 0.75 m at 1050 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-16-6|16|511|Other deterministic changes|Lower respiratory system|n/a|
2-3-16|Rn-So+80d-WL 1050,30-2 1/78|1| 77|Rn-222 gas|1050|working level months|Inhalation| Inhaled over 0.75 m at 1050 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-16-7|16|542|Other deterministic changes|Lower respiratory system|n/a|
2-3-16|Rn-So+80d-WL 1050,30-2 1/78|1| 77|Rn-222 gas|1050|working level months|Inhalation| Inhaled over 0.75 m at 1050 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-16-8|16|550|Other deterministic changes|Lower respiratory system|n/a|
2-3-16|Rn-So+80d-WL 1050,30-2 1/78|1| 77|Rn-222 gas|1050|working level months|Inhalation| Inhaled over 0.75 m at 1050 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-16-9|16|550|Other deterministic changes|Lower respiratory system|n/a|
2-3-16|Rn-So+80d-WL 1050,30-2 1/78|1| 77|Rn-222 gas|1050|working level months|Inhalation| Inhaled over 0.75 m at 1050 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-16-10|16|566|Other deterministic changes|Lower respiratory system|n/a|
2-3-16|Rn-So+80d-WL 1050,30-2 1/78|1| 77|Rn-222 gas|1050|working level months|Inhalation| Inhaled over 0.75 m at 1050 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-16-11|16|584|Other deterministic changes|Lower respiratory system|n/a|
2-3-16|Rn-So+80d-WL 1050,30-2 1/78|1| 77|Rn-222 gas|1050|working level months|Inhalation| Inhaled over 0.75 m at 1050 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-16-12|16|587|Neoplasia malignant|Integumentary system,MA: 0000151 - skin|,MPATH: 446 - squamous cell carcinoma|
2-3-16|Rn-So+80d-WL 1050,30-2 1/78|1| 77|Rn-222 gas|1050|working level months|Inhalation| Inhaled over 0.75 m at 1050 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-16-13|16|593|Other deterministic changes|Lower respiratory system|n/a|
2-3-16|Rn-So+80d-WL 1050,30-2 1/78|1| 77|Rn-222 gas|1050|working level months|Inhalation| Inhaled over 0.75 m at 1050 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-16-14|16|630|Neoplasia malignant|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 549 - carcinoma|
2-3-16|Rn-So+80d-WL 1050,30-2 1/78|1| 77|Rn-222 gas|1050|working level months|Inhalation| Inhaled over 0.75 m at 1050 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-16-15|16|669|Neoplasia malignant|Lower respiratory system|n/a|
2-3-16|Rn-So+80d-WL 1050,30-2 1/78|1| 77|Rn-222 gas|1050|working level months|Inhalation| Inhaled over 0.75 m at 1050 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-16-16|16|669|Other deterministic changes|Lower respiratory system|n/a|
2-3-16|Rn-So+80d-WL 1050,30-2 1/78|1| 77|Rn-222 gas|1050|working level months|Inhalation| Inhaled over 0.75 m at 1050 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-16-17|16|715|Neoplasia malignant|Pancreas among hepato-pancreatic system diseases,MA: 0000120 - pancreas|,MPATH: 268 - adenocarcinoma|
2-3-16|Rn-So+80d-WL 1050,30-2 1/78|1| 77|Rn-222 gas|1050|working level months|Inhalation| Inhaled over 0.75 m at 1050 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-16-18|16|726|Neoplasia malignant|Lower respiratory system|n/a|
2-3-16|Rn-So+80d-WL 1050,30-2 1/78|1| 77|Rn-222 gas|1050|working level months|Inhalation| Inhaled over 0.75 m at 1050 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-16-19|16|731|Hyperplastic changes|Lower respiratory system|n/a|
2-3-16|Rn-So+80d-WL 1050,30-2 1/78|1| 77|Rn-222 gas|1050|working level months|Inhalation| Inhaled over 0.75 m at 1050 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-16-20|16|754|Other deterministic changes|Lower respiratory system|n/a|
2-3-16|Rn-So+80d-WL 1050,30-2 1/78|1| 77|Rn-222 gas|1050|working level months|Inhalation| Inhaled over 0.75 m at 1050 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-16-21|16|762|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-3-16|Rn-So+80d-WL 1050,30-2 1/78|1| 77|Rn-222 gas|1050|working level months|Inhalation| Inhaled over 0.75 m at 1050 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-16-22|16|773|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-3-16|Rn-So+80d-WL 1050,30-2 1/78|1| 77|Rn-222 gas|1050|working level months|Inhalation| Inhaled over 0.75 m at 1050 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-16-23|16|788|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-16|Rn-So+80d-WL 1050,30-2 1/78|1| 77|Rn-222 gas|1050|working level months|Inhalation| Inhaled over 0.75 m at 1050 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-16-24|16|836|Hyperplastic changes|Lower respiratory system|n/a|
2-3-16|Rn-So+80d-WL 1050,30-2 1/78|1| 77|Rn-222 gas|1050|working level months|Inhalation| Inhaled over 0.75 m at 1050 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-16-25|16|853|Hyperplastic changes|Lower respiratory system|n/a|
2-3-16|Rn-So+80d-WL 1050,30-2 1/78|2| 157|soot||unit code not relevant|Injection, intratracheal| intratrach.|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-16-1|16|28|Other deterministic changes|Lower respiratory system|n/a|
2-3-16|Rn-So+80d-WL 1050,30-2 1/78|2| 157|soot||unit code not relevant|Injection, intratracheal| intratrach.|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-16-2|16|29|Other deterministic changes|Lower respiratory system|n/a|
2-3-16|Rn-So+80d-WL 1050,30-2 1/78|2| 157|soot||unit code not relevant|Injection, intratracheal| intratrach.|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-16-3|16|314|Other deterministic changes|Lower respiratory system|n/a|
2-3-16|Rn-So+80d-WL 1050,30-2 1/78|2| 157|soot||unit code not relevant|Injection, intratracheal| intratrach.|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-16-4|16|493|Other deterministic changes|Lower respiratory system|n/a|
2-3-16|Rn-So+80d-WL 1050,30-2 1/78|2| 157|soot||unit code not relevant|Injection, intratracheal| intratrach.|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-16-5|16|501|Other deterministic changes|Lower respiratory system|n/a|
2-3-16|Rn-So+80d-WL 1050,30-2 1/78|2| 157|soot||unit code not relevant|Injection, intratracheal| intratrach.|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-16-6|16|511|Other deterministic changes|Lower respiratory system|n/a|
2-3-16|Rn-So+80d-WL 1050,30-2 1/78|2| 157|soot||unit code not relevant|Injection, intratracheal| intratrach.|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-16-7|16|542|Other deterministic changes|Lower respiratory system|n/a|
2-3-16|Rn-So+80d-WL 1050,30-2 1/78|2| 157|soot||unit code not relevant|Injection, intratracheal| intratrach.|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-16-8|16|550|Other deterministic changes|Lower respiratory system|n/a|
2-3-16|Rn-So+80d-WL 1050,30-2 1/78|2| 157|soot||unit code not relevant|Injection, intratracheal| intratrach.|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-16-9|16|550|Other deterministic changes|Lower respiratory system|n/a|
2-3-16|Rn-So+80d-WL 1050,30-2 1/78|2| 157|soot||unit code not relevant|Injection, intratracheal| intratrach.|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-16-10|16|566|Other deterministic changes|Lower respiratory system|n/a|
2-3-16|Rn-So+80d-WL 1050,30-2 1/78|2| 157|soot||unit code not relevant|Injection, intratracheal| intratrach.|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-16-11|16|584|Other deterministic changes|Lower respiratory system|n/a|
2-3-16|Rn-So+80d-WL 1050,30-2 1/78|2| 157|soot||unit code not relevant|Injection, intratracheal| intratrach.|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-16-12|16|587|Neoplasia malignant|Integumentary system,MA: 0000151 - skin|,MPATH: 446 - squamous cell carcinoma|
2-3-16|Rn-So+80d-WL 1050,30-2 1/78|2| 157|soot||unit code not relevant|Injection, intratracheal| intratrach.|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-16-13|16|593|Other deterministic changes|Lower respiratory system|n/a|
2-3-16|Rn-So+80d-WL 1050,30-2 1/78|2| 157|soot||unit code not relevant|Injection, intratracheal| intratrach.|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-16-14|16|630|Neoplasia malignant|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 549 - carcinoma|
2-3-16|Rn-So+80d-WL 1050,30-2 1/78|2| 157|soot||unit code not relevant|Injection, intratracheal| intratrach.|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-16-15|16|669|Neoplasia malignant|Lower respiratory system|n/a|
2-3-16|Rn-So+80d-WL 1050,30-2 1/78|2| 157|soot||unit code not relevant|Injection, intratracheal| intratrach.|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-16-16|16|669|Other deterministic changes|Lower respiratory system|n/a|
2-3-16|Rn-So+80d-WL 1050,30-2 1/78|2| 157|soot||unit code not relevant|Injection, intratracheal| intratrach.|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-16-17|16|715|Neoplasia malignant|Pancreas among hepato-pancreatic system diseases,MA: 0000120 - pancreas|,MPATH: 268 - adenocarcinoma|
2-3-16|Rn-So+80d-WL 1050,30-2 1/78|2| 157|soot||unit code not relevant|Injection, intratracheal| intratrach.|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-16-18|16|726|Neoplasia malignant|Lower respiratory system|n/a|
2-3-16|Rn-So+80d-WL 1050,30-2 1/78|2| 157|soot||unit code not relevant|Injection, intratracheal| intratrach.|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-16-19|16|731|Hyperplastic changes|Lower respiratory system|n/a|
2-3-16|Rn-So+80d-WL 1050,30-2 1/78|2| 157|soot||unit code not relevant|Injection, intratracheal| intratrach.|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-16-20|16|754|Other deterministic changes|Lower respiratory system|n/a|
2-3-16|Rn-So+80d-WL 1050,30-2 1/78|2| 157|soot||unit code not relevant|Injection, intratracheal| intratrach.|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-16-21|16|762|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-3-16|Rn-So+80d-WL 1050,30-2 1/78|2| 157|soot||unit code not relevant|Injection, intratracheal| intratrach.|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-16-22|16|773|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-3-16|Rn-So+80d-WL 1050,30-2 1/78|2| 157|soot||unit code not relevant|Injection, intratracheal| intratrach.|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-16-23|16|788|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-16|Rn-So+80d-WL 1050,30-2 1/78|2| 157|soot||unit code not relevant|Injection, intratracheal| intratrach.|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-16-24|16|836|Hyperplastic changes|Lower respiratory system|n/a|
2-3-16|Rn-So+80d-WL 1050,30-2 1/78|2| 157|soot||unit code not relevant|Injection, intratracheal| intratrach.|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-16-25|16|853|Hyperplastic changes|Lower respiratory system|n/a|
2-3-17|Rn-So+82d-WL 1600,S57 G2RS 4/84|Sequence:1, Age:77,Type:Rn-222 gas,Quantity:1600,Unit:working level months,Application:Inhalation, Remarks:Inhaled over 2 m at 3000 WL|56 (0 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|No information on individuals available for this study
2-3-17|Rn-So+82d-WL 1600,S57 G2RS 4/84|Sequence:2, Age:159,Type:soot,Quantity:10,Unit:milligrams,Application:Injection, intratracheal, Remarks:intratrach. 4* 30 d|56 (0 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|No information on individuals available for this study
2-3-18|Rn-So+171d-WL 2100,49/48 1/82|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1.5 m at 1050 WL|90 (90 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-18-1|18|263|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-3-18|Rn-So+171d-WL 2100,49/48 1/82|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1.5 m at 1050 WL|90 (90 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-18-2|18|267|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-3-18|Rn-So+171d-WL 2100,49/48 1/82|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1.5 m at 1050 WL|90 (90 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-18-3|18|270|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-3-18|Rn-So+171d-WL 2100,49/48 1/82|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1.5 m at 1050 WL|90 (90 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-18-4|18|271|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-3-18|Rn-So+171d-WL 2100,49/48 1/82|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1.5 m at 1050 WL|90 (90 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-18-5|18|272|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-3-18|Rn-So+171d-WL 2100,49/48 1/82|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1.5 m at 1050 WL|90 (90 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-18-6|18|272|Other deterministic changes|Lower respiratory system|n/a|
2-3-18|Rn-So+171d-WL 2100,49/48 1/82|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1.5 m at 1050 WL|90 (90 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-18-7|18|274|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-3-18|Rn-So+171d-WL 2100,49/48 1/82|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1.5 m at 1050 WL|90 (90 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-18-8|18|277|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-3-18|Rn-So+171d-WL 2100,49/48 1/82|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1.5 m at 1050 WL|90 (90 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-18-9|18|282|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-3-18|Rn-So+171d-WL 2100,49/48 1/82|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1.5 m at 1050 WL|90 (90 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-18-10|18|283|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-3-18|Rn-So+171d-WL 2100,49/48 1/82|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1.5 m at 1050 WL|90 (90 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-18-11|18|284|Other deterministic changes|Whole body|n/a|
2-3-18|Rn-So+171d-WL 2100,49/48 1/82|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1.5 m at 1050 WL|90 (90 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-18-12|18|286|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-3-18|Rn-So+171d-WL 2100,49/48 1/82|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1.5 m at 1050 WL|90 (90 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-18-13|18|286|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-3-18|Rn-So+171d-WL 2100,49/48 1/82|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1.5 m at 1050 WL|90 (90 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-18-14|18|286|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-3-18|Rn-So+171d-WL 2100,49/48 1/82|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1.5 m at 1050 WL|90 (90 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-18-15|18|286|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-3-18|Rn-So+171d-WL 2100,49/48 1/82|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1.5 m at 1050 WL|90 (90 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-18-16|18|286|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-3-18|Rn-So+171d-WL 2100,49/48 1/82|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1.5 m at 1050 WL|90 (90 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-18-17|18|286|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-3-18|Rn-So+171d-WL 2100,49/48 1/82|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1.5 m at 1050 WL|90 (90 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-18-18|18|286|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-3-18|Rn-So+171d-WL 2100,49/48 1/82|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1.5 m at 1050 WL|90 (90 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-18-19|18|286|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-3-18|Rn-So+171d-WL 2100,49/48 1/82|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1.5 m at 1050 WL|90 (90 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-18-20|18|286|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-3-18|Rn-So+171d-WL 2100,49/48 1/82|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1.5 m at 1050 WL|90 (90 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-18-21|18|286|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-3-18|Rn-So+171d-WL 2100,49/48 1/82|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1.5 m at 1050 WL|90 (90 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-18-22|18|286|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-3-18|Rn-So+171d-WL 2100,49/48 1/82|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1.5 m at 1050 WL|90 (90 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-18-23|18|286|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-3-18|Rn-So+171d-WL 2100,49/48 1/82|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1.5 m at 1050 WL|90 (90 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-18-24|18|286|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-3-18|Rn-So+171d-WL 2100,49/48 1/82|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1.5 m at 1050 WL|90 (90 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-18-25|18|286|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-3-18|Rn-So+171d-WL 2100,49/48 1/82|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1.5 m at 1050 WL|90 (90 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-18-26|18|286|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-3-18|Rn-So+171d-WL 2100,49/48 1/82|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1.5 m at 1050 WL|90 (90 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-18-27|18|286|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-3-18|Rn-So+171d-WL 2100,49/48 1/82|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1.5 m at 1050 WL|90 (90 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-18-28|18|286|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-3-18|Rn-So+171d-WL 2100,49/48 1/82|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1.5 m at 1050 WL|90 (90 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-18-29|18|286|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-3-18|Rn-So+171d-WL 2100,49/48 1/82|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1.5 m at 1050 WL|90 (90 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-18-30|18|286|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-3-18|Rn-So+171d-WL 2100,49/48 1/82|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1.5 m at 1050 WL|90 (90 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-18-31|18|286|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-3-18|Rn-So+171d-WL 2100,49/48 1/82|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1.5 m at 1050 WL|90 (90 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-18-32|18|286|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-3-18|Rn-So+171d-WL 2100,49/48 1/82|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1.5 m at 1050 WL|90 (90 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-18-33|18|286|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-3-18|Rn-So+171d-WL 2100,49/48 1/82|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1.5 m at 1050 WL|90 (90 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-18-34|18|288|Other deterministic changes|Lower respiratory system|n/a|
2-3-18|Rn-So+171d-WL 2100,49/48 1/82|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1.5 m at 1050 WL|90 (90 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-18-35|18|288|Other deterministic changes|Lower respiratory system|n/a|
2-3-18|Rn-So+171d-WL 2100,49/48 1/82|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1.5 m at 1050 WL|90 (90 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-18-36|18|289|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-3-18|Rn-So+171d-WL 2100,49/48 1/82|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1.5 m at 1050 WL|90 (90 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-18-37|18|299|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-3-18|Rn-So+171d-WL 2100,49/48 1/82|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1.5 m at 1050 WL|90 (90 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-18-38|18|299|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-3-18|Rn-So+171d-WL 2100,49/48 1/82|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1.5 m at 1050 WL|90 (90 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-18-39|18|299|Other deterministic changes|Lower respiratory system|n/a|
2-3-18|Rn-So+171d-WL 2100,49/48 1/82|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1.5 m at 1050 WL|90 (90 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-18-40|18|304|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-3-18|Rn-So+171d-WL 2100,49/48 1/82|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1.5 m at 1050 WL|90 (90 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-18-41|18|305|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-3-18|Rn-So+171d-WL 2100,49/48 1/82|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1.5 m at 1050 WL|90 (90 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-18-42|18|309|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-3-18|Rn-So+171d-WL 2100,49/48 1/82|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1.5 m at 1050 WL|90 (90 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-18-43|18|309|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-3-18|Rn-So+171d-WL 2100,49/48 1/82|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1.5 m at 1050 WL|90 (90 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-18-44|18|312|Other deterministic changes|Lower respiratory system|n/a|
2-3-18|Rn-So+171d-WL 2100,49/48 1/82|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1.5 m at 1050 WL|90 (90 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-18-45|18|320|Other deterministic changes|Lower respiratory system|n/a|
2-3-18|Rn-So+171d-WL 2100,49/48 1/82|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1.5 m at 1050 WL|90 (90 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-18-46|18|322|Other deterministic changes|Whole body|n/a|
2-3-18|Rn-So+171d-WL 2100,49/48 1/82|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1.5 m at 1050 WL|90 (90 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-18-47|18|323|Other deterministic changes|Lower respiratory system|n/a|
2-3-18|Rn-So+171d-WL 2100,49/48 1/82|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1.5 m at 1050 WL|90 (90 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-18-48|18|324|Preneoplastic changes|Lower respiratory system,MA: 0000422 - bronchiole|,MPATH: 171 - squamous metaplasia|
2-3-18|Rn-So+171d-WL 2100,49/48 1/82|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1.5 m at 1050 WL|90 (90 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-18-49|18|325|Preneoplastic changes|Lower respiratory system,MA: 0000422 - bronchiole|,MPATH: 171 - squamous metaplasia|
2-3-18|Rn-So+171d-WL 2100,49/48 1/82|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1.5 m at 1050 WL|90 (90 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-18-50|18|327|Preneoplastic changes|Lower respiratory system,MA: 0000422 - bronchiole|,MPATH: 171 - squamous metaplasia|
2-3-18|Rn-So+171d-WL 2100,49/48 1/82|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1.5 m at 1050 WL|90 (90 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-18-51|18|327|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-3-18|Rn-So+171d-WL 2100,49/48 1/82|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1.5 m at 1050 WL|90 (90 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-18-52|18|329|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-3-18|Rn-So+171d-WL 2100,49/48 1/82|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1.5 m at 1050 WL|90 (90 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-18-53|18|330|Other deterministic changes|Lower respiratory system|n/a|
2-3-18|Rn-So+171d-WL 2100,49/48 1/82|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1.5 m at 1050 WL|90 (90 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-18-54|18|334|Other deterministic changes|Lower respiratory system|n/a|
2-3-18|Rn-So+171d-WL 2100,49/48 1/82|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1.5 m at 1050 WL|90 (90 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-18-55|18|334|Other deterministic changes|Lower respiratory system|n/a|
2-3-18|Rn-So+171d-WL 2100,49/48 1/82|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1.5 m at 1050 WL|90 (90 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-18-56|18|335|Other deterministic changes|Lower respiratory system|n/a|
2-3-18|Rn-So+171d-WL 2100,49/48 1/82|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1.5 m at 1050 WL|90 (90 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-18-57|18|336|Other deterministic changes|Whole body|n/a|
2-3-18|Rn-So+171d-WL 2100,49/48 1/82|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1.5 m at 1050 WL|90 (90 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-18-58|18|347|Other deterministic changes|Lower respiratory system|n/a|
2-3-18|Rn-So+171d-WL 2100,49/48 1/82|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1.5 m at 1050 WL|90 (90 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-18-59|18|354|Other deterministic changes|Lower respiratory system|n/a|
2-3-18|Rn-So+171d-WL 2100,49/48 1/82|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1.5 m at 1050 WL|90 (90 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-18-60|18|354|Other deterministic changes|Lower respiratory system|n/a|
2-3-18|Rn-So+171d-WL 2100,49/48 1/82|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1.5 m at 1050 WL|90 (90 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-18-61|18|354|Other deterministic changes|Lower respiratory system|n/a|
2-3-18|Rn-So+171d-WL 2100,49/48 1/82|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1.5 m at 1050 WL|90 (90 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-18-62|18|354|Other deterministic changes|Lower respiratory system|n/a|
2-3-18|Rn-So+171d-WL 2100,49/48 1/82|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1.5 m at 1050 WL|90 (90 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-18-63|18|355|Other deterministic changes|Lower respiratory system|n/a|
2-3-18|Rn-So+171d-WL 2100,49/48 1/82|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1.5 m at 1050 WL|90 (90 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-18-64|18|364|Other deterministic changes|Lower respiratory system|n/a|
2-3-18|Rn-So+171d-WL 2100,49/48 1/82|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1.5 m at 1050 WL|90 (90 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-18-65|18|368|Other deterministic changes|Lower respiratory system|n/a|
2-3-18|Rn-So+171d-WL 2100,49/48 1/82|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1.5 m at 1050 WL|90 (90 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-18-66|18|369|Other deterministic changes|Lower respiratory system|n/a|
2-3-18|Rn-So+171d-WL 2100,49/48 1/82|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1.5 m at 1050 WL|90 (90 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-18-67|18|375|Other deterministic changes|Lower respiratory system|n/a|
2-3-18|Rn-So+171d-WL 2100,49/48 1/82|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1.5 m at 1050 WL|90 (90 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-18-68|18|375|Other deterministic changes|Lower respiratory system|n/a|
2-3-18|Rn-So+171d-WL 2100,49/48 1/82|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1.5 m at 1050 WL|90 (90 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-18-69|18|377|Other deterministic changes|Lower respiratory system|n/a|
2-3-18|Rn-So+171d-WL 2100,49/48 1/82|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1.5 m at 1050 WL|90 (90 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-18-70|18|382|Other deterministic changes|Lower respiratory system|n/a|
2-3-18|Rn-So+171d-WL 2100,49/48 1/82|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1.5 m at 1050 WL|90 (90 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-18-71|18|385|Other deterministic changes|Lower respiratory system|n/a|
2-3-18|Rn-So+171d-WL 2100,49/48 1/82|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1.5 m at 1050 WL|90 (90 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-18-72|18|395|Other deterministic changes|Lower respiratory system|n/a|
2-3-18|Rn-So+171d-WL 2100,49/48 1/82|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1.5 m at 1050 WL|90 (90 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-18-73|18|404|Other deterministic changes|Lower respiratory system|n/a|
2-3-18|Rn-So+171d-WL 2100,49/48 1/82|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1.5 m at 1050 WL|90 (90 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-18-74|18|410|Other deterministic changes|Lower respiratory system|n/a|
2-3-18|Rn-So+171d-WL 2100,49/48 1/82|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1.5 m at 1050 WL|90 (90 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-18-75|18|414|Other deterministic changes|Lower respiratory system|n/a|
2-3-18|Rn-So+171d-WL 2100,49/48 1/82|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1.5 m at 1050 WL|90 (90 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-18-76|18|426|Other deterministic changes|Lower respiratory system|n/a|
2-3-18|Rn-So+171d-WL 2100,49/48 1/82|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1.5 m at 1050 WL|90 (90 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-18-77|18|435|Other deterministic changes|Lower respiratory system|n/a|
2-3-18|Rn-So+171d-WL 2100,49/48 1/82|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1.5 m at 1050 WL|90 (90 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-18-78|18|441|Other deterministic changes|Lower respiratory system|n/a|
2-3-18|Rn-So+171d-WL 2100,49/48 1/82|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1.5 m at 1050 WL|90 (90 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-18-79|18|471|Other deterministic changes|Lower respiratory system|n/a|
2-3-18|Rn-So+171d-WL 2100,49/48 1/82|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1.5 m at 1050 WL|90 (90 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-18-80|18|472|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-18|Rn-So+171d-WL 2100,49/48 1/82|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1.5 m at 1050 WL|90 (90 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-18-81|18|482|Other deterministic changes|Whole body|n/a|
2-3-18|Rn-So+171d-WL 2100,49/48 1/82|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1.5 m at 1050 WL|90 (90 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-18-82|18|501|Other deterministic changes|Lower respiratory system|n/a|
2-3-18|Rn-So+171d-WL 2100,49/48 1/82|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1.5 m at 1050 WL|90 (90 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-18-83|18|523|Other deterministic changes|Lower respiratory system|n/a|
2-3-18|Rn-So+171d-WL 2100,49/48 1/82|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1.5 m at 1050 WL|90 (90 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-18-84|18|547|Other deterministic changes|Lower respiratory system|n/a|
2-3-18|Rn-So+171d-WL 2100,49/48 1/82|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1.5 m at 1050 WL|90 (90 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-18-85|18|560|Other deterministic changes|Lower respiratory system|n/a|
2-3-18|Rn-So+171d-WL 2100,49/48 1/82|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1.5 m at 1050 WL|90 (90 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-18-86|18|560|Other deterministic changes|Lower respiratory system|n/a|
2-3-18|Rn-So+171d-WL 2100,49/48 1/82|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1.5 m at 1050 WL|90 (90 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-18-87|18|560|Other deterministic changes|Lower respiratory system|n/a|
2-3-18|Rn-So+171d-WL 2100,49/48 1/82|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1.5 m at 1050 WL|90 (90 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-18-88|18|579|Other deterministic changes|Whole body|n/a|
2-3-18|Rn-So+171d-WL 2100,49/48 1/82|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1.5 m at 1050 WL|90 (90 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-18-89|18|579|Other deterministic changes|Whole body|n/a|
2-3-18|Rn-So+171d-WL 2100,49/48 1/82|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1.5 m at 1050 WL|90 (90 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-18-90|18|579|Other deterministic changes|Whole body|n/a|
2-3-18|Rn-So+171d-WL 2100,49/48 1/82|2| 248|soot|50|milligrams|Injection, intratracheal| intratrach. 4* 30 d repeat at 277 d|90 (90 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-18-1|18|263|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-3-18|Rn-So+171d-WL 2100,49/48 1/82|2| 248|soot|50|milligrams|Injection, intratracheal| intratrach. 4* 30 d repeat at 277 d|90 (90 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-18-2|18|267|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-3-18|Rn-So+171d-WL 2100,49/48 1/82|2| 248|soot|50|milligrams|Injection, intratracheal| intratrach. 4* 30 d repeat at 277 d|90 (90 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-18-3|18|270|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-3-18|Rn-So+171d-WL 2100,49/48 1/82|2| 248|soot|50|milligrams|Injection, intratracheal| intratrach. 4* 30 d repeat at 277 d|90 (90 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-18-4|18|271|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-3-18|Rn-So+171d-WL 2100,49/48 1/82|2| 248|soot|50|milligrams|Injection, intratracheal| intratrach. 4* 30 d repeat at 277 d|90 (90 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-18-5|18|272|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-3-18|Rn-So+171d-WL 2100,49/48 1/82|2| 248|soot|50|milligrams|Injection, intratracheal| intratrach. 4* 30 d repeat at 277 d|90 (90 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-18-6|18|272|Other deterministic changes|Lower respiratory system|n/a|
2-3-18|Rn-So+171d-WL 2100,49/48 1/82|2| 248|soot|50|milligrams|Injection, intratracheal| intratrach. 4* 30 d repeat at 277 d|90 (90 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-18-7|18|274|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-3-18|Rn-So+171d-WL 2100,49/48 1/82|2| 248|soot|50|milligrams|Injection, intratracheal| intratrach. 4* 30 d repeat at 277 d|90 (90 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-18-8|18|277|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-3-18|Rn-So+171d-WL 2100,49/48 1/82|2| 248|soot|50|milligrams|Injection, intratracheal| intratrach. 4* 30 d repeat at 277 d|90 (90 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-18-9|18|282|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-3-18|Rn-So+171d-WL 2100,49/48 1/82|2| 248|soot|50|milligrams|Injection, intratracheal| intratrach. 4* 30 d repeat at 277 d|90 (90 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-18-10|18|283|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-3-18|Rn-So+171d-WL 2100,49/48 1/82|2| 248|soot|50|milligrams|Injection, intratracheal| intratrach. 4* 30 d repeat at 277 d|90 (90 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-18-11|18|284|Other deterministic changes|Whole body|n/a|
2-3-18|Rn-So+171d-WL 2100,49/48 1/82|2| 248|soot|50|milligrams|Injection, intratracheal| intratrach. 4* 30 d repeat at 277 d|90 (90 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-18-12|18|286|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-3-18|Rn-So+171d-WL 2100,49/48 1/82|2| 248|soot|50|milligrams|Injection, intratracheal| intratrach. 4* 30 d repeat at 277 d|90 (90 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-18-13|18|286|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-3-18|Rn-So+171d-WL 2100,49/48 1/82|2| 248|soot|50|milligrams|Injection, intratracheal| intratrach. 4* 30 d repeat at 277 d|90 (90 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-18-14|18|286|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-3-18|Rn-So+171d-WL 2100,49/48 1/82|2| 248|soot|50|milligrams|Injection, intratracheal| intratrach. 4* 30 d repeat at 277 d|90 (90 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-18-15|18|286|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-3-18|Rn-So+171d-WL 2100,49/48 1/82|2| 248|soot|50|milligrams|Injection, intratracheal| intratrach. 4* 30 d repeat at 277 d|90 (90 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-18-16|18|286|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-3-18|Rn-So+171d-WL 2100,49/48 1/82|2| 248|soot|50|milligrams|Injection, intratracheal| intratrach. 4* 30 d repeat at 277 d|90 (90 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-18-17|18|286|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-3-18|Rn-So+171d-WL 2100,49/48 1/82|2| 248|soot|50|milligrams|Injection, intratracheal| intratrach. 4* 30 d repeat at 277 d|90 (90 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-18-18|18|286|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-3-18|Rn-So+171d-WL 2100,49/48 1/82|2| 248|soot|50|milligrams|Injection, intratracheal| intratrach. 4* 30 d repeat at 277 d|90 (90 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-18-19|18|286|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-3-18|Rn-So+171d-WL 2100,49/48 1/82|2| 248|soot|50|milligrams|Injection, intratracheal| intratrach. 4* 30 d repeat at 277 d|90 (90 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-18-20|18|286|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-3-18|Rn-So+171d-WL 2100,49/48 1/82|2| 248|soot|50|milligrams|Injection, intratracheal| intratrach. 4* 30 d repeat at 277 d|90 (90 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-18-21|18|286|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-3-18|Rn-So+171d-WL 2100,49/48 1/82|2| 248|soot|50|milligrams|Injection, intratracheal| intratrach. 4* 30 d repeat at 277 d|90 (90 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-18-22|18|286|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-3-18|Rn-So+171d-WL 2100,49/48 1/82|2| 248|soot|50|milligrams|Injection, intratracheal| intratrach. 4* 30 d repeat at 277 d|90 (90 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-18-23|18|286|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-3-18|Rn-So+171d-WL 2100,49/48 1/82|2| 248|soot|50|milligrams|Injection, intratracheal| intratrach. 4* 30 d repeat at 277 d|90 (90 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-18-24|18|286|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-3-18|Rn-So+171d-WL 2100,49/48 1/82|2| 248|soot|50|milligrams|Injection, intratracheal| intratrach. 4* 30 d repeat at 277 d|90 (90 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-18-25|18|286|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-3-18|Rn-So+171d-WL 2100,49/48 1/82|2| 248|soot|50|milligrams|Injection, intratracheal| intratrach. 4* 30 d repeat at 277 d|90 (90 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-18-26|18|286|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-3-18|Rn-So+171d-WL 2100,49/48 1/82|2| 248|soot|50|milligrams|Injection, intratracheal| intratrach. 4* 30 d repeat at 277 d|90 (90 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-18-27|18|286|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-3-18|Rn-So+171d-WL 2100,49/48 1/82|2| 248|soot|50|milligrams|Injection, intratracheal| intratrach. 4* 30 d repeat at 277 d|90 (90 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-18-28|18|286|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-3-18|Rn-So+171d-WL 2100,49/48 1/82|2| 248|soot|50|milligrams|Injection, intratracheal| intratrach. 4* 30 d repeat at 277 d|90 (90 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-18-29|18|286|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-3-18|Rn-So+171d-WL 2100,49/48 1/82|2| 248|soot|50|milligrams|Injection, intratracheal| intratrach. 4* 30 d repeat at 277 d|90 (90 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-18-30|18|286|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-3-18|Rn-So+171d-WL 2100,49/48 1/82|2| 248|soot|50|milligrams|Injection, intratracheal| intratrach. 4* 30 d repeat at 277 d|90 (90 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-18-31|18|286|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-3-18|Rn-So+171d-WL 2100,49/48 1/82|2| 248|soot|50|milligrams|Injection, intratracheal| intratrach. 4* 30 d repeat at 277 d|90 (90 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-18-32|18|286|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-3-18|Rn-So+171d-WL 2100,49/48 1/82|2| 248|soot|50|milligrams|Injection, intratracheal| intratrach. 4* 30 d repeat at 277 d|90 (90 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-18-33|18|286|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-3-18|Rn-So+171d-WL 2100,49/48 1/82|2| 248|soot|50|milligrams|Injection, intratracheal| intratrach. 4* 30 d repeat at 277 d|90 (90 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-18-34|18|288|Other deterministic changes|Lower respiratory system|n/a|
2-3-18|Rn-So+171d-WL 2100,49/48 1/82|2| 248|soot|50|milligrams|Injection, intratracheal| intratrach. 4* 30 d repeat at 277 d|90 (90 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-18-35|18|288|Other deterministic changes|Lower respiratory system|n/a|
2-3-18|Rn-So+171d-WL 2100,49/48 1/82|2| 248|soot|50|milligrams|Injection, intratracheal| intratrach. 4* 30 d repeat at 277 d|90 (90 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-18-36|18|289|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-3-18|Rn-So+171d-WL 2100,49/48 1/82|2| 248|soot|50|milligrams|Injection, intratracheal| intratrach. 4* 30 d repeat at 277 d|90 (90 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-18-37|18|299|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-3-18|Rn-So+171d-WL 2100,49/48 1/82|2| 248|soot|50|milligrams|Injection, intratracheal| intratrach. 4* 30 d repeat at 277 d|90 (90 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-18-38|18|299|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-3-18|Rn-So+171d-WL 2100,49/48 1/82|2| 248|soot|50|milligrams|Injection, intratracheal| intratrach. 4* 30 d repeat at 277 d|90 (90 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-18-39|18|299|Other deterministic changes|Lower respiratory system|n/a|
2-3-18|Rn-So+171d-WL 2100,49/48 1/82|2| 248|soot|50|milligrams|Injection, intratracheal| intratrach. 4* 30 d repeat at 277 d|90 (90 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-18-40|18|304|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-3-18|Rn-So+171d-WL 2100,49/48 1/82|2| 248|soot|50|milligrams|Injection, intratracheal| intratrach. 4* 30 d repeat at 277 d|90 (90 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-18-41|18|305|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-3-18|Rn-So+171d-WL 2100,49/48 1/82|2| 248|soot|50|milligrams|Injection, intratracheal| intratrach. 4* 30 d repeat at 277 d|90 (90 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-18-42|18|309|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-3-18|Rn-So+171d-WL 2100,49/48 1/82|2| 248|soot|50|milligrams|Injection, intratracheal| intratrach. 4* 30 d repeat at 277 d|90 (90 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-18-43|18|309|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-3-18|Rn-So+171d-WL 2100,49/48 1/82|2| 248|soot|50|milligrams|Injection, intratracheal| intratrach. 4* 30 d repeat at 277 d|90 (90 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-18-44|18|312|Other deterministic changes|Lower respiratory system|n/a|
2-3-18|Rn-So+171d-WL 2100,49/48 1/82|2| 248|soot|50|milligrams|Injection, intratracheal| intratrach. 4* 30 d repeat at 277 d|90 (90 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-18-45|18|320|Other deterministic changes|Lower respiratory system|n/a|
2-3-18|Rn-So+171d-WL 2100,49/48 1/82|2| 248|soot|50|milligrams|Injection, intratracheal| intratrach. 4* 30 d repeat at 277 d|90 (90 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-18-46|18|322|Other deterministic changes|Whole body|n/a|
2-3-18|Rn-So+171d-WL 2100,49/48 1/82|2| 248|soot|50|milligrams|Injection, intratracheal| intratrach. 4* 30 d repeat at 277 d|90 (90 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-18-47|18|323|Other deterministic changes|Lower respiratory system|n/a|
2-3-18|Rn-So+171d-WL 2100,49/48 1/82|2| 248|soot|50|milligrams|Injection, intratracheal| intratrach. 4* 30 d repeat at 277 d|90 (90 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-18-48|18|324|Preneoplastic changes|Lower respiratory system,MA: 0000422 - bronchiole|,MPATH: 171 - squamous metaplasia|
2-3-18|Rn-So+171d-WL 2100,49/48 1/82|2| 248|soot|50|milligrams|Injection, intratracheal| intratrach. 4* 30 d repeat at 277 d|90 (90 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-18-49|18|325|Preneoplastic changes|Lower respiratory system,MA: 0000422 - bronchiole|,MPATH: 171 - squamous metaplasia|
2-3-18|Rn-So+171d-WL 2100,49/48 1/82|2| 248|soot|50|milligrams|Injection, intratracheal| intratrach. 4* 30 d repeat at 277 d|90 (90 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-18-50|18|327|Preneoplastic changes|Lower respiratory system,MA: 0000422 - bronchiole|,MPATH: 171 - squamous metaplasia|
2-3-18|Rn-So+171d-WL 2100,49/48 1/82|2| 248|soot|50|milligrams|Injection, intratracheal| intratrach. 4* 30 d repeat at 277 d|90 (90 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-18-51|18|327|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-3-18|Rn-So+171d-WL 2100,49/48 1/82|2| 248|soot|50|milligrams|Injection, intratracheal| intratrach. 4* 30 d repeat at 277 d|90 (90 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-18-52|18|329|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-3-18|Rn-So+171d-WL 2100,49/48 1/82|2| 248|soot|50|milligrams|Injection, intratracheal| intratrach. 4* 30 d repeat at 277 d|90 (90 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-18-53|18|330|Other deterministic changes|Lower respiratory system|n/a|
2-3-18|Rn-So+171d-WL 2100,49/48 1/82|2| 248|soot|50|milligrams|Injection, intratracheal| intratrach. 4* 30 d repeat at 277 d|90 (90 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-18-54|18|334|Other deterministic changes|Lower respiratory system|n/a|
2-3-18|Rn-So+171d-WL 2100,49/48 1/82|2| 248|soot|50|milligrams|Injection, intratracheal| intratrach. 4* 30 d repeat at 277 d|90 (90 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-18-55|18|334|Other deterministic changes|Lower respiratory system|n/a|
2-3-18|Rn-So+171d-WL 2100,49/48 1/82|2| 248|soot|50|milligrams|Injection, intratracheal| intratrach. 4* 30 d repeat at 277 d|90 (90 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-18-56|18|335|Other deterministic changes|Lower respiratory system|n/a|
2-3-18|Rn-So+171d-WL 2100,49/48 1/82|2| 248|soot|50|milligrams|Injection, intratracheal| intratrach. 4* 30 d repeat at 277 d|90 (90 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-18-57|18|336|Other deterministic changes|Whole body|n/a|
2-3-18|Rn-So+171d-WL 2100,49/48 1/82|2| 248|soot|50|milligrams|Injection, intratracheal| intratrach. 4* 30 d repeat at 277 d|90 (90 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-18-58|18|347|Other deterministic changes|Lower respiratory system|n/a|
2-3-18|Rn-So+171d-WL 2100,49/48 1/82|2| 248|soot|50|milligrams|Injection, intratracheal| intratrach. 4* 30 d repeat at 277 d|90 (90 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-18-59|18|354|Other deterministic changes|Lower respiratory system|n/a|
2-3-18|Rn-So+171d-WL 2100,49/48 1/82|2| 248|soot|50|milligrams|Injection, intratracheal| intratrach. 4* 30 d repeat at 277 d|90 (90 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-18-60|18|354|Other deterministic changes|Lower respiratory system|n/a|
2-3-18|Rn-So+171d-WL 2100,49/48 1/82|2| 248|soot|50|milligrams|Injection, intratracheal| intratrach. 4* 30 d repeat at 277 d|90 (90 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-18-61|18|354|Other deterministic changes|Lower respiratory system|n/a|
2-3-18|Rn-So+171d-WL 2100,49/48 1/82|2| 248|soot|50|milligrams|Injection, intratracheal| intratrach. 4* 30 d repeat at 277 d|90 (90 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-18-62|18|354|Other deterministic changes|Lower respiratory system|n/a|
2-3-18|Rn-So+171d-WL 2100,49/48 1/82|2| 248|soot|50|milligrams|Injection, intratracheal| intratrach. 4* 30 d repeat at 277 d|90 (90 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-18-63|18|355|Other deterministic changes|Lower respiratory system|n/a|
2-3-18|Rn-So+171d-WL 2100,49/48 1/82|2| 248|soot|50|milligrams|Injection, intratracheal| intratrach. 4* 30 d repeat at 277 d|90 (90 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-18-64|18|364|Other deterministic changes|Lower respiratory system|n/a|
2-3-18|Rn-So+171d-WL 2100,49/48 1/82|2| 248|soot|50|milligrams|Injection, intratracheal| intratrach. 4* 30 d repeat at 277 d|90 (90 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-18-65|18|368|Other deterministic changes|Lower respiratory system|n/a|
2-3-18|Rn-So+171d-WL 2100,49/48 1/82|2| 248|soot|50|milligrams|Injection, intratracheal| intratrach. 4* 30 d repeat at 277 d|90 (90 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-18-66|18|369|Other deterministic changes|Lower respiratory system|n/a|
2-3-18|Rn-So+171d-WL 2100,49/48 1/82|2| 248|soot|50|milligrams|Injection, intratracheal| intratrach. 4* 30 d repeat at 277 d|90 (90 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-18-67|18|375|Other deterministic changes|Lower respiratory system|n/a|
2-3-18|Rn-So+171d-WL 2100,49/48 1/82|2| 248|soot|50|milligrams|Injection, intratracheal| intratrach. 4* 30 d repeat at 277 d|90 (90 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-18-68|18|375|Other deterministic changes|Lower respiratory system|n/a|
2-3-18|Rn-So+171d-WL 2100,49/48 1/82|2| 248|soot|50|milligrams|Injection, intratracheal| intratrach. 4* 30 d repeat at 277 d|90 (90 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-18-69|18|377|Other deterministic changes|Lower respiratory system|n/a|
2-3-18|Rn-So+171d-WL 2100,49/48 1/82|2| 248|soot|50|milligrams|Injection, intratracheal| intratrach. 4* 30 d repeat at 277 d|90 (90 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-18-70|18|382|Other deterministic changes|Lower respiratory system|n/a|
2-3-18|Rn-So+171d-WL 2100,49/48 1/82|2| 248|soot|50|milligrams|Injection, intratracheal| intratrach. 4* 30 d repeat at 277 d|90 (90 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-18-71|18|385|Other deterministic changes|Lower respiratory system|n/a|
2-3-18|Rn-So+171d-WL 2100,49/48 1/82|2| 248|soot|50|milligrams|Injection, intratracheal| intratrach. 4* 30 d repeat at 277 d|90 (90 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-18-72|18|395|Other deterministic changes|Lower respiratory system|n/a|
2-3-18|Rn-So+171d-WL 2100,49/48 1/82|2| 248|soot|50|milligrams|Injection, intratracheal| intratrach. 4* 30 d repeat at 277 d|90 (90 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-18-73|18|404|Other deterministic changes|Lower respiratory system|n/a|
2-3-18|Rn-So+171d-WL 2100,49/48 1/82|2| 248|soot|50|milligrams|Injection, intratracheal| intratrach. 4* 30 d repeat at 277 d|90 (90 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-18-74|18|410|Other deterministic changes|Lower respiratory system|n/a|
2-3-18|Rn-So+171d-WL 2100,49/48 1/82|2| 248|soot|50|milligrams|Injection, intratracheal| intratrach. 4* 30 d repeat at 277 d|90 (90 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-18-75|18|414|Other deterministic changes|Lower respiratory system|n/a|
2-3-18|Rn-So+171d-WL 2100,49/48 1/82|2| 248|soot|50|milligrams|Injection, intratracheal| intratrach. 4* 30 d repeat at 277 d|90 (90 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-18-76|18|426|Other deterministic changes|Lower respiratory system|n/a|
2-3-18|Rn-So+171d-WL 2100,49/48 1/82|2| 248|soot|50|milligrams|Injection, intratracheal| intratrach. 4* 30 d repeat at 277 d|90 (90 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-18-77|18|435|Other deterministic changes|Lower respiratory system|n/a|
2-3-18|Rn-So+171d-WL 2100,49/48 1/82|2| 248|soot|50|milligrams|Injection, intratracheal| intratrach. 4* 30 d repeat at 277 d|90 (90 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-18-78|18|441|Other deterministic changes|Lower respiratory system|n/a|
2-3-18|Rn-So+171d-WL 2100,49/48 1/82|2| 248|soot|50|milligrams|Injection, intratracheal| intratrach. 4* 30 d repeat at 277 d|90 (90 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-18-79|18|471|Other deterministic changes|Lower respiratory system|n/a|
2-3-18|Rn-So+171d-WL 2100,49/48 1/82|2| 248|soot|50|milligrams|Injection, intratracheal| intratrach. 4* 30 d repeat at 277 d|90 (90 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-18-80|18|472|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-18|Rn-So+171d-WL 2100,49/48 1/82|2| 248|soot|50|milligrams|Injection, intratracheal| intratrach. 4* 30 d repeat at 277 d|90 (90 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-18-81|18|482|Other deterministic changes|Whole body|n/a|
2-3-18|Rn-So+171d-WL 2100,49/48 1/82|2| 248|soot|50|milligrams|Injection, intratracheal| intratrach. 4* 30 d repeat at 277 d|90 (90 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-18-82|18|501|Other deterministic changes|Lower respiratory system|n/a|
2-3-18|Rn-So+171d-WL 2100,49/48 1/82|2| 248|soot|50|milligrams|Injection, intratracheal| intratrach. 4* 30 d repeat at 277 d|90 (90 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-18-83|18|523|Other deterministic changes|Lower respiratory system|n/a|
2-3-18|Rn-So+171d-WL 2100,49/48 1/82|2| 248|soot|50|milligrams|Injection, intratracheal| intratrach. 4* 30 d repeat at 277 d|90 (90 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-18-84|18|547|Other deterministic changes|Lower respiratory system|n/a|
2-3-18|Rn-So+171d-WL 2100,49/48 1/82|2| 248|soot|50|milligrams|Injection, intratracheal| intratrach. 4* 30 d repeat at 277 d|90 (90 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-18-85|18|560|Other deterministic changes|Lower respiratory system|n/a|
2-3-18|Rn-So+171d-WL 2100,49/48 1/82|2| 248|soot|50|milligrams|Injection, intratracheal| intratrach. 4* 30 d repeat at 277 d|90 (90 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-18-86|18|560|Other deterministic changes|Lower respiratory system|n/a|
2-3-18|Rn-So+171d-WL 2100,49/48 1/82|2| 248|soot|50|milligrams|Injection, intratracheal| intratrach. 4* 30 d repeat at 277 d|90 (90 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-18-87|18|560|Other deterministic changes|Lower respiratory system|n/a|
2-3-18|Rn-So+171d-WL 2100,49/48 1/82|2| 248|soot|50|milligrams|Injection, intratracheal| intratrach. 4* 30 d repeat at 277 d|90 (90 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-18-88|18|579|Other deterministic changes|Whole body|n/a|
2-3-18|Rn-So+171d-WL 2100,49/48 1/82|2| 248|soot|50|milligrams|Injection, intratracheal| intratrach. 4* 30 d repeat at 277 d|90 (90 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-18-89|18|579|Other deterministic changes|Whole body|n/a|
2-3-18|Rn-So+171d-WL 2100,49/48 1/82|2| 248|soot|50|milligrams|Injection, intratracheal| intratrach. 4* 30 d repeat at 277 d|90 (90 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-18-90|18|579|Other deterministic changes|Whole body|n/a|
2-3-19|Rn-So+30d-WL 2240,36-2 4/79|1| 77|Rn-222 gas|2240|working level months|Inhalation| Inhaled over 2.5 m at 1200 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-19-1|19|358|Other deterministic changes|Lower respiratory system|n/a|
2-3-19|Rn-So+30d-WL 2240,36-2 4/79|1| 77|Rn-222 gas|2240|working level months|Inhalation| Inhaled over 2.5 m at 1200 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-19-2|19|358|Other deterministic changes|Lower respiratory system|n/a|
2-3-19|Rn-So+30d-WL 2240,36-2 4/79|1| 77|Rn-222 gas|2240|working level months|Inhalation| Inhaled over 2.5 m at 1200 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-19-3|19|408|Hyperplastic changes|Lower respiratory system|n/a|
2-3-19|Rn-So+30d-WL 2240,36-2 4/79|1| 77|Rn-222 gas|2240|working level months|Inhalation| Inhaled over 2.5 m at 1200 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-19-4|19|562|Hyperplastic changes|Lower respiratory system|n/a|
2-3-19|Rn-So+30d-WL 2240,36-2 4/79|1| 77|Rn-222 gas|2240|working level months|Inhalation| Inhaled over 2.5 m at 1200 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-19-5|19|570|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-3-19|Rn-So+30d-WL 2240,36-2 4/79|1| 77|Rn-222 gas|2240|working level months|Inhalation| Inhaled over 2.5 m at 1200 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-19-6|19|581|Other deterministic changes|Lower respiratory system|n/a|
2-3-19|Rn-So+30d-WL 2240,36-2 4/79|1| 77|Rn-222 gas|2240|working level months|Inhalation| Inhaled over 2.5 m at 1200 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-19-7|19|645|Hyperplastic changes|Lower respiratory system|n/a|
2-3-19|Rn-So+30d-WL 2240,36-2 4/79|1| 77|Rn-222 gas|2240|working level months|Inhalation| Inhaled over 2.5 m at 1200 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-19-8|19|794|Inflammation and/or fibrotic diseases|Musculo-skeletal system,MA: 0000011 - connective tissue|,MPATH: 212 - inflammation|
2-3-19|Rn-So+30d-WL 2240,36-2 4/79|1| 77|Rn-222 gas|2240|working level months|Inhalation| Inhaled over 2.5 m at 1200 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-19-9|19|885|Inflammation and/or fibrotic diseases|Musculo-skeletal system,MA: 0000011 - connective tissue|,MPATH: 212 - inflammation|
2-3-19|Rn-So+30d-WL 2240,36-2 4/79|1| 77|Rn-222 gas|2240|working level months|Inhalation| Inhaled over 2.5 m at 1200 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-19-10|19|905|Other deterministic changes|Lower respiratory system|n/a|
2-3-19|Rn-So+30d-WL 2240,36-2 4/79|2| 107|soot||unit code not relevant|Injection, intratracheal| intratrach. for 30 d|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-19-1|19|358|Other deterministic changes|Lower respiratory system|n/a|
2-3-19|Rn-So+30d-WL 2240,36-2 4/79|2| 107|soot||unit code not relevant|Injection, intratracheal| intratrach. for 30 d|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-19-2|19|358|Other deterministic changes|Lower respiratory system|n/a|
2-3-19|Rn-So+30d-WL 2240,36-2 4/79|2| 107|soot||unit code not relevant|Injection, intratracheal| intratrach. for 30 d|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-19-3|19|408|Hyperplastic changes|Lower respiratory system|n/a|
2-3-19|Rn-So+30d-WL 2240,36-2 4/79|2| 107|soot||unit code not relevant|Injection, intratracheal| intratrach. for 30 d|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-19-4|19|562|Hyperplastic changes|Lower respiratory system|n/a|
2-3-19|Rn-So+30d-WL 2240,36-2 4/79|2| 107|soot||unit code not relevant|Injection, intratracheal| intratrach. for 30 d|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-19-5|19|570|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-3-19|Rn-So+30d-WL 2240,36-2 4/79|2| 107|soot||unit code not relevant|Injection, intratracheal| intratrach. for 30 d|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-19-6|19|581|Other deterministic changes|Lower respiratory system|n/a|
2-3-19|Rn-So+30d-WL 2240,36-2 4/79|2| 107|soot||unit code not relevant|Injection, intratracheal| intratrach. for 30 d|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-19-7|19|645|Hyperplastic changes|Lower respiratory system|n/a|
2-3-19|Rn-So+30d-WL 2240,36-2 4/79|2| 107|soot||unit code not relevant|Injection, intratracheal| intratrach. for 30 d|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-19-8|19|794|Inflammation and/or fibrotic diseases|Musculo-skeletal system,MA: 0000011 - connective tissue|,MPATH: 212 - inflammation|
2-3-19|Rn-So+30d-WL 2240,36-2 4/79|2| 107|soot||unit code not relevant|Injection, intratracheal| intratrach. for 30 d|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-19-9|19|885|Inflammation and/or fibrotic diseases|Musculo-skeletal system,MA: 0000011 - connective tissue|,MPATH: 212 - inflammation|
2-3-19|Rn-So+30d-WL 2240,36-2 4/79|2| 107|soot||unit code not relevant|Injection, intratracheal| intratrach. for 30 d|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-19-10|19|905|Other deterministic changes|Lower respiratory system|n/a|
2-3-20|Rn-So+80d-WL 3000,31-1 2/78|1| 77|Rn-222 gas|3000|working level months|Inhalation| Inhaled over 2 m at 1500 WL|15 (15 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-20-1|20|56|Other deterministic changes|Lower respiratory system|n/a|
2-3-20|Rn-So+80d-WL 3000,31-1 2/78|1| 77|Rn-222 gas|3000|working level months|Inhalation| Inhaled over 2 m at 1500 WL|15 (15 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-20-2|20|75|Neoplasia malignant|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 549 - carcinoma|
2-3-20|Rn-So+80d-WL 3000,31-1 2/78|1| 77|Rn-222 gas|3000|working level months|Inhalation| Inhaled over 2 m at 1500 WL|15 (15 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-20-3|20|320|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-20|Rn-So+80d-WL 3000,31-1 2/78|1| 77|Rn-222 gas|3000|working level months|Inhalation| Inhaled over 2 m at 1500 WL|15 (15 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-20-4|20|389|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-20|Rn-So+80d-WL 3000,31-1 2/78|1| 77|Rn-222 gas|3000|working level months|Inhalation| Inhaled over 2 m at 1500 WL|15 (15 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-20-5|20|472|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-3-20|Rn-So+80d-WL 3000,31-1 2/78|1| 77|Rn-222 gas|3000|working level months|Inhalation| Inhaled over 2 m at 1500 WL|15 (15 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-20-6|20|529|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-20|Rn-So+80d-WL 3000,31-1 2/78|1| 77|Rn-222 gas|3000|working level months|Inhalation| Inhaled over 2 m at 1500 WL|15 (15 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-20-7|20|556|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
2-3-20|Rn-So+80d-WL 3000,31-1 2/78|1| 77|Rn-222 gas|3000|working level months|Inhalation| Inhaled over 2 m at 1500 WL|15 (15 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-20-8|20|558|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-20|Rn-So+80d-WL 3000,31-1 2/78|1| 77|Rn-222 gas|3000|working level months|Inhalation| Inhaled over 2 m at 1500 WL|15 (15 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-20-9|20|584|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-20|Rn-So+80d-WL 3000,31-1 2/78|1| 77|Rn-222 gas|3000|working level months|Inhalation| Inhaled over 2 m at 1500 WL|15 (15 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-20-10|20|598|Hyperplastic changes|Lower respiratory system|n/a|
2-3-20|Rn-So+80d-WL 3000,31-1 2/78|1| 77|Rn-222 gas|3000|working level months|Inhalation| Inhaled over 2 m at 1500 WL|15 (15 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-20-11|20|636|Hyperplastic changes|Lower respiratory system|n/a|
2-3-20|Rn-So+80d-WL 3000,31-1 2/78|1| 77|Rn-222 gas|3000|working level months|Inhalation| Inhaled over 2 m at 1500 WL|15 (15 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-20-12|20|657|Hyperplastic changes|Lower respiratory system|n/a|
2-3-20|Rn-So+80d-WL 3000,31-1 2/78|1| 77|Rn-222 gas|3000|working level months|Inhalation| Inhaled over 2 m at 1500 WL|15 (15 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-20-13|20|682|Neoplasia malignant|Integumentary system,MA: 0000151 - skin|,MPATH: 446 - squamous cell carcinoma|
2-3-20|Rn-So+80d-WL 3000,31-1 2/78|1| 77|Rn-222 gas|3000|working level months|Inhalation| Inhaled over 2 m at 1500 WL|15 (15 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-20-14|20|682|Hyperplastic changes|Lower respiratory system|n/a|
2-3-20|Rn-So+80d-WL 3000,31-1 2/78|1| 77|Rn-222 gas|3000|working level months|Inhalation| Inhaled over 2 m at 1500 WL|15 (15 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-20-15|20|683|Hyperplastic changes|Lower respiratory system|n/a|
2-3-20|Rn-So+80d-WL 3000,31-1 2/78|2| 107|Diesel soot||unit code not relevant|Injection, intratracheal| intratrach. for 30 d|15 (15 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-20-1|20|56|Other deterministic changes|Lower respiratory system|n/a|
2-3-20|Rn-So+80d-WL 3000,31-1 2/78|2| 107|Diesel soot||unit code not relevant|Injection, intratracheal| intratrach. for 30 d|15 (15 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-20-2|20|75|Neoplasia malignant|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 549 - carcinoma|
2-3-20|Rn-So+80d-WL 3000,31-1 2/78|2| 107|Diesel soot||unit code not relevant|Injection, intratracheal| intratrach. for 30 d|15 (15 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-20-3|20|320|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-20|Rn-So+80d-WL 3000,31-1 2/78|2| 107|Diesel soot||unit code not relevant|Injection, intratracheal| intratrach. for 30 d|15 (15 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-20-4|20|389|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-20|Rn-So+80d-WL 3000,31-1 2/78|2| 107|Diesel soot||unit code not relevant|Injection, intratracheal| intratrach. for 30 d|15 (15 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-20-5|20|472|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-3-20|Rn-So+80d-WL 3000,31-1 2/78|2| 107|Diesel soot||unit code not relevant|Injection, intratracheal| intratrach. for 30 d|15 (15 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-20-6|20|529|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-20|Rn-So+80d-WL 3000,31-1 2/78|2| 107|Diesel soot||unit code not relevant|Injection, intratracheal| intratrach. for 30 d|15 (15 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-20-7|20|556|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
2-3-20|Rn-So+80d-WL 3000,31-1 2/78|2| 107|Diesel soot||unit code not relevant|Injection, intratracheal| intratrach. for 30 d|15 (15 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-20-8|20|558|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-20|Rn-So+80d-WL 3000,31-1 2/78|2| 107|Diesel soot||unit code not relevant|Injection, intratracheal| intratrach. for 30 d|15 (15 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-20-9|20|584|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-20|Rn-So+80d-WL 3000,31-1 2/78|2| 107|Diesel soot||unit code not relevant|Injection, intratracheal| intratrach. for 30 d|15 (15 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-20-10|20|598|Hyperplastic changes|Lower respiratory system|n/a|
2-3-20|Rn-So+80d-WL 3000,31-1 2/78|2| 107|Diesel soot||unit code not relevant|Injection, intratracheal| intratrach. for 30 d|15 (15 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-20-11|20|636|Hyperplastic changes|Lower respiratory system|n/a|
2-3-20|Rn-So+80d-WL 3000,31-1 2/78|2| 107|Diesel soot||unit code not relevant|Injection, intratracheal| intratrach. for 30 d|15 (15 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-20-12|20|657|Hyperplastic changes|Lower respiratory system|n/a|
2-3-20|Rn-So+80d-WL 3000,31-1 2/78|2| 107|Diesel soot||unit code not relevant|Injection, intratracheal| intratrach. for 30 d|15 (15 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-20-13|20|682|Neoplasia malignant|Integumentary system,MA: 0000151 - skin|,MPATH: 446 - squamous cell carcinoma|
2-3-20|Rn-So+80d-WL 3000,31-1 2/78|2| 107|Diesel soot||unit code not relevant|Injection, intratracheal| intratrach. for 30 d|15 (15 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-20-14|20|682|Hyperplastic changes|Lower respiratory system|n/a|
2-3-20|Rn-So+80d-WL 3000,31-1 2/78|2| 107|Diesel soot||unit code not relevant|Injection, intratracheal| intratrach. for 30 d|15 (15 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-20-15|20|683|Hyperplastic changes|Lower respiratory system|n/a|
2-3-21|Rn-SO2-100d-WL 2100,19-2 6/76|1| 155|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-21-1|21|278|Other deterministic changes|Lower respiratory system|n/a|
2-3-21|Rn-SO2-100d-WL 2100,19-2 6/76|1| 155|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-21-2|21|308|Other deterministic changes|Whole body|n/a|
2-3-21|Rn-SO2-100d-WL 2100,19-2 6/76|1| 155|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-21-3|21|361|Other deterministic changes|Whole body|n/a|
2-3-21|Rn-SO2-100d-WL 2100,19-2 6/76|1| 155|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-21-4|21|386|Preneoplastic changes|Lower respiratory system,MA: 0000422 - bronchiole|,MPATH: 171 - squamous metaplasia|
2-3-21|Rn-SO2-100d-WL 2100,19-2 6/76|1| 155|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-21-5|21|430|Other deterministic changes|Whole body|n/a|
2-3-21|Rn-SO2-100d-WL 2100,19-2 6/76|1| 155|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-21-6|21|477|Other deterministic changes|Lower respiratory system|n/a|
2-3-21|Rn-SO2-100d-WL 2100,19-2 6/76|1| 155|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-21-7|21|508|Neoplasia malignant|Urinary system,MA: 0002636 - lower urinary tract|,MPATH: 549 - carcinoma|
2-3-21|Rn-SO2-100d-WL 2100,19-2 6/76|1| 155|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-21-8|21|514|Other deterministic changes|Lower respiratory system|n/a|
2-3-21|Rn-SO2-100d-WL 2100,19-2 6/76|1| 155|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-21-9|21|523|Other deterministic changes|Lower respiratory system|n/a|
2-3-21|Rn-SO2-100d-WL 2100,19-2 6/76|1| 155|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-21-10|21|526|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 409 - fibrous histiocytoma|
2-3-21|Rn-SO2-100d-WL 2100,19-2 6/76|1| 155|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-21-11|21|526|Neoplasia malignant|Pancreas among hepato-pancreatic system diseases,MA: 0000120 - pancreas| benign,MPATH: 268 - adenocarcinoma|
2-3-21|Rn-SO2-100d-WL 2100,19-2 6/76|1| 155|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-21-12|21|529|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-3-21|Rn-SO2-100d-WL 2100,19-2 6/76|1| 155|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-21-13|21|553|Other deterministic changes|Lower respiratory system|n/a|
2-3-21|Rn-SO2-100d-WL 2100,19-2 6/76|1| 155|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-21-14|21|554|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-21|Rn-SO2-100d-WL 2100,19-2 6/76|1| 155|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-21-15|21|574|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-21|Rn-SO2-100d-WL 2100,19-2 6/76|1| 155|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-21-16|21|589|Hyperplastic changes|Lower respiratory system|n/a|
2-3-21|Rn-SO2-100d-WL 2100,19-2 6/76|1| 155|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-21-17|21|596|Hyperplastic changes|Lower respiratory system|n/a|
2-3-21|Rn-SO2-100d-WL 2100,19-2 6/76|1| 155|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-21-18|21|596|Hyperplastic changes|Lower respiratory system|n/a|
2-3-21|Rn-SO2-100d-WL 2100,19-2 6/76|1| 155|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-21-19|21|610|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-21|Rn-SO2-100d-WL 2100,19-2 6/76|1| 155|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-21-20|21|614|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-3-21|Rn-SO2-100d-WL 2100,19-2 6/76|1| 155|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-21-21|21|632|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-3-21|Rn-SO2-100d-WL 2100,19-2 6/76|1| 155|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-21-22|21|637|Other deterministic changes|Lower respiratory system|n/a|
2-3-21|Rn-SO2-100d-WL 2100,19-2 6/76|1| 155|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-21-23|21|638|Other deterministic changes|Lower respiratory system|n/a|
2-3-21|Rn-SO2-100d-WL 2100,19-2 6/76|1| 155|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-21-24|21|638|Neoplasia malignant|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 549 - carcinoma|
2-3-21|Rn-SO2-100d-WL 2100,19-2 6/76|1| 155|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-21-25|21|638|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-21|Rn-SO2-100d-WL 2100,19-2 6/76|1| 155|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-21-26|21|640|Hyperplastic changes|Lower respiratory system|n/a|
2-3-21|Rn-SO2-100d-WL 2100,19-2 6/76|1| 155|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-21-27|21|642|Neoplasia malignant|Lower respiratory system|n/a|
2-3-21|Rn-SO2-100d-WL 2100,19-2 6/76|1| 155|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-21-28|21|642|Neoplasia malignant|Lower respiratory system|n/a|
2-3-21|Rn-SO2-100d-WL 2100,19-2 6/76|1| 155|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-21-29|21|642|Neoplasia malignant|Lower respiratory system|n/a|
2-3-21|Rn-SO2-100d-WL 2100,19-2 6/76|1| 155|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-21-30|21|642|Neoplasia benign|Lower respiratory system,MA: 0000436 - bronchus|,MPATH: 270 - adenoma|
2-3-21|Rn-SO2-100d-WL 2100,19-2 6/76|1| 155|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-21-31|21|659|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-21|Rn-SO2-100d-WL 2100,19-2 6/76|1| 155|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-21-32|21|664|Neoplasia malignant|Lower respiratory system|n/a|
2-3-21|Rn-SO2-100d-WL 2100,19-2 6/76|1| 155|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-21-33|21|665|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-21|Rn-SO2-100d-WL 2100,19-2 6/76|1| 155|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-21-34|21|672|Neoplasia malignant|Lower respiratory system|n/a|
2-3-21|Rn-SO2-100d-WL 2100,19-2 6/76|1| 155|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-21-35|21|678|Neoplasia malignant|Kidney among urinary system diseases,MA: 0000368 - kidney| benign,MPATH: 549 - carcinoma|
2-3-21|Rn-SO2-100d-WL 2100,19-2 6/76|1| 155|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-21-36|21|678|Other deterministic changes|Lower respiratory system|n/a|
2-3-21|Rn-SO2-100d-WL 2100,19-2 6/76|1| 155|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-21-37|21|686|Other deterministic changes|Lower respiratory system|n/a|
2-3-21|Rn-SO2-100d-WL 2100,19-2 6/76|1| 155|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-21-38|21|698|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-21|Rn-SO2-100d-WL 2100,19-2 6/76|1| 155|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-21-39|21|698|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-21|Rn-SO2-100d-WL 2100,19-2 6/76|1| 155|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-21-40|21|698|Neoplasia malignant|Lower respiratory system|n/a|
2-3-21|Rn-SO2-100d-WL 2100,19-2 6/76|2| 55|sulfur dioxide||unit code not relevant|Inhalation| inhaled|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-21-1|21|278|Other deterministic changes|Lower respiratory system|n/a|
2-3-21|Rn-SO2-100d-WL 2100,19-2 6/76|2| 55|sulfur dioxide||unit code not relevant|Inhalation| inhaled|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-21-2|21|308|Other deterministic changes|Whole body|n/a|
2-3-21|Rn-SO2-100d-WL 2100,19-2 6/76|2| 55|sulfur dioxide||unit code not relevant|Inhalation| inhaled|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-21-3|21|361|Other deterministic changes|Whole body|n/a|
2-3-21|Rn-SO2-100d-WL 2100,19-2 6/76|2| 55|sulfur dioxide||unit code not relevant|Inhalation| inhaled|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-21-4|21|386|Preneoplastic changes|Lower respiratory system,MA: 0000422 - bronchiole|,MPATH: 171 - squamous metaplasia|
2-3-21|Rn-SO2-100d-WL 2100,19-2 6/76|2| 55|sulfur dioxide||unit code not relevant|Inhalation| inhaled|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-21-5|21|430|Other deterministic changes|Whole body|n/a|
2-3-21|Rn-SO2-100d-WL 2100,19-2 6/76|2| 55|sulfur dioxide||unit code not relevant|Inhalation| inhaled|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-21-6|21|477|Other deterministic changes|Lower respiratory system|n/a|
2-3-21|Rn-SO2-100d-WL 2100,19-2 6/76|2| 55|sulfur dioxide||unit code not relevant|Inhalation| inhaled|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-21-7|21|508|Neoplasia malignant|Urinary system,MA: 0002636 - lower urinary tract|,MPATH: 549 - carcinoma|
2-3-21|Rn-SO2-100d-WL 2100,19-2 6/76|2| 55|sulfur dioxide||unit code not relevant|Inhalation| inhaled|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-21-8|21|514|Other deterministic changes|Lower respiratory system|n/a|
2-3-21|Rn-SO2-100d-WL 2100,19-2 6/76|2| 55|sulfur dioxide||unit code not relevant|Inhalation| inhaled|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-21-9|21|523|Other deterministic changes|Lower respiratory system|n/a|
2-3-21|Rn-SO2-100d-WL 2100,19-2 6/76|2| 55|sulfur dioxide||unit code not relevant|Inhalation| inhaled|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-21-10|21|526|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 409 - fibrous histiocytoma|
2-3-21|Rn-SO2-100d-WL 2100,19-2 6/76|2| 55|sulfur dioxide||unit code not relevant|Inhalation| inhaled|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-21-11|21|526|Neoplasia malignant|Pancreas among hepato-pancreatic system diseases,MA: 0000120 - pancreas| benign,MPATH: 268 - adenocarcinoma|
2-3-21|Rn-SO2-100d-WL 2100,19-2 6/76|2| 55|sulfur dioxide||unit code not relevant|Inhalation| inhaled|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-21-12|21|529|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-3-21|Rn-SO2-100d-WL 2100,19-2 6/76|2| 55|sulfur dioxide||unit code not relevant|Inhalation| inhaled|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-21-13|21|553|Other deterministic changes|Lower respiratory system|n/a|
2-3-21|Rn-SO2-100d-WL 2100,19-2 6/76|2| 55|sulfur dioxide||unit code not relevant|Inhalation| inhaled|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-21-14|21|554|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-21|Rn-SO2-100d-WL 2100,19-2 6/76|2| 55|sulfur dioxide||unit code not relevant|Inhalation| inhaled|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-21-15|21|574|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-21|Rn-SO2-100d-WL 2100,19-2 6/76|2| 55|sulfur dioxide||unit code not relevant|Inhalation| inhaled|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-21-16|21|589|Hyperplastic changes|Lower respiratory system|n/a|
2-3-21|Rn-SO2-100d-WL 2100,19-2 6/76|2| 55|sulfur dioxide||unit code not relevant|Inhalation| inhaled|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-21-17|21|596|Hyperplastic changes|Lower respiratory system|n/a|
2-3-21|Rn-SO2-100d-WL 2100,19-2 6/76|2| 55|sulfur dioxide||unit code not relevant|Inhalation| inhaled|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-21-18|21|596|Hyperplastic changes|Lower respiratory system|n/a|
2-3-21|Rn-SO2-100d-WL 2100,19-2 6/76|2| 55|sulfur dioxide||unit code not relevant|Inhalation| inhaled|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-21-19|21|610|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-21|Rn-SO2-100d-WL 2100,19-2 6/76|2| 55|sulfur dioxide||unit code not relevant|Inhalation| inhaled|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-21-20|21|614|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-3-21|Rn-SO2-100d-WL 2100,19-2 6/76|2| 55|sulfur dioxide||unit code not relevant|Inhalation| inhaled|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-21-21|21|632|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-3-21|Rn-SO2-100d-WL 2100,19-2 6/76|2| 55|sulfur dioxide||unit code not relevant|Inhalation| inhaled|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-21-22|21|637|Other deterministic changes|Lower respiratory system|n/a|
2-3-21|Rn-SO2-100d-WL 2100,19-2 6/76|2| 55|sulfur dioxide||unit code not relevant|Inhalation| inhaled|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-21-23|21|638|Other deterministic changes|Lower respiratory system|n/a|
2-3-21|Rn-SO2-100d-WL 2100,19-2 6/76|2| 55|sulfur dioxide||unit code not relevant|Inhalation| inhaled|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-21-24|21|638|Neoplasia malignant|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 549 - carcinoma|
2-3-21|Rn-SO2-100d-WL 2100,19-2 6/76|2| 55|sulfur dioxide||unit code not relevant|Inhalation| inhaled|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-21-25|21|638|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-21|Rn-SO2-100d-WL 2100,19-2 6/76|2| 55|sulfur dioxide||unit code not relevant|Inhalation| inhaled|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-21-26|21|640|Hyperplastic changes|Lower respiratory system|n/a|
2-3-21|Rn-SO2-100d-WL 2100,19-2 6/76|2| 55|sulfur dioxide||unit code not relevant|Inhalation| inhaled|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-21-27|21|642|Neoplasia malignant|Lower respiratory system|n/a|
2-3-21|Rn-SO2-100d-WL 2100,19-2 6/76|2| 55|sulfur dioxide||unit code not relevant|Inhalation| inhaled|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-21-28|21|642|Neoplasia malignant|Lower respiratory system|n/a|
2-3-21|Rn-SO2-100d-WL 2100,19-2 6/76|2| 55|sulfur dioxide||unit code not relevant|Inhalation| inhaled|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-21-29|21|642|Neoplasia malignant|Lower respiratory system|n/a|
2-3-21|Rn-SO2-100d-WL 2100,19-2 6/76|2| 55|sulfur dioxide||unit code not relevant|Inhalation| inhaled|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-21-30|21|642|Neoplasia benign|Lower respiratory system,MA: 0000436 - bronchus|,MPATH: 270 - adenoma|
2-3-21|Rn-SO2-100d-WL 2100,19-2 6/76|2| 55|sulfur dioxide||unit code not relevant|Inhalation| inhaled|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-21-31|21|659|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-21|Rn-SO2-100d-WL 2100,19-2 6/76|2| 55|sulfur dioxide||unit code not relevant|Inhalation| inhaled|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-21-32|21|664|Neoplasia malignant|Lower respiratory system|n/a|
2-3-21|Rn-SO2-100d-WL 2100,19-2 6/76|2| 55|sulfur dioxide||unit code not relevant|Inhalation| inhaled|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-21-33|21|665|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-21|Rn-SO2-100d-WL 2100,19-2 6/76|2| 55|sulfur dioxide||unit code not relevant|Inhalation| inhaled|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-21-34|21|672|Neoplasia malignant|Lower respiratory system|n/a|
2-3-21|Rn-SO2-100d-WL 2100,19-2 6/76|2| 55|sulfur dioxide||unit code not relevant|Inhalation| inhaled|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-21-35|21|678|Neoplasia malignant|Kidney among urinary system diseases,MA: 0000368 - kidney| benign,MPATH: 549 - carcinoma|
2-3-21|Rn-SO2-100d-WL 2100,19-2 6/76|2| 55|sulfur dioxide||unit code not relevant|Inhalation| inhaled|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-21-36|21|678|Other deterministic changes|Lower respiratory system|n/a|
2-3-21|Rn-SO2-100d-WL 2100,19-2 6/76|2| 55|sulfur dioxide||unit code not relevant|Inhalation| inhaled|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-21-37|21|686|Other deterministic changes|Lower respiratory system|n/a|
2-3-21|Rn-SO2-100d-WL 2100,19-2 6/76|2| 55|sulfur dioxide||unit code not relevant|Inhalation| inhaled|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-21-38|21|698|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-21|Rn-SO2-100d-WL 2100,19-2 6/76|2| 55|sulfur dioxide||unit code not relevant|Inhalation| inhaled|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-21-39|21|698|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-21|Rn-SO2-100d-WL 2100,19-2 6/76|2| 55|sulfur dioxide||unit code not relevant|Inhalation| inhaled|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-21-40|21|698|Neoplasia malignant|Lower respiratory system|n/a|
2-3-22|Rn-SO2+150d-WL 2100,19-1 6/76|1| 155|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-22-1|22|320|Other deterministic changes|Lower respiratory system|n/a|
2-3-22|Rn-SO2+150d-WL 2100,19-1 6/76|1| 155|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-22-2|22|435|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system| benign,MPATH: 408 - soft tissue fibrosarcoma|
2-3-22|Rn-SO2+150d-WL 2100,19-1 6/76|1| 155|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-22-3|22|443|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-3-22|Rn-SO2+150d-WL 2100,19-1 6/76|1| 155|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-22-4|22|453|Other deterministic changes|Whole body|n/a|
2-3-22|Rn-SO2+150d-WL 2100,19-1 6/76|1| 155|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-22-5|22|498|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-3-22|Rn-SO2+150d-WL 2100,19-1 6/76|1| 155|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-22-6|22|523|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-3-22|Rn-SO2+150d-WL 2100,19-1 6/76|1| 155|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-22-7|22|523|Other deterministic changes|Whole body|n/a|
2-3-22|Rn-SO2+150d-WL 2100,19-1 6/76|1| 155|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-22-8|22|525|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-3-22|Rn-SO2+150d-WL 2100,19-1 6/76|1| 155|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-22-9|22|530|Neoplasia malignant|Integumentary system,MA: 0000151 - skin|,MPATH: 446 - squamous cell carcinoma|
2-3-22|Rn-SO2+150d-WL 2100,19-1 6/76|1| 155|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-22-10|22|583|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-22|Rn-SO2+150d-WL 2100,19-1 6/76|1| 155|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-22-11|22|583|Neoplasia malignant|Lower respiratory system|n/a|
2-3-22|Rn-SO2+150d-WL 2100,19-1 6/76|1| 155|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-22-12|22|606|Neoplasia benign|Lower respiratory system|n/a|
2-3-22|Rn-SO2+150d-WL 2100,19-1 6/76|1| 155|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-22-13|22|612|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland|,MPATH: 218 - neoplasm|
2-3-22|Rn-SO2+150d-WL 2100,19-1 6/76|1| 155|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-22-14|22|613|Other deterministic changes|Lower respiratory system|n/a|
2-3-22|Rn-SO2+150d-WL 2100,19-1 6/76|1| 155|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-22-15|22|633|Neoplasia benign|Lower respiratory system|n/a|
2-3-22|Rn-SO2+150d-WL 2100,19-1 6/76|1| 155|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-22-16|22|633|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-3-22|Rn-SO2+150d-WL 2100,19-1 6/76|1| 155|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-22-17|22|682|Neoplasia malignant|Lower respiratory system|n/a|
2-3-22|Rn-SO2+150d-WL 2100,19-1 6/76|1| 155|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-22-18|22|682|Other deterministic changes|Lower respiratory system|n/a|
2-3-22|Rn-SO2+150d-WL 2100,19-1 6/76|1| 155|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-22-19|22|703|Neoplasia malignant|Lower respiratory system|n/a|
2-3-22|Rn-SO2+150d-WL 2100,19-1 6/76|1| 155|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-22-20|22|719|Neoplasia malignant|Lower respiratory system|n/a|
2-3-22|Rn-SO2+150d-WL 2100,19-1 6/76|1| 155|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-22-21|22|725|Changes due to an abnormal circulation|Bloodvessels among cardiovascular system|n/a|
2-3-22|Rn-SO2+150d-WL 2100,19-1 6/76|1| 155|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-22-22|22|733|Neoplasia malignant|Lymphatic vessels among cardiovascular system| benign|
2-3-22|Rn-SO2+150d-WL 2100,19-1 6/76|1| 155|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-22-23|22|740|Neoplasia malignant|Lower respiratory system|n/a|
2-3-22|Rn-SO2+150d-WL 2100,19-1 6/76|1| 155|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-22-24|22|740|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-3-22|Rn-SO2+150d-WL 2100,19-1 6/76|1| 155|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-22-25|22|742|Neoplasia malignant|Lower respiratory system|n/a|
2-3-22|Rn-SO2+150d-WL 2100,19-1 6/76|1| 155|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-22-26|22|742|Neoplasia malignant|Lower respiratory system|n/a|
2-3-22|Rn-SO2+150d-WL 2100,19-1 6/76|1| 155|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-22-27|22|750|Neoplasia malignant|Lower respiratory system|n/a|
2-3-22|Rn-SO2+150d-WL 2100,19-1 6/76|1| 155|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-22-28|22|759|Hyperplastic changes|Lower respiratory system|n/a|
2-3-22|Rn-SO2+150d-WL 2100,19-1 6/76|1| 155|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-22-29|22|764|Neoplasia malignant|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 549 - carcinoma|
2-3-22|Rn-SO2+150d-WL 2100,19-1 6/76|1| 155|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-22-30|22|764|Neoplasia benign|Lower respiratory system|n/a|
2-3-22|Rn-SO2+150d-WL 2100,19-1 6/76|1| 155|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-22-31|22|764|Neoplasia malignant|Spleen and thymus  among haematolymphatic system|n/a|
2-3-22|Rn-SO2+150d-WL 2100,19-1 6/76|1| 155|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-22-32|22|774|Neoplasia benign|Lower respiratory system|n/a|
2-3-22|Rn-SO2+150d-WL 2100,19-1 6/76|1| 155|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-22-33|22|779|Neoplasia malignant|Lower respiratory system|n/a|
2-3-22|Rn-SO2+150d-WL 2100,19-1 6/76|1| 155|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-22-34|22|782|Other deterministic changes|Lower respiratory system|n/a|
2-3-22|Rn-SO2+150d-WL 2100,19-1 6/76|1| 155|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-22-35|22|795|Neoplasia malignant|Other local manifestations and miscellaneus| benign|
2-3-22|Rn-SO2+150d-WL 2100,19-1 6/76|1| 155|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-22-36|22|796|Neoplasia malignant|Lower respiratory system|n/a|
2-3-22|Rn-SO2+150d-WL 2100,19-1 6/76|1| 155|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-22-37|22|814|Neoplasia benign|Lower respiratory system|n/a|
2-3-22|Rn-SO2+150d-WL 2100,19-1 6/76|1| 155|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-22-38|22|814|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-22|Rn-SO2+150d-WL 2100,19-1 6/76|1| 155|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-22-39|22|814|Hyperplastic changes|Lower respiratory system|n/a|
2-3-22|Rn-SO2+150d-WL 2100,19-1 6/76|1| 155|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-22-40|22|814|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-22|Rn-SO2+150d-WL 2100,19-1 6/76|2| 305|sulfur dioxide||unit code not relevant|Inhalation| inhaled|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-22-1|22|320|Other deterministic changes|Lower respiratory system|n/a|
2-3-22|Rn-SO2+150d-WL 2100,19-1 6/76|2| 305|sulfur dioxide||unit code not relevant|Inhalation| inhaled|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-22-2|22|435|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system| benign,MPATH: 408 - soft tissue fibrosarcoma|
2-3-22|Rn-SO2+150d-WL 2100,19-1 6/76|2| 305|sulfur dioxide||unit code not relevant|Inhalation| inhaled|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-22-3|22|443|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-3-22|Rn-SO2+150d-WL 2100,19-1 6/76|2| 305|sulfur dioxide||unit code not relevant|Inhalation| inhaled|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-22-4|22|453|Other deterministic changes|Whole body|n/a|
2-3-22|Rn-SO2+150d-WL 2100,19-1 6/76|2| 305|sulfur dioxide||unit code not relevant|Inhalation| inhaled|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-22-5|22|498|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-3-22|Rn-SO2+150d-WL 2100,19-1 6/76|2| 305|sulfur dioxide||unit code not relevant|Inhalation| inhaled|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-22-6|22|523|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-3-22|Rn-SO2+150d-WL 2100,19-1 6/76|2| 305|sulfur dioxide||unit code not relevant|Inhalation| inhaled|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-22-7|22|523|Other deterministic changes|Whole body|n/a|
2-3-22|Rn-SO2+150d-WL 2100,19-1 6/76|2| 305|sulfur dioxide||unit code not relevant|Inhalation| inhaled|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-22-8|22|525|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-3-22|Rn-SO2+150d-WL 2100,19-1 6/76|2| 305|sulfur dioxide||unit code not relevant|Inhalation| inhaled|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-22-9|22|530|Neoplasia malignant|Integumentary system,MA: 0000151 - skin|,MPATH: 446 - squamous cell carcinoma|
2-3-22|Rn-SO2+150d-WL 2100,19-1 6/76|2| 305|sulfur dioxide||unit code not relevant|Inhalation| inhaled|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-22-10|22|583|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-22|Rn-SO2+150d-WL 2100,19-1 6/76|2| 305|sulfur dioxide||unit code not relevant|Inhalation| inhaled|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-22-11|22|583|Neoplasia malignant|Lower respiratory system|n/a|
2-3-22|Rn-SO2+150d-WL 2100,19-1 6/76|2| 305|sulfur dioxide||unit code not relevant|Inhalation| inhaled|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-22-12|22|606|Neoplasia benign|Lower respiratory system|n/a|
2-3-22|Rn-SO2+150d-WL 2100,19-1 6/76|2| 305|sulfur dioxide||unit code not relevant|Inhalation| inhaled|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-22-13|22|612|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland|,MPATH: 218 - neoplasm|
2-3-22|Rn-SO2+150d-WL 2100,19-1 6/76|2| 305|sulfur dioxide||unit code not relevant|Inhalation| inhaled|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-22-14|22|613|Other deterministic changes|Lower respiratory system|n/a|
2-3-22|Rn-SO2+150d-WL 2100,19-1 6/76|2| 305|sulfur dioxide||unit code not relevant|Inhalation| inhaled|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-22-15|22|633|Neoplasia benign|Lower respiratory system|n/a|
2-3-22|Rn-SO2+150d-WL 2100,19-1 6/76|2| 305|sulfur dioxide||unit code not relevant|Inhalation| inhaled|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-22-16|22|633|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-3-22|Rn-SO2+150d-WL 2100,19-1 6/76|2| 305|sulfur dioxide||unit code not relevant|Inhalation| inhaled|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-22-17|22|682|Neoplasia malignant|Lower respiratory system|n/a|
2-3-22|Rn-SO2+150d-WL 2100,19-1 6/76|2| 305|sulfur dioxide||unit code not relevant|Inhalation| inhaled|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-22-18|22|682|Other deterministic changes|Lower respiratory system|n/a|
2-3-22|Rn-SO2+150d-WL 2100,19-1 6/76|2| 305|sulfur dioxide||unit code not relevant|Inhalation| inhaled|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-22-19|22|703|Neoplasia malignant|Lower respiratory system|n/a|
2-3-22|Rn-SO2+150d-WL 2100,19-1 6/76|2| 305|sulfur dioxide||unit code not relevant|Inhalation| inhaled|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-22-20|22|719|Neoplasia malignant|Lower respiratory system|n/a|
2-3-22|Rn-SO2+150d-WL 2100,19-1 6/76|2| 305|sulfur dioxide||unit code not relevant|Inhalation| inhaled|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-22-21|22|725|Changes due to an abnormal circulation|Bloodvessels among cardiovascular system|n/a|
2-3-22|Rn-SO2+150d-WL 2100,19-1 6/76|2| 305|sulfur dioxide||unit code not relevant|Inhalation| inhaled|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-22-22|22|733|Neoplasia malignant|Lymphatic vessels among cardiovascular system| benign|
2-3-22|Rn-SO2+150d-WL 2100,19-1 6/76|2| 305|sulfur dioxide||unit code not relevant|Inhalation| inhaled|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-22-23|22|740|Neoplasia malignant|Lower respiratory system|n/a|
2-3-22|Rn-SO2+150d-WL 2100,19-1 6/76|2| 305|sulfur dioxide||unit code not relevant|Inhalation| inhaled|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-22-24|22|740|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-3-22|Rn-SO2+150d-WL 2100,19-1 6/76|2| 305|sulfur dioxide||unit code not relevant|Inhalation| inhaled|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-22-25|22|742|Neoplasia malignant|Lower respiratory system|n/a|
2-3-22|Rn-SO2+150d-WL 2100,19-1 6/76|2| 305|sulfur dioxide||unit code not relevant|Inhalation| inhaled|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-22-26|22|742|Neoplasia malignant|Lower respiratory system|n/a|
2-3-22|Rn-SO2+150d-WL 2100,19-1 6/76|2| 305|sulfur dioxide||unit code not relevant|Inhalation| inhaled|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-22-27|22|750|Neoplasia malignant|Lower respiratory system|n/a|
2-3-22|Rn-SO2+150d-WL 2100,19-1 6/76|2| 305|sulfur dioxide||unit code not relevant|Inhalation| inhaled|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-22-28|22|759|Hyperplastic changes|Lower respiratory system|n/a|
2-3-22|Rn-SO2+150d-WL 2100,19-1 6/76|2| 305|sulfur dioxide||unit code not relevant|Inhalation| inhaled|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-22-29|22|764|Neoplasia malignant|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 549 - carcinoma|
2-3-22|Rn-SO2+150d-WL 2100,19-1 6/76|2| 305|sulfur dioxide||unit code not relevant|Inhalation| inhaled|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-22-30|22|764|Neoplasia benign|Lower respiratory system|n/a|
2-3-22|Rn-SO2+150d-WL 2100,19-1 6/76|2| 305|sulfur dioxide||unit code not relevant|Inhalation| inhaled|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-22-31|22|764|Neoplasia malignant|Spleen and thymus  among haematolymphatic system|n/a|
2-3-22|Rn-SO2+150d-WL 2100,19-1 6/76|2| 305|sulfur dioxide||unit code not relevant|Inhalation| inhaled|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-22-32|22|774|Neoplasia benign|Lower respiratory system|n/a|
2-3-22|Rn-SO2+150d-WL 2100,19-1 6/76|2| 305|sulfur dioxide||unit code not relevant|Inhalation| inhaled|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-22-33|22|779|Neoplasia malignant|Lower respiratory system|n/a|
2-3-22|Rn-SO2+150d-WL 2100,19-1 6/76|2| 305|sulfur dioxide||unit code not relevant|Inhalation| inhaled|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-22-34|22|782|Other deterministic changes|Lower respiratory system|n/a|
2-3-22|Rn-SO2+150d-WL 2100,19-1 6/76|2| 305|sulfur dioxide||unit code not relevant|Inhalation| inhaled|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-22-35|22|795|Neoplasia malignant|Other local manifestations and miscellaneus| benign|
2-3-22|Rn-SO2+150d-WL 2100,19-1 6/76|2| 305|sulfur dioxide||unit code not relevant|Inhalation| inhaled|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-22-36|22|796|Neoplasia malignant|Lower respiratory system|n/a|
2-3-22|Rn-SO2+150d-WL 2100,19-1 6/76|2| 305|sulfur dioxide||unit code not relevant|Inhalation| inhaled|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-22-37|22|814|Neoplasia benign|Lower respiratory system|n/a|
2-3-22|Rn-SO2+150d-WL 2100,19-1 6/76|2| 305|sulfur dioxide||unit code not relevant|Inhalation| inhaled|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-22-38|22|814|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-22|Rn-SO2+150d-WL 2100,19-1 6/76|2| 305|sulfur dioxide||unit code not relevant|Inhalation| inhaled|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-22-39|22|814|Hyperplastic changes|Lower respiratory system|n/a|
2-3-22|Rn-SO2+150d-WL 2100,19-1 6/76|2| 305|sulfur dioxide||unit code not relevant|Inhalation| inhaled|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-3-22-40|22|814|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-23|Rn-Tr1-90d-WL 0,22-3 6/76|1| 123|trichlorethylene|100|parts per million|Inhalation| inhal. 90d|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-3-23-1|23|625|Other deterministic changes|Whole body|n/a|
2-3-23|Rn-Tr1-90d-WL 0,22-3 6/76|1| 123|trichlorethylene|100|parts per million|Inhalation| inhal. 90d|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-3-23-2|23|641|Other deterministic changes|Whole body|n/a|
2-3-23|Rn-Tr1-90d-WL 0,22-3 6/76|1| 123|trichlorethylene|100|parts per million|Inhalation| inhal. 90d|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-3-23-3|23|685|Other deterministic changes|Lower respiratory system|n/a|
2-3-23|Rn-Tr1-90d-WL 0,22-3 6/76|1| 123|trichlorethylene|100|parts per million|Inhalation| inhal. 90d|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-3-23-4|23|699|Other deterministic changes|Lower respiratory system|n/a|
2-3-23|Rn-Tr1-90d-WL 0,22-3 6/76|1| 123|trichlorethylene|100|parts per million|Inhalation| inhal. 90d|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-3-23-5|23|774|Other deterministic changes|Whole body|n/a|
2-3-23|Rn-Tr1-90d-WL 0,22-3 6/76|1| 123|trichlorethylene|100|parts per million|Inhalation| inhal. 90d|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-3-23-6|23|778|Other deterministic changes|Lower respiratory system|n/a|
2-3-23|Rn-Tr1-90d-WL 0,22-3 6/76|1| 123|trichlorethylene|100|parts per million|Inhalation| inhal. 90d|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-3-23-7|23|792|Other deterministic changes|Lower respiratory system|n/a|
2-3-23|Rn-Tr1-90d-WL 0,22-3 6/76|1| 123|trichlorethylene|100|parts per million|Inhalation| inhal. 90d|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-3-23-8|23|792|Other deterministic changes|Lower respiratory system|n/a|
2-3-23|Rn-Tr1-90d-WL 0,22-3 6/76|1| 123|trichlorethylene|100|parts per million|Inhalation| inhal. 90d|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-3-23-9|23|792|Other deterministic changes|Lower respiratory system|n/a|
2-3-23|Rn-Tr1-90d-WL 0,22-3 6/76|1| 123|trichlorethylene|100|parts per million|Inhalation| inhal. 90d|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-3-23-10|23|792|Other deterministic changes|Lower respiratory system|n/a|
2-3-23|Rn-Tr1-90d-WL 0,22-3 6/76|1| 123|trichlorethylene|100|parts per million|Inhalation| inhal. 90d|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-3-23-11|23|808|Other deterministic changes|Lower respiratory system|n/a|
2-3-23|Rn-Tr1-90d-WL 0,22-3 6/76|1| 123|trichlorethylene|100|parts per million|Inhalation| inhal. 90d|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-3-23-12|23|812|Neoplasia malignant|Lower respiratory system|n/a|
2-3-23|Rn-Tr1-90d-WL 0,22-3 6/76|1| 123|trichlorethylene|100|parts per million|Inhalation| inhal. 90d|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-3-23-13|23|813|Other deterministic changes|Lower respiratory system|n/a|
2-3-23|Rn-Tr1-90d-WL 0,22-3 6/76|1| 123|trichlorethylene|100|parts per million|Inhalation| inhal. 90d|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-3-23-14|23|813|Other deterministic changes|Lower respiratory system|n/a|
2-3-23|Rn-Tr1-90d-WL 0,22-3 6/76|1| 123|trichlorethylene|100|parts per million|Inhalation| inhal. 90d|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-3-23-15|23|820|Other deterministic changes|Lower respiratory system|n/a|
2-3-23|Rn-Tr1-90d-WL 0,22-3 6/76|1| 123|trichlorethylene|100|parts per million|Inhalation| inhal. 90d|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-3-23-16|23|840|Other deterministic changes|Lower respiratory system|n/a|
2-3-23|Rn-Tr1-90d-WL 0,22-3 6/76|1| 123|trichlorethylene|100|parts per million|Inhalation| inhal. 90d|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-3-23-17|23|860|Other deterministic changes|Lower respiratory system|n/a|
2-3-23|Rn-Tr1-90d-WL 0,22-3 6/76|1| 123|trichlorethylene|100|parts per million|Inhalation| inhal. 90d|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-3-23-18|23|906|Other deterministic changes|Lower respiratory system|n/a|
2-3-23|Rn-Tr1-90d-WL 0,22-3 6/76|1| 123|trichlorethylene|100|parts per million|Inhalation| inhal. 90d|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-3-23-19|23|913|Other deterministic changes|Lower respiratory system|n/a|
2-3-23|Rn-Tr1-90d-WL 0,22-3 6/76|1| 123|trichlorethylene|100|parts per million|Inhalation| inhal. 90d|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-3-23-20|23|932|Other deterministic changes|Lower respiratory system|n/a|
2-3-24|Rn-Tr5-90d-WL 0,22-6 6/76|2| 123|trichlorethylene|500|parts per million|Inhalation| inhal. 90d|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-3-24-1|24|11|Other deterministic changes|Lower respiratory system|n/a|
2-3-24|Rn-Tr5-90d-WL 0,22-6 6/76|2| 123|trichlorethylene|500|parts per million|Inhalation| inhal. 90d|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-3-24-2|24|409|Other deterministic changes|Whole body|n/a|
2-3-24|Rn-Tr5-90d-WL 0,22-6 6/76|2| 123|trichlorethylene|500|parts per million|Inhalation| inhal. 90d|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-3-24-3|24|530|Other deterministic changes|Lower respiratory system|n/a|
2-3-24|Rn-Tr5-90d-WL 0,22-6 6/76|2| 123|trichlorethylene|500|parts per million|Inhalation| inhal. 90d|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-3-24-4|24|621|Neoplasia malignant|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 549 - carcinoma|
2-3-24|Rn-Tr5-90d-WL 0,22-6 6/76|2| 123|trichlorethylene|500|parts per million|Inhalation| inhal. 90d|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-3-24-5|24|641|Other deterministic changes|Lower respiratory system|n/a|
2-3-24|Rn-Tr5-90d-WL 0,22-6 6/76|2| 123|trichlorethylene|500|parts per million|Inhalation| inhal. 90d|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-3-24-6|24|668|Other deterministic changes|Lower respiratory system|n/a|
2-3-24|Rn-Tr5-90d-WL 0,22-6 6/76|2| 123|trichlorethylene|500|parts per million|Inhalation| inhal. 90d|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-3-24-7|24|675|Other deterministic changes|Whole body|n/a|
2-3-24|Rn-Tr5-90d-WL 0,22-6 6/76|2| 123|trichlorethylene|500|parts per million|Inhalation| inhal. 90d|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-3-24-8|24|677|Other deterministic changes|Whole body|n/a|
2-3-24|Rn-Tr5-90d-WL 0,22-6 6/76|2| 123|trichlorethylene|500|parts per million|Inhalation| inhal. 90d|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-3-24-9|24|739|Other deterministic changes|Lower respiratory system|n/a|
2-3-24|Rn-Tr5-90d-WL 0,22-6 6/76|2| 123|trichlorethylene|500|parts per million|Inhalation| inhal. 90d|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-3-24-10|24|762|Other deterministic changes|Lower respiratory system|n/a|
2-3-24|Rn-Tr5-90d-WL 0,22-6 6/76|2| 123|trichlorethylene|500|parts per million|Inhalation| inhal. 90d|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-3-24-11|24|777|Other deterministic changes|Lower respiratory system|n/a|
2-3-24|Rn-Tr5-90d-WL 0,22-6 6/76|2| 123|trichlorethylene|500|parts per million|Inhalation| inhal. 90d|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-3-24-12|24|778|Other deterministic changes|Lower respiratory system|n/a|
2-3-24|Rn-Tr5-90d-WL 0,22-6 6/76|2| 123|trichlorethylene|500|parts per million|Inhalation| inhal. 90d|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-3-24-13|24|785|Other deterministic changes|Lower respiratory system|n/a|
2-3-24|Rn-Tr5-90d-WL 0,22-6 6/76|2| 123|trichlorethylene|500|parts per million|Inhalation| inhal. 90d|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-3-24-14|24|813|Other deterministic changes|Lower respiratory system|n/a|
2-3-24|Rn-Tr5-90d-WL 0,22-6 6/76|2| 123|trichlorethylene|500|parts per million|Inhalation| inhal. 90d|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-3-24-15|24|820|Other deterministic changes|Lower respiratory system|n/a|
2-3-24|Rn-Tr5-90d-WL 0,22-6 6/76|2| 123|trichlorethylene|500|parts per million|Inhalation| inhal. 90d|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-3-24-16|24|820|Other deterministic changes|Lower respiratory system|n/a|
2-3-24|Rn-Tr5-90d-WL 0,22-6 6/76|2| 123|trichlorethylene|500|parts per million|Inhalation| inhal. 90d|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-3-24-17|24|820|Other deterministic changes|Lower respiratory system|n/a|
2-3-24|Rn-Tr5-90d-WL 0,22-6 6/76|2| 123|trichlorethylene|500|parts per million|Inhalation| inhal. 90d|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-3-24-18|24|820|Other deterministic changes|Lower respiratory system|n/a|
2-3-24|Rn-Tr5-90d-WL 0,22-6 6/76|2| 123|trichlorethylene|500|parts per million|Inhalation| inhal. 90d|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-3-24-19|24|845|Other deterministic changes|Lower respiratory system|n/a|
2-3-24|Rn-Tr5-90d-WL 0,22-6 6/76|2| 123|trichlorethylene|500|parts per million|Inhalation| inhal. 90d|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-3-24-20|24|857|Other deterministic changes|Lower respiratory system|n/a|
2-3-25|Rn-Tr1-90d-WL 1900,22-2 6/76|1| 213|Rn-222 gas|1900|working level months|Inhalation| Inhaled over 1.5 m at 1500 WL|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-3-25-1|25|20|Other deterministic changes|Lower respiratory system|n/a|
2-3-25|Rn-Tr1-90d-WL 1900,22-2 6/76|1| 213|Rn-222 gas|1900|working level months|Inhalation| Inhaled over 1.5 m at 1500 WL|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-3-25-2|25|617|Other deterministic changes|Lower respiratory system|n/a|
2-3-25|Rn-Tr1-90d-WL 1900,22-2 6/76|1| 213|Rn-222 gas|1900|working level months|Inhalation| Inhaled over 1.5 m at 1500 WL|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-3-25-3|25|643|Other deterministic changes|Lower respiratory system|n/a|
2-3-25|Rn-Tr1-90d-WL 1900,22-2 6/76|1| 213|Rn-222 gas|1900|working level months|Inhalation| Inhaled over 1.5 m at 1500 WL|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-3-25-4|25|667|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
2-3-25|Rn-Tr1-90d-WL 1900,22-2 6/76|1| 213|Rn-222 gas|1900|working level months|Inhalation| Inhaled over 1.5 m at 1500 WL|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-3-25-5|25|684|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-25|Rn-Tr1-90d-WL 1900,22-2 6/76|1| 213|Rn-222 gas|1900|working level months|Inhalation| Inhaled over 1.5 m at 1500 WL|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-3-25-6|25|741|Neoplasia malignant|Spleen and thymus  among haematolymphatic system,MA: 0000141 - spleen|,MPATH: 242 - hemangiosarcoma|
2-3-25|Rn-Tr1-90d-WL 1900,22-2 6/76|1| 213|Rn-222 gas|1900|working level months|Inhalation| Inhaled over 1.5 m at 1500 WL|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-3-25-7|25|766|Hyperplastic changes|Lower respiratory system|n/a|
2-3-25|Rn-Tr1-90d-WL 1900,22-2 6/76|1| 213|Rn-222 gas|1900|working level months|Inhalation| Inhaled over 1.5 m at 1500 WL|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-3-25-8|25|776|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-25|Rn-Tr1-90d-WL 1900,22-2 6/76|1| 213|Rn-222 gas|1900|working level months|Inhalation| Inhaled over 1.5 m at 1500 WL|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-3-25-9|25|776|Hyperplastic changes|Lower respiratory system|n/a|
2-3-25|Rn-Tr1-90d-WL 1900,22-2 6/76|1| 213|Rn-222 gas|1900|working level months|Inhalation| Inhaled over 1.5 m at 1500 WL|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-3-25-10|25|797|Other deterministic changes|Whole body|n/a|
2-3-25|Rn-Tr1-90d-WL 1900,22-2 6/76|1| 213|Rn-222 gas|1900|working level months|Inhalation| Inhaled over 1.5 m at 1500 WL|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-3-25-11|25|808|Other deterministic changes|Lower respiratory system|n/a|
2-3-25|Rn-Tr1-90d-WL 1900,22-2 6/76|1| 213|Rn-222 gas|1900|working level months|Inhalation| Inhaled over 1.5 m at 1500 WL|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-3-25-12|25|808|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-3-25|Rn-Tr1-90d-WL 1900,22-2 6/76|1| 213|Rn-222 gas|1900|working level months|Inhalation| Inhaled over 1.5 m at 1500 WL|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-3-25-13|25|828|Other deterministic changes|Lower respiratory system|n/a|
2-3-25|Rn-Tr1-90d-WL 1900,22-2 6/76|1| 213|Rn-222 gas|1900|working level months|Inhalation| Inhaled over 1.5 m at 1500 WL|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-3-25-14|25|829|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-25|Rn-Tr1-90d-WL 1900,22-2 6/76|1| 213|Rn-222 gas|1900|working level months|Inhalation| Inhaled over 1.5 m at 1500 WL|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-3-25-15|25|835|Other deterministic changes|Lower respiratory system|n/a|
2-3-25|Rn-Tr1-90d-WL 1900,22-2 6/76|1| 213|Rn-222 gas|1900|working level months|Inhalation| Inhaled over 1.5 m at 1500 WL|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-3-25-16|25|868|Other deterministic changes|Lower respiratory system|n/a|
2-3-25|Rn-Tr1-90d-WL 1900,22-2 6/76|1| 213|Rn-222 gas|1900|working level months|Inhalation| Inhaled over 1.5 m at 1500 WL|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-3-25-17|25|914|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-25|Rn-Tr1-90d-WL 1900,22-2 6/76|1| 213|Rn-222 gas|1900|working level months|Inhalation| Inhaled over 1.5 m at 1500 WL|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-3-25-18|25|921|Other deterministic changes|Lower respiratory system|n/a|
2-3-25|Rn-Tr1-90d-WL 1900,22-2 6/76|1| 213|Rn-222 gas|1900|working level months|Inhalation| Inhaled over 1.5 m at 1500 WL|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-3-25-19|25|931|Hyperplastic changes|Lower respiratory system|n/a|
2-3-25|Rn-Tr1-90d-WL 1900,22-2 6/76|1| 213|Rn-222 gas|1900|working level months|Inhalation| Inhaled over 1.5 m at 1500 WL|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-3-25-20|25|970|Other deterministic changes|Lower respiratory system|n/a|
2-3-25|Rn-Tr1-90d-WL 1900,22-2 6/76|2| 123|trichlorethylene|100|parts per million|Inhalation| inhal. 90d|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-3-25-1|25|20|Other deterministic changes|Lower respiratory system|n/a|
2-3-25|Rn-Tr1-90d-WL 1900,22-2 6/76|2| 123|trichlorethylene|100|parts per million|Inhalation| inhal. 90d|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-3-25-2|25|617|Other deterministic changes|Lower respiratory system|n/a|
2-3-25|Rn-Tr1-90d-WL 1900,22-2 6/76|2| 123|trichlorethylene|100|parts per million|Inhalation| inhal. 90d|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-3-25-3|25|643|Other deterministic changes|Lower respiratory system|n/a|
2-3-25|Rn-Tr1-90d-WL 1900,22-2 6/76|2| 123|trichlorethylene|100|parts per million|Inhalation| inhal. 90d|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-3-25-4|25|667|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
2-3-25|Rn-Tr1-90d-WL 1900,22-2 6/76|2| 123|trichlorethylene|100|parts per million|Inhalation| inhal. 90d|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-3-25-5|25|684|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-25|Rn-Tr1-90d-WL 1900,22-2 6/76|2| 123|trichlorethylene|100|parts per million|Inhalation| inhal. 90d|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-3-25-6|25|741|Neoplasia malignant|Spleen and thymus  among haematolymphatic system,MA: 0000141 - spleen|,MPATH: 242 - hemangiosarcoma|
2-3-25|Rn-Tr1-90d-WL 1900,22-2 6/76|2| 123|trichlorethylene|100|parts per million|Inhalation| inhal. 90d|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-3-25-7|25|766|Hyperplastic changes|Lower respiratory system|n/a|
2-3-25|Rn-Tr1-90d-WL 1900,22-2 6/76|2| 123|trichlorethylene|100|parts per million|Inhalation| inhal. 90d|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-3-25-8|25|776|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-25|Rn-Tr1-90d-WL 1900,22-2 6/76|2| 123|trichlorethylene|100|parts per million|Inhalation| inhal. 90d|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-3-25-9|25|776|Hyperplastic changes|Lower respiratory system|n/a|
2-3-25|Rn-Tr1-90d-WL 1900,22-2 6/76|2| 123|trichlorethylene|100|parts per million|Inhalation| inhal. 90d|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-3-25-10|25|797|Other deterministic changes|Whole body|n/a|
2-3-25|Rn-Tr1-90d-WL 1900,22-2 6/76|2| 123|trichlorethylene|100|parts per million|Inhalation| inhal. 90d|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-3-25-11|25|808|Other deterministic changes|Lower respiratory system|n/a|
2-3-25|Rn-Tr1-90d-WL 1900,22-2 6/76|2| 123|trichlorethylene|100|parts per million|Inhalation| inhal. 90d|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-3-25-12|25|808|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-3-25|Rn-Tr1-90d-WL 1900,22-2 6/76|2| 123|trichlorethylene|100|parts per million|Inhalation| inhal. 90d|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-3-25-13|25|828|Other deterministic changes|Lower respiratory system|n/a|
2-3-25|Rn-Tr1-90d-WL 1900,22-2 6/76|2| 123|trichlorethylene|100|parts per million|Inhalation| inhal. 90d|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-3-25-14|25|829|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-25|Rn-Tr1-90d-WL 1900,22-2 6/76|2| 123|trichlorethylene|100|parts per million|Inhalation| inhal. 90d|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-3-25-15|25|835|Other deterministic changes|Lower respiratory system|n/a|
2-3-25|Rn-Tr1-90d-WL 1900,22-2 6/76|2| 123|trichlorethylene|100|parts per million|Inhalation| inhal. 90d|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-3-25-16|25|868|Other deterministic changes|Lower respiratory system|n/a|
2-3-25|Rn-Tr1-90d-WL 1900,22-2 6/76|2| 123|trichlorethylene|100|parts per million|Inhalation| inhal. 90d|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-3-25-17|25|914|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-25|Rn-Tr1-90d-WL 1900,22-2 6/76|2| 123|trichlorethylene|100|parts per million|Inhalation| inhal. 90d|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-3-25-18|25|921|Other deterministic changes|Lower respiratory system|n/a|
2-3-25|Rn-Tr1-90d-WL 1900,22-2 6/76|2| 123|trichlorethylene|100|parts per million|Inhalation| inhal. 90d|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-3-25-19|25|931|Hyperplastic changes|Lower respiratory system|n/a|
2-3-25|Rn-Tr1-90d-WL 1900,22-2 6/76|2| 123|trichlorethylene|100|parts per million|Inhalation| inhal. 90d|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-3-25-20|25|970|Other deterministic changes|Lower respiratory system|n/a|
2-3-26|Rn-Tr5-90d-WL 1900,22-3 6/76|1| 213|Rn-222 gas|1900|working level months|Inhalation| Inhaled over 1.5 m at 1500 WL|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-3-26-1|26|407|Other deterministic changes|Whole body|n/a|
2-3-26|Rn-Tr5-90d-WL 1900,22-3 6/76|1| 213|Rn-222 gas|1900|working level months|Inhalation| Inhaled over 1.5 m at 1500 WL|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-3-26-2|26|568|Other deterministic changes|Whole body|n/a|
2-3-26|Rn-Tr5-90d-WL 1900,22-3 6/76|1| 213|Rn-222 gas|1900|working level months|Inhalation| Inhaled over 1.5 m at 1500 WL|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-3-26-3|26|665|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
2-3-26|Rn-Tr5-90d-WL 1900,22-3 6/76|1| 213|Rn-222 gas|1900|working level months|Inhalation| Inhaled over 1.5 m at 1500 WL|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-3-26-4|26|667|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-26|Rn-Tr5-90d-WL 1900,22-3 6/76|1| 213|Rn-222 gas|1900|working level months|Inhalation| Inhaled over 1.5 m at 1500 WL|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-3-26-5|26|692|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 242 - hemangiosarcoma|
2-3-26|Rn-Tr5-90d-WL 1900,22-3 6/76|1| 213|Rn-222 gas|1900|working level months|Inhalation| Inhaled over 1.5 m at 1500 WL|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-3-26-6|26|726|Other deterministic changes|Whole body|n/a|
2-3-26|Rn-Tr5-90d-WL 1900,22-3 6/76|1| 213|Rn-222 gas|1900|working level months|Inhalation| Inhaled over 1.5 m at 1500 WL|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-3-26-7|26|728|Other deterministic changes|Lower respiratory system|n/a|
2-3-26|Rn-Tr5-90d-WL 1900,22-3 6/76|1| 213|Rn-222 gas|1900|working level months|Inhalation| Inhaled over 1.5 m at 1500 WL|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-3-26-8|26|751|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-26|Rn-Tr5-90d-WL 1900,22-3 6/76|1| 213|Rn-222 gas|1900|working level months|Inhalation| Inhaled over 1.5 m at 1500 WL|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-3-26-9|26|772|Hyperplastic changes|Lower respiratory system|n/a|
2-3-26|Rn-Tr5-90d-WL 1900,22-3 6/76|1| 213|Rn-222 gas|1900|working level months|Inhalation| Inhaled over 1.5 m at 1500 WL|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-3-26-10|26|776|Other deterministic changes|Lower respiratory system|n/a|
2-3-26|Rn-Tr5-90d-WL 1900,22-3 6/76|1| 213|Rn-222 gas|1900|working level months|Inhalation| Inhaled over 1.5 m at 1500 WL|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-3-26-11|26|787|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-3-26|Rn-Tr5-90d-WL 1900,22-3 6/76|1| 213|Rn-222 gas|1900|working level months|Inhalation| Inhaled over 1.5 m at 1500 WL|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-3-26-12|26|788|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-26|Rn-Tr5-90d-WL 1900,22-3 6/76|1| 213|Rn-222 gas|1900|working level months|Inhalation| Inhaled over 1.5 m at 1500 WL|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-3-26-13|26|801|Hyperplastic changes|Lower respiratory system|n/a|
2-3-26|Rn-Tr5-90d-WL 1900,22-3 6/76|1| 213|Rn-222 gas|1900|working level months|Inhalation| Inhaled over 1.5 m at 1500 WL|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-3-26-14|26|801|Neoplasia malignant|Lower respiratory system|n/a|
2-3-26|Rn-Tr5-90d-WL 1900,22-3 6/76|1| 213|Rn-222 gas|1900|working level months|Inhalation| Inhaled over 1.5 m at 1500 WL|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-3-26-15|26|801|Hyperplastic changes|Lower respiratory system|n/a|
2-3-26|Rn-Tr5-90d-WL 1900,22-3 6/76|1| 213|Rn-222 gas|1900|working level months|Inhalation| Inhaled over 1.5 m at 1500 WL|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-3-26-16|26|805|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-3-26|Rn-Tr5-90d-WL 1900,22-3 6/76|1| 213|Rn-222 gas|1900|working level months|Inhalation| Inhaled over 1.5 m at 1500 WL|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-3-26-17|26|829|Other deterministic changes|Lower respiratory system|n/a|
2-3-26|Rn-Tr5-90d-WL 1900,22-3 6/76|1| 213|Rn-222 gas|1900|working level months|Inhalation| Inhaled over 1.5 m at 1500 WL|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-3-26-18|26|833|Inflammation and/or fibrotic diseases|Lower respiratory system,MA: 0000415 - lung|,MPATH: 215 - granulomatous inflammation|
2-3-26|Rn-Tr5-90d-WL 1900,22-3 6/76|1| 213|Rn-222 gas|1900|working level months|Inhalation| Inhaled over 1.5 m at 1500 WL|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-3-26-19|26|908|Other deterministic changes|Lower respiratory system|n/a|
2-3-26|Rn-Tr5-90d-WL 1900,22-3 6/76|1| 213|Rn-222 gas|1900|working level months|Inhalation| Inhaled over 1.5 m at 1500 WL|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-3-26-20|26|914|Other deterministic changes|Lower respiratory system|n/a|
2-3-26|Rn-Tr5-90d-WL 1900,22-3 6/76|2| 123|trichlorethylene|500|parts per million|Inhalation| inhal. 90d|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-3-26-1|26|407|Other deterministic changes|Whole body|n/a|
2-3-26|Rn-Tr5-90d-WL 1900,22-3 6/76|2| 123|trichlorethylene|500|parts per million|Inhalation| inhal. 90d|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-3-26-2|26|568|Other deterministic changes|Whole body|n/a|
2-3-26|Rn-Tr5-90d-WL 1900,22-3 6/76|2| 123|trichlorethylene|500|parts per million|Inhalation| inhal. 90d|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-3-26-3|26|665|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
2-3-26|Rn-Tr5-90d-WL 1900,22-3 6/76|2| 123|trichlorethylene|500|parts per million|Inhalation| inhal. 90d|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-3-26-4|26|667|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-26|Rn-Tr5-90d-WL 1900,22-3 6/76|2| 123|trichlorethylene|500|parts per million|Inhalation| inhal. 90d|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-3-26-5|26|692|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 242 - hemangiosarcoma|
2-3-26|Rn-Tr5-90d-WL 1900,22-3 6/76|2| 123|trichlorethylene|500|parts per million|Inhalation| inhal. 90d|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-3-26-6|26|726|Other deterministic changes|Whole body|n/a|
2-3-26|Rn-Tr5-90d-WL 1900,22-3 6/76|2| 123|trichlorethylene|500|parts per million|Inhalation| inhal. 90d|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-3-26-7|26|728|Other deterministic changes|Lower respiratory system|n/a|
2-3-26|Rn-Tr5-90d-WL 1900,22-3 6/76|2| 123|trichlorethylene|500|parts per million|Inhalation| inhal. 90d|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-3-26-8|26|751|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-26|Rn-Tr5-90d-WL 1900,22-3 6/76|2| 123|trichlorethylene|500|parts per million|Inhalation| inhal. 90d|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-3-26-9|26|772|Hyperplastic changes|Lower respiratory system|n/a|
2-3-26|Rn-Tr5-90d-WL 1900,22-3 6/76|2| 123|trichlorethylene|500|parts per million|Inhalation| inhal. 90d|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-3-26-10|26|776|Other deterministic changes|Lower respiratory system|n/a|
2-3-26|Rn-Tr5-90d-WL 1900,22-3 6/76|2| 123|trichlorethylene|500|parts per million|Inhalation| inhal. 90d|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-3-26-11|26|787|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-3-26|Rn-Tr5-90d-WL 1900,22-3 6/76|2| 123|trichlorethylene|500|parts per million|Inhalation| inhal. 90d|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-3-26-12|26|788|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-3-26|Rn-Tr5-90d-WL 1900,22-3 6/76|2| 123|trichlorethylene|500|parts per million|Inhalation| inhal. 90d|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-3-26-13|26|801|Hyperplastic changes|Lower respiratory system|n/a|
2-3-26|Rn-Tr5-90d-WL 1900,22-3 6/76|2| 123|trichlorethylene|500|parts per million|Inhalation| inhal. 90d|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-3-26-14|26|801|Neoplasia malignant|Lower respiratory system|n/a|
2-3-26|Rn-Tr5-90d-WL 1900,22-3 6/76|2| 123|trichlorethylene|500|parts per million|Inhalation| inhal. 90d|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-3-26-15|26|801|Hyperplastic changes|Lower respiratory system|n/a|
2-3-26|Rn-Tr5-90d-WL 1900,22-3 6/76|2| 123|trichlorethylene|500|parts per million|Inhalation| inhal. 90d|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-3-26-16|26|805|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-3-26|Rn-Tr5-90d-WL 1900,22-3 6/76|2| 123|trichlorethylene|500|parts per million|Inhalation| inhal. 90d|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-3-26-17|26|829|Other deterministic changes|Lower respiratory system|n/a|
2-3-26|Rn-Tr5-90d-WL 1900,22-3 6/76|2| 123|trichlorethylene|500|parts per million|Inhalation| inhal. 90d|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-3-26-18|26|833|Inflammation and/or fibrotic diseases|Lower respiratory system,MA: 0000415 - lung|,MPATH: 215 - granulomatous inflammation|
2-3-26|Rn-Tr5-90d-WL 1900,22-3 6/76|2| 123|trichlorethylene|500|parts per million|Inhalation| inhal. 90d|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-3-26-19|26|908|Other deterministic changes|Lower respiratory system|n/a|
2-3-26|Rn-Tr5-90d-WL 1900,22-3 6/76|2| 123|trichlorethylene|500|parts per million|Inhalation| inhal. 90d|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-3-26-20|26|914|Other deterministic changes|Lower respiratory system|n/a|
		
